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Abstract
Among the classes of organic transformations, cycloaddition reactions constitute a 
powerM and versatile strategy for the rapid assembly of complex polycyclic scaffolds 
in a highly stereoselective fashion. A unique feature of this class of reactions resides 
in the possibility to alter the geometry and coordination number of the metal centre in 
order to increase the reactivity and selectivity of the process. Hence, the development 
of this strategy highlighted the opportunity to synthesize complex molecular 
architectures in a highly convergent and stereoselective manner using mild operating 
conditions, thereby improving the efficiency with respect to atom-economy and 
environmentally benign synthesis. Among the metal-catalysed carbocyclisation 
reactions, the Pauson-Khand (PK) methodology enables the straightforward 
construction of cyclopentenone derivatives from readily available synthons. 
Distinguishing feature of this reaction is the incoiporation of a carbon monoxide unit 
into a polycyclic framework with the production of carbonyl systems that are 
amenable of further functionalisation. In this context, we performed a detailed 
computational analysis of the mechanism of the Rh-catalysed diastereoselective PK 
reaction. This study outlined the possibility to enhance the reactivity of 1,6-enynes 
towards the carbocyclisation through the incorporation of electron-withdrawing 
substituents on the alkyne terminus. Further experimental analysis revealed that the 
employment of a chlorine substituent on the alkyne moiety exerted a beneficial effect 
on the reactivity of 1,6-enynes and thereby provided a novel highly diastereoselective 
Rh-catalysed PK reaction at room temperature. The enhanced reactivity of chlorinated 
1,6-enynes was subsequently exploited in the Rh-catalysed asymmetric PK reaction. 
A detailed optimisation study revealed that the electronic and geometric properties of
iv
chiral bisphosphine ligands exerted a remarkable influence on the reactivity of 1,6- 
enynes towards the carbocyclisation process. Hence, the synergic combination of 
chlorinated 1,6-enynes and SEGPHOS-type bisphosphine ligands allowed a highly 
enantioselective rhodium-catalysed PK reaction of substrates that are generally 
unreactive, such as 1,6-enynes bearing substituents on the alkene position. Hence, 
methodology expanded the synthetic potential of the PK reaction and moreover, 
provided a highly enantioselective construction of bicyclopentenone scaffolds under 
extremely mild operating conditions.
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CHAPTER 1
EXPERIMENTAL AND COMPUTATIONAL STUDIES ON RHODIUM(I)- 
CATALYSED [2+2+1] DIASTEREOSELECTIVE PAUSON-KHAND 
CARBOCYCLISATIONS AT ROOM TEMPERATURE
1.1 Introduction.
1.1.1. Transition Metal-catalysed Carbocyclisation Reactions.
Among the classes of organic transformations, cycloaddition reactions provide an efficient 
and versatile tool for the direct assembly of complex polycyclic scaffolds from simple starting 
materials in a single operation.1 The discovery and implementation of transition metal- 
catalysed cycloaddition reactions has broadened the scope and the versatility of this powerful 
strategy. This allows synthetic processes that either do not occur via classic pericyclic 
reactions or are difficult to accomplish in the absence of a catalyst. A unique feature of this 
class of reactions is the opportunity to tune the geometry and coordination number of the 
metal centre in order to increase the reactivity and selectivity of the process. Hence, the 
development of this strategy highlights the construction of complex molecular architectures in 
a highly convergent and stereoselective manner using milder reaction conditions, thereby 
improving the efficiency with respect to atom-economy and making the process more 
environmentally benign.
In this context, the Pauson-Khand (PK) reaction2 provides an effective strategy for the rapid 
construction of cyclopentenone derivatives from readily available synthons. A distinguishing 
feature of this methodology is the incorporation of a carbon monoxide unit into a polycyclic 
framework with the production of carbonyl systems that are amenable to further synthetic 
elaboration. Since its inception in 1971, the Pauson-Khand reaction3,4 has undergone 
extensive development, thereby gaining wide acceptance as a powerful strategy for the
1
expeditious synthesis of polycyclic structures. A unique feature in the development of this 
method is the ability for rhodium(I) complexes to overcome the use of stoichiometric 
transition metal and promote PK reactions with a high degree of reactivity and 
stereoselectivity. The following dissertation will highlight the overall advancements in this 
process and describe the development of novel computationally-designed and experimentally 
confirmed stereoselective rhodium(I)-catalysed PK reactions.
1.2. The Pauson-Khand Reaction.
1.2.1. Historical Background.
In a preliminary study, Pauson and coworkers disclosed the ability of (alkynyl)- 
hexacarbonyldicobalt complexes to react in presence of norbornadiene and promote the 
formation of arenecobalt derivatives 3 and 4 by reverse Diels-Alder type cleavage or 
displacement of an apical carbon monoxide moiety by the aromatic solvent (Scheme l.l).4
Scheme 1.1. Synthesis of arenecobalt products from (alkynyl)hexacarbonyldicobalt 
complexes.
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r1 = H, R2 = H, Ph, Me, Et reverse Diels-Alder
reaction
In addition to the abovementioned products, further detailed studies revealed the concurrent 
cobalt-catalysed formation of “hydrocarbon and ketonic products from norbornadiene, 
acetylene and carbon monoxide" (Eq. l.l).4
2
a) R1 = H, RZ=H, Me, Ph
b) R1 = R2 = Ph 
C) Ri = r2 = Et
The reaction generally provided a single exo adduct and a single regioisomer was detected 
when monosubstituted alkynes were employed (R1 = H, R2 ^ Me, Ph).3b However, irreversible 
exo-endo isomerisation was observed on norbornadiene derivatives and further confirmed by 
prolonged heating of the originally isolated exo-adduct in presence of dicobalt octacarbonyl.3 
Despite the low intrinsic reactivity and limited substrate scope to symmetrical strained 
alkenes (norbomene and norbornadiene), this unexpected formal [2+2+1] cycloaddition of an 
alkyne, alkene and carbon monoxide furnished an intriguing approach for the construction of 
bicyclopentenone derivatives from readily available starting materials.3b The abovementioned 
process, which is commonly referred to as the Pauson-Khand reaction, has been the subject of 
intensive synthetic studies. The opportunity to exploit a wide array of substituted starting 
materials and, thus, enhance the degree of complexity of the resulting adducts provided a 
significant driving force in the development of new methodologies towards target-oriented 
total synthesis. Nonetheless, the critical challenge to overcome the requirement of 
stoichiometric transition metals and harsh reaction conditions prompted the synthetic organic 
community to explore alternative transition metals and more viable reaction conditions.
In this context, rhodium complexes played a primary role in offering a valid alternative to 
stoichiometric protocols and confer enhanced reactivity and selectivity to the overall 
methodology. This chapter will discuss the relevant aspects related to the pivotal work of 
Pauson and Khand, as well highlighting further advancements within this field. This will 
include the development of catalytic processes, use of alternative transition metals and 
implementation of the Pauson-Khand reaction towards the total synthesis of biologically 
active natural products.
3
1.2.2. Proposed Mechanism of the Pauson-Khand Reaction.
The ability to accurately determine the mechanism of the cobalt-mediated PK reaction has 
been the subject of extensive theoretical and synthetic studies. A critical limitation in the 
understanding of the mechanism resided in the lack of any observable intermediate in the 
process, albeit the initial (alkynyl)hexacarbonyldicobalt species can be isolated as a stable 
tetrahedral bimetallic cluster.5
Scheme 1.2. Postulated mechanism of the cobalt-mediated Pauson-Khand reaction.
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Despite the limited experimental mechanistic data, pivotal studies by Magnus6 and Schore7 
set the basis for the current and widely accepted mechanism of the Co-mediated Pauson- 
Khand reaction (Scheme 1.2). The aforementioned postulated pathway confirmed the initial
4
experimental findings by Pauson and Khand and successfully rationalised the stereochemical 
outcome of the PKR in the context of the total synthesis of polycyclic natural products.6 The 
initial step of the reaction involved displacement of a carbon monoxide molecule from the 
(alkynyl)hexacarbonyldicobalt complex i and the formation of a vacant coordination site. 
Dissociative loss of CO is a highly endothermic process and is commonly regarded as the 
rate-determining step. The olefin insertion step to provide iii is considered to be the stereo- 
and regiochemistry-determining step in the reaction. Additional mechanistic studies by 
Nakamura,88 Pericas8b and Gimbert80 provided further insights into the energy of the reaction 
intermediates (Scheme 1.3) and confirmed the validity of the mechanism hypothesised by 
Magnus and Schore.
Scheme 1.3. Mechanistic energy profile of the dicobaltacycle formation.
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Notably, further examination of natural charges of the cobalt atoms throughout the process 
clarified the role of the two metal centres in the reaction.88 Despite the fact that all the bond­
forming events occurs on a single metal centre, the second cobalt atom did not act as a mere
5
spectator, but exerted a remarkable electronic effect by balancing the variation of natural 
charge of the first cobalt atom throughout the process,
1.2.3. Cobalt-catalysed Pauson-Khand Reaction.
Despite the importance of the seminal work by Pauson and Khand, the reaction suffered from 
severe limitations, including low reactivity, stoichiometric use of metal catalyst and substrate 
scope. The first significant attempt to overcome the reaction drawbacks was accomplished by 
Schore and Croudace in 1981 (Scheme 1.4).9 In this context, they utilised tethered enynes as 
reaction precursors, which effectively improved the reactivity of the system, and thus allowed 
the exploitation of unstrained alkenes to be utilised under an atmospheric pressure of carbon 
monoxide.
Scheme 1.4. Schore’s intramolecular cobalt-catalysed PK reaction of l,«-enynes.
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The ability of tethered enynes to circumvent alkene regioselectivity issues, coupled with the 
abundance of bicyclopentane scaffolds in natural products defined the intramolecular Pauson- 
Kliand reaction as a privileged methodology for the total synthesis of polycyclic natural 
targets. Despite the significant improvement regarding substrate scope and optimisation of 
operational conditions, many of these reaction use stoichiometric cobalt, which coupled to the 
moderate reactivity still constitute a major drawback in the process.9
The next sections will highlight the recent advances in the development of a general approach 
to the cobalt-mediated Pauson-Khand reaction.
C02(CO)gj CO
------------- ►
95 °C
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1.2.3.1. Use of Additives.
As previously mentioned, the rate determining step of the reaction involves displacement of a 
carbon monoxide molecule from the hexacarbonyldicobalt complex, which results in the 
formation of an unstable complex that has a vacant coordination site. According to these 
predictions, an increase in rate could be achieved by lowering the activation barrier energy of 
the dissociative step. The first major breakthrough was accomplished by Jeong and Schreiber, 
who independently examined the influence of amine iV-oxide additives, such as TMANO10 
and NMO,11 in the cobalt-mediated PKR. As outlined in Scheme 1.5, amine A-oxides could 
efficiently facilitate the formation of a vacant coordination site by oxidation of a CO ligand to 
CO2 and subsequent decarboxylation. As a result of enhanced reactivity, exploitation of these 
additives could finally overcome thermal process limitations and circumvent the issue of 
prolonged reaction times. Widespread acceptance of the beneficial effect of A-oxides 
additives prompted further investigations into the potential development of this strategy.
Scheme 1.5. Mechanism of CO displacement catalysed by amine A-oxides.
Rl
ocN/X\ ,co
iCd,C \
0* CO
cS'CO
CO
1
®o Rl ^R2
R3N-0 oc /X\_ ,co
R?N-o-c£rrcfcS°
VOco
nr3
C02
Rl .R2 
ocs xco^Co,—CA-co
O CO co 
10
o0
©N.
Me ■ Me Me
0©
Me'0>
TMANO NMO
An effective strategy to promote the carbon monoxide dissociation was the preliminary 
treatment of the initial cobalt complex with a Lewis base. Coordination of the base was 
believed to enhance the electron density on the metal centre and the lability of the metal-CO
7
6 bond, thereby favouring the subsequent alkene insertion.12 Leveraging this concept, a wide 
range of additives have been employed as promoters in the cobalt-catalysed reaction.
Scheme 1.6. Primary amines as promoters in the intramolecular PK reaction.
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Elegant studies by Sugihama and coworkers demonstrated the ability of hard Lewis bases, 
such as aliphatic primary amines (Scheme 1.6), to enhance CO dissociation and dramatically 
increase the rate of the reaction.13 A seminal report by Krafft et a/.,14 which was inspired by 
the enhanced reactivity of homopropargylic alkynyl sulfides, prompted the group to probe the 
utilisation of sulfur derivatives as potential promoters in the cobalt-catalysed PK reaction (Eq. 
1.2).15 Aliphatic sulfides as additives proved to exert a significant influence on the catalyst, 
thereby allowing the construction of polycyclic structures that are not generally accessible via 
the thermal PK reaction.
r-=o
Ph
13
Co2{CO)8i DCE
n-BuSMe--------------►
83 °C 
81%
Q
Ph
=o
14
(1.2)
I.2.3.2. Development of the Catalytic Cobalt-catalysed Pauson-Khand Reaction.
The use of promoters provided an attractive methodology in terms of addressing the issues of 
limited substrate scope and extended reaction times. In light of these promising results, 
further investigations focused on the development of a general catalytic process. In this 
context, seminal studies by Rautenstrauch (Eq. 1.3) reported the first effective catalytic PK
8
reaction.16 Despite the impressive TON (turnover number) of 110 by employing 0.022 mol% 
of catalyst, the reaction suffered from severe limitations in terms of operating conditions and 
reproducibility.
[Co2(CO)8] (0.022 mol%)
CO (100 atm) 
ethylene (40 atm)
toluene -----------------►
150 °C
15 47% 16
Based on his previous work regarding the beneficial effect of amine yV-oxides as promoters,10 
Jeong successfully developed a practical catalytic protocol employing phosphites as coligands 
(Eq. 1.4),17 Remarkable features were the applicability of the methodology to a wide range of 
substituted enynes and reduced catalyst loading, albeit high CO pressure (3 atm.) was 
essential to achieve useful levels of conversion.
[Co2(CO)3] (3 mol%)
P(OPh)3 (10 mol%)
Me02Cv CO (3 atm), DME Me02CNv/'''-Ts£\ _
Me02C'>V--^ 12o °c Me02C">V'Ly=0 (1-4)
17 82% 18
Scheme 1.7. Dicobalt hexacarbonyl complexes a catalytic precursor for the PK reaction.
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Additional studies by Livinghouse18 and Krafft19 provided the first photochemical and thermal 
catalytic PK reaction, thus avoiding the use of promoters. As outlined in the aforementioned 
studies, the use of high purity dicobalt octacarbonyl was crucial to achieve high yields under 
catalytic reaction conditions. This limitation prompted a re-evaluation of the catalytic system 
with the development of an air-stable catalyst surrogate. In this context, Livinghouse20 
showed that air-stable CojfCOValkyne complex 20 underwent reductive decomplexation by 
treatment with Et3SiH and the resulting (carbonyl)cobalt byproduct displayed catalytic 
activity towards the PK reaction (Scheme 1.7). Subsequent studies by Krafft21 described that 
air-stable and crystalline Co2(CO)8-enyne 19 could act as catalyst precursor without the 
requirement of EtsSiH and Lewis-base promoters (Scheme 1.7). Additionally, the Gibson 
group developed of an economical and air-stable triphenylphosphine dicobalt catalyst, which 
displayed good reactivity for both the inter- and intramolecular PK reaction (Eq. 1.5).22
^Ph * /b
21 22
[Co2(PPh3){CO)7] (5 mol%) 
DME, CO (1 atm)
75 °C 
96%
H
23
Perez-Castells envisioned that a CO-pretreated “paste” of powdered molecular sieves and 
terr-BuOH could subsequently determine a slow release of CO during the course of the PK 
reaction (Scheme 1.8).23 Hence, the employment of this “paste” in the catalytic PKR could 
effectively eliminate the requirement of toxic CO operating environment, which previously 
proved to be imperative for catalyst turnover.
Scheme 1.8. Effect of the CO-pretreated molecular sieves on the Co-catalysed PK reaction.
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Since the inception of the cobalt-catalysed PK reaction, considerable effort has been devoted 
towards the establishment of an efficient and general methodology. Major accomplishments 
have been achieved with respect to reactivity, stereoselectivity and development of catalytic 
variants. Nonetheless, severe substrate limitations and lack of overall reactivity provided the 
impetus to examine alternative transition metals that enable general and efficient catalytic 
process.
1,2,4, Transition Metal Catalysed Pauson-Khand Reactions.
1.2.4.1, Molybdenum.
Early work by Hanaoka and Mukai on PK reactions focused on the ability of group 6 
elements (Cr, Mo, W) to form isoelectronic complexes of hexacarbonyldicobalt congeners 
(Eq. 1.6).24 Consequently, experimental studies demonstrated the ability of molybdenum 
complexes to catalyse the PK reaction, thus providing a valid alternative to the classic cobalt- 
catalysed process.25
26
+ /b ---- o
24 27
M = MoCp(CO)2
WCp(CO)2
Co(CO)3
(1.6)
As previously established for the cobalt-catalysed protocol, the ability of promoters to 
displace a CO ligand proved to be essential for substrate coordination.11’13,15 Similarly, low- 
valent organotransition metal carbonyl complexes could extrude a CO ligand in the presence 
of coordinating hard Lewis bases and allow the formation of a vacant coordination site. 
Rationalising these experimental observations, Jeong envisioned the ability of promoters to 
generate a coordination vacancy on carbonyl molybdenum complexes and thereby enhance 
the interaction between the metal centre and enyne (Scheme 1,9).26,27
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Scheme 1.9. Mo-mediated PK reaction.
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Extensive screening of promoters revealed that DMSO was crucial to promote CO 
decomplexation and thereby achieve high levels of reactivity (Eq. 1.7).
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18
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Additional studies focused on the examination of catalytic process under an atmosphere of 
carbon monoxide. In contrast to the cobalt-catalysed manifold, amine 7V-oxides promoters had 
a detrimental effect on the systems reactivity.26 In the context of developing an efficient 
methodology, Carretero sought to address the issue of poor reactivity and lack of beneficial 
additives by altering the ligand environment around the metal centre.
Me02C_/ ^
Me02C^V^
17
Mo(CO)3(DMF)3
DCM
RT, 15 min 
83%
Me02C^/ 
Me02C'?\^—'
18
(1.8)
Partial replacement of the carbon monoxide ligands with more labile DMF ligands proved to 
be essential to circumvent the disfavoured CO decomplexation step, thus providing a 
spontaneous room temperature cyclocarbonylation in the absence of additives or promoters
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(Eq. 1.8).28 Despite the impressive advancements in the molybdenum-mediated PK reaction 
of 1,6-enynes, the inability to develop a catalytic process has prompted the development of 
alternative methodologies in terms of atom economy and applicability in total synthesis. 
Nonetheless, molybdenum catalysis provides a suitable alternative due to its exceptional and 
unique reactivity in the context of the allenic and hetero-Pauson-Khand reactions.
I.2.4.I.I. Allenic Pauson-Khand Reaction.
A significant initial drawback for the development of an allene-type Pauson-Khand lay in the 
propensity of dicobalt octacarbonyl to catalyse allene polymerisation.29
Scheme 1.10. Regioselectivity in the Mo-catalysed PK reaction of allenynes.
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However, the high reactivity profile provided by the unique structural and electronic 
arrangement of the cumulated diene moiety inspired the Bmmmond group to probe the 
catalytic activity of alternative transition metals in the context of the allenic Pauson-Khand 
reaction. Treatment of allenynes under conditions reported by Jeong,26 resulted in the 
regioselective formation of a-methylene cyclopentenones (Scheme 1.10, pathway B).30 The 
intrinsic value of this methodology relied on the unprecedented preferential reactivity of the 
internal Jt-bond of the allene and the ubiquity of a-methylene motifs in biologically active
13
compounds. Additional studies focused on the allene substitution pattern in order to direct the 
regiochemical outcome towards terminal jr-bond. Notably, internal substituted allenes 
dramatically influenced the regiochemical pathway and promote the selective formation of the 
bicyclo[4.3.0]nonane ring system (Scheme 1.10, pathway A).31 Hence, the allenic moiety 
provided regioselective access to polycyclic motifs that are generally not accessible via the 
classic PK reaction of 1,6-enynes, and established the molybdenum-catalysed PKR of 
allenynes as a complementary and powerful strategy for the synthesis of biologically active 
compounds (Scheme 1.10).32
I.2.4.I.2. Hetero-Pauson-Khand Reaction.
The hetero-Pauson-Kliand reaction recently emerged as a powerful strategy for the rapid 
construction of butenolide derivatives.
Scheme 1.11. Ti-mediated hetero-PK reaction of unsaturated carbonyl derivatives.
Cp2Ti(PMe3)2 
(1.1 eq.) 
CO (1.1 atm)
70 °C
Cp2Ti(PNle3)2 
(1 eq.)
CO (1 atm)
RT
R = Me, Ph 32 R = H
O
H
34
Buchwald Crowe
Independent studies by Buchwald33 and Crowe34 demonstrated that titanium metallacycles 
promote the formation of y-butyrolactones via tandem reductive cyclisation/carbonylation of 
tethered unsaturated carbonyl derivatives (Scheme 1.11). Interestingly,the replacement of the 
alkene moiety with an alkyne led to a dramatic drop in reactivity, which was attributed to the 
unfavoured CO insertion into the hindered Ti-C(sp2) bond.33,34 The first catalytic method for 
the conversion of yne-aldehydes into bicyclic a,(3-unsaturated lactones was achieved by
14
Murai and Chatani,35 albeit very harsh thermal conditions. In this process, the substitution on 
the alkyne moiety proved to be critical to promote CO insertion into the Ru-C(sp ) 
metallacycle bond (Eq, 1.9).
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In light of the catalytic activity of molybdenum hexacarbonyl in allene-type hetero-PK 
reactions,30’31 Carretero envisioned that enhanced catalytic activity of Mo(CO)3(DMF)328 
could effectively overcome the poor reactivity of yne-aldehydes in the hetero-PK reaction.36 
This resulted in the development of a room temperature Mo-mediated carbocyclisation of 1,6 
and 1,7-yne aldehydes, which, in contrast to previous protocols, could overcome the 
drawback of thermal processes and prolonged reaction times, to provide a highly convergent 
approach to bicyclic butenolides (Scheme 1.12).36
Scheme 1.12. Butenolide synthesis by Mo-mediated hetero-PK reaction of yne-aldehydes.
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1.2.4.2. Iron and Ruthenium.
The acknowledged ability of pentacarbonyl iron to promote intramolecular carbonylative 
coupling of enynes provided the rationale to pursue its suitability for iron-catalysed Pauson- 
Khand reactions. Early reports by Pearson and Dubbert confirmed the viability of the
15
approach, albeit stoichiometric, and the necessity of high temperature and pressure (Eq.
1.10).37
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In a recent development, Murai38 and Matsudo39 reported the catalytic ruthenium-catalysed 
cyclocarbonylation of 1,6-diynes40 using Ru3(CO)i2 for the Pauson-Khand reaction (Eq. 1.11). 
Although high CO pressure and harsh temperatures remained an intrinsic limitation, 
experimental investigations demonstrated that Ru3(CO)i2 has higher catalytic activity relative 
to its iron congener (2 mol%).38'39
Ru3(CO)12 (2 mol%)
Me02C^/^^-TMS CO (15 atm), acetone Me02C.
MeOaC'X-''^ 160°C, 20hrs ^ MeOaC
40
95%
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41
(1.11)
Additional studies focused on the applicability of the methodology towards the intermolecular 
reaction. In this context, the efficiency of the intermolecular PK reaction relied on a reactive 
strained alkene and the alkyne counterpart in order to promote a regioselective 
transformation. Inspired by seminal studies by Krafft,14 Yoshida envisioned that tethering a 
coordinating heteroatom to the alkene counterpart could perform a dual role of enhancing the 
substrate reactivity and simultaneously act as a stereodirecting group by interaction with the 
metal centre. Consequent experimental investigations demonstrated the ability of alkenyl(2- 
pyridyl)silanes to undergo Ru-catalysed intermolecular PK reaction and deliver a highly 
convergent cyclopentenone synthesis (Eq. 1.12).41a
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The mechanism of the reaction is thought to involve the initial dissociation of the ruthenium 
cluster i and formation of Ru(alkenylsilane) complex iii (Scheme 1.13).41b
Scheme 1.13. Mechanism of the Ru-catalysed intermolecular PK reaction of 
vinylpyridylsilanes.
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Alkyne coordination and stereospecific oxidative addition provides metallacycle vi. Retention 
of the pyridyl-Ru coordination directs a stereospecific CO migratory insertion into the Ru- 
C(sp2) bond and provides mthenacycle vii. Reductive elimination and desilylation of 
intermediate ix affords cyclopentenone x. Further mechanistic studies clarified the beneficial 
role of the pyridyl moiety in terms of dissociation of the initial imreactive ruthenium cluster 
and enhancement of the coordinating aptitude of the alkene group for oxidative addition.4115 
As a result, the overall process required low catalyst loading and atmospherical CO pressure. 
Although very little effort has been devoted towards the synthetic application of the Ru- 
catalysed PK reaction, the recent development of a tandem RCM/hetero-Pauson-Khand
17
reaction demonstrated the ability of this strategy for the construction of complex molecular
targets (Eq. 1.13).42
Grubbs II cat. (10%) 
100°C, 1 h 
---------------------- ►-
then
NaOMe (20% mol), 
CO (7 atm), 180 °C 45
(1.13)
1.2.4.3 Nickel and Palladium.
Early reports on Ni-catalysed allene cycloadditions disclosed the ability of isocyanides to 
insert into a Ni-C(sp3) bond and serve as a ur-component for the synthesis of 
iminocyclopentenes that, upon hydrolysis, provided the corresponding cyclopentenone 
adducts.43 The ability of isocyanides to serve as a CO surrogate, provided Buchwald and 
coworkers the impetus to develop the first example of a Ni-catalysed Pauson-Khand reaction 
(Eq. 1.14).44 The choice of trialkylsilyl cyanides was crucial in terms of avoiding the 
formation of unreactive Ni-isocyanide species and increasing the reactivity of the 
cycloadducts to hydrolysis.
44
Ni(COD)2L (5 mol%)
DMF, TIPSCN, 110 °C
-------------------------------------------- *■
then
H+
60%
Ph /—. Ph
L= )=N W (1-14) 
Ph Ph
Despite its role in metal-catalysed reactions, palladium had not been extensively explored in 
the [2+2+1] reactions, until in 2005 the Yang group developed the first example of a Pd- 
catalysed PK reaction (Eq. 1.15).45a,b The synthetic value of this effective methodology lay in 
the mild operating conditions and employment of a readily available catalyst, which provides 
wide substrate scope.
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Me02Cw/ ^ 
MeOaC^X^;. 
17
PdCl2(15 moI%), 
TMTU, LiCI, 
CO (1 atm), THF
60 °C( 24 h 
82%
Me°2CV'T%=O
18
(1.15)
Moreover, the thiourea ligand46 and lithium chloride were critical for an efficient catalyst 
turnover, which prompted additional investigations into the reaction mechanism.450 
Experimentally confirmed computational studies clarified the key role of the above mentioned 
additives and outlined the unique mechanistic pathway of the Pd-catalysed PK reaction 
(Scheme 1.14).45c The mechanism of the reaction involves initial coordination of the enyne ii 
to PdCy^, followed by a stereospecific syw-addition of the Pd-Cl bond to the alkyne moiety. 
After subsequent alkene and carbon monoxide insertion to provide intermediate v, palladium 
oxidatively inserts into the vinyl-chloride bond leading to the formation of palladacycle vii. 
Reductive elimination affords the desired bicyclopentenone adduct viii.
Scheme 1.14. Proposed mechanistic pathway of the Pd-catalysed PK reaction.
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The investigation of the electronic influence of ligands in the reaction outlined the ability of 
the thiourea ligands to dramatically decrease the energy barrier for the intramolecular 
oxidative addition and stabilise the transition state vi for the formation of Pd(IV) species vii’ 
(Scheme 1.15).45c Additionally, the chelating effect of the lithium atom further stabilise the 
octahedral geometry of the resulting oxidative addition product vii’, thereby enhancing the 
reactivity the overall transformation.
Scheme 1.15. Chelation-based stabilisation in the transition state of the Pd-catalysed PKR.
Cl i J
1.2.4.4. Rhodium and Iridium.
Prior to the development of the first rhodium-catalysed approach, the PK reaction had 
undergone extensive development and was successfully exploited with a wide array of 
transition metals. Nonetheless, previously discussed limitations in terms of operating reaction 
conditions and substrate scope failed to satisfy the potential of the methodology. Livinghouse 
and Wender estabilished the ability of rhodium catalysts in [4+2]47 and [5+2]48 cycloaddition 
reactions to provide elegant access to six- and seven-membered bicyclic scaffolds. Hence, 
acknowledged catalytic activity and aptitude of this metal to selectively assemble multiple Jt- 
components prompted the investigation of a rhodium-catalysed [2+2+1] carbocyclisation in 
order to overcome the previously encountered limitations. Narasaka49 and Jeong50 
independently reported the first rhodium-catalysed PK reaction in 1998 (Scheme 1.16). 
Remarkable features of these methodologies included low catalyst loading and the ability to
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conduct the process under an atmospheric pressure of CO. Additionally, high catalytic 
activity displayed by phosphine-substituted rhodium complexes50 provided a concrete 
opportunity to generate a chiral environment in the system and deliver an asymmetric variant 
of the process.51
Scheme 1.16. Rh-catalysed PK reaction of 1,6-enynes.
[RhCI(CO)(dppp)]2 (2.5 mol%)
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--------------------------------
110 °C 
82%
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44
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toluene, CO (1 atm)
130 °C 
83%
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Further discussion in this chapter will provide additional insight into the Rh-catalysed 
diastereoselective PK reaction and describe the optimisation and achievement of an efficient 
diastereoselective methodology. Chapter 2 will examine the asymmetric variant of the process 
and describe the development of a highly enantioselective variant. The investigation of the 
iridium-catalysed process has been exclusively carried out in the context of the asymmetric 
PK process and will be thus highlighted in the second chapter.
1.3. Rhodium-Catalysed Cyclocarbonylation Reactions,
1.3.1 Allenic [2+2+1] Pauson-Khand Reaction.
The exquisite reactivity of allenynes in the Mo-mediated PK reaction,30,31 prompted the 
Bmmmond52 and Mukai53 groups to probe the feasibility of a rhodium-catalysed process. 
These studies confirmed the enhanced reactivity of the allene moiety in Rh-catalysed 
cycloadditions and provided a highly convergent strategy for the assembly of bicyclo[4.3.0] 
skeletons (Scheme 1.17).
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Scheme 1.17. Rh-catalysed PK reaction of allenynes.
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Additionally, the allene moiety broadened the scope of the methodology to the unprecedented 
construction of novel bicyclo[5.3.0] scaffolds, thereby expanding the applicability of the 
process towards the synthesis of seven-membered ring containing target molecules (Scheme 
1.18).53a,b
Scheme 1.18. Synthesis of bicyclo[4.3.0] and [5.3.0] scaffolds by Rh-catalysed allenic PK 
reaction.
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Early reports by Itoh54 prompted Mukai to investigate the reactivity of allene-enes in the 
context of a PK reaction.530 A remarkable limitation with the process was the diminished 
reactivity of the alkene compared to the alkyne.
Nonetheless, controlling the carbon monoxide pressure provided optimal reactivity and 
allowed the stereoselective formation of bicyclo[4.3.0] and [5.3.0] bicyclic adducts (Scheme 
1.19).53c The outstanding reactivity of the allene moiety in the context of Rh-catalysed 
cyclocarbonylation reactions was further demonstrated with a [2+2+1] cycloaddition of a bis-
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allene to generate bicyclo[6.3.0] and [7.3.0] skeletons, thereby overcoming the inherent 
limitations of 1,8- and 1,9-enynes to construct these type of scaffolds (Scheme 1.20).53d
Scheme 1.19. Rh-catalysed PK reaction of l,«-allenes.
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Scheme 1.20. Rh-catalysed PK reaction of l,«-bisallenes.
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1.3.2. Dienyl [2+2+1] Pauson-Khand Reaction.
Wender and coworkers recognised the possibility of replacing the alkene counterpart with a 
more reactive diene moiety and to facilitate the Rh-catalysed [4+2+1] cycloaddition. 
Experimental observations demonstrated that the diene moiety behaves as a 2ji component 
and results in the development of the first Rh-catalysed dienyl PK reaction (Eq. 1.16).55a
Me02C
Me02C
[RhCI(CO)(PPh3)2]
(1 mol%), AgSbF6
[Pr (1 mol%), CO (1 atm)
--------------------------------►
RT
57
Me02C
Me02C
Pr
58
(1.16)
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Detailed optimisation of the solvent system and substrate concentration proved to be crucial 
in order to avoid the undesired formation of [4+2] adducts and provided a diastereoselective 
synthesis of bicyclopentenone derivatives imder mild operating conditions. The inherent 
reactivity of diene and alkyne components in the intramolecular PK reaction provided the 
basis for the development of the corresponding intermolecular manifold (Eq. 1.17).55b Careful 
control of thermal conditions was required in order to circumvent the formation of [4+2] and 
[2+2+2] adducts and, moreover, significant excess of the diene component was crucial to 
achieve excellent reactivity.
OMe
MeO
59
(10 eq.) 
60
[RhCI(CO)2]2 (5 moI%)
(1.17)
Additional studies demonstrated the ability of 1,3-dienes to display reactivity comparable to 
the alkyne moiety and culminated in the development of the first Rh-catalysed diene-ene 
[2+2+1] cycloaddition (Eq. 1.18).55c Distinguishing features of the methodology included 
high degrees of diastereocontrol and simultaneous formation of three contiguous stereogenic 
centres.
MeC^CsV 1]
62
[RhCI(CO)2]2 (5 mol%)
M6O2C.
Me02C'
H
t
H
63
=0
/pr
(1.18)
Elegant computational studies by Baik56 provided additional insight into the role of the diene 
moiety in the reaction. These studies demonstrated that the oxidative addition process requires 
a high electron density on the metal centre and is disfavoured by the presence of jt-electron
24
withdrawing CO ligands. In this context, ri2->ri4 reorganisation of the diene moiety in i drives 
the expulsion of the CO ligand from the metal centre with concomitant formation of a 
coordinatively saturated electron-rich Rli(I) species ii, thereby enhancing the rate of oxidative 
addition in the process (Scheme 1.21),56
Scheme 1.21. Oxidative addition step in the Rh-catalysed PK reaction of diene-enes.
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1.3.3. [3+2+1] and [3+3+1] Cycloadditions.
Extensive studies by Wender and coworkers outlined the ability of vinylcyclopropanes to act 
as a reactive component in Rh-catalysed [5+2] cycloaddition reactions.48 In contrast, the 
employment of cyclopropanes as a 328 component in metal-catalysed cycloadditions remained 
largely unexplored, due to propensity of the corresponding metallocyclobutanes to undergo (3- 
hydride elimination.57
Scheme 1.22. Postulated mechanism for the [3+2+1] cycloaddition of yne-cyclopropanes.
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However, Narasaka envisioned that incorporation of a cyclopropane component into an 
enyne-type structure could favour preferential alkyne coordination to the metallacyclobutane, 
which would suppress competitive [3-hydride elimination and promote the formation of six- 
membered metallacycle. Subsequent CO insertion and reductive elimination would afford the 
desired adduct (Scheme 1.22).58 Rationalisation of the mechanistic hypothesis provided the 
first example of a Rh-catalysed [3+2+1] carbocyclisation reaction (Eq. 1.19). The 
methodology provided a unique approach to the synthesis of bicyclohexenone derivatives, 
albeit with the requirement of harsh thermal conditions and high CO pressure.58
Me02C
Me02C
[RhCI(CO)2]2 (10 mol%) 
1,2-DCB, CO (4 atm)
160 °C
63
48%
Me02Cv^Y^rj0
Me02C^VA^J
64
(1.19)
Renewed interest in the strategy by Yu and coworkers originated from the exploitation of a 
fr'c/ws-vinylcyclopropane moiety to provide a [3C2s] synthon in the Rh-catalysed [3+2] 
cycloaddition reaction.59 Hence, employment of the latter in the corresponding Rh-catalysed 
[3+2+1] process could effectively overcome the poor reactivity of cyclopropanes and provide 
a mild approach to the synthesis of bicyclohexenone adducts (Eq. 1.20).60
[RhCI(CO)2]2 (5 moI%) 
toluene, CO (1 atm) 
--------------------------- ►
80 °C
65 85%
TsVsJ
66
(1.20)
Additional experimental studies revealed that minor modifications in the operating conditions 
could alter the mechanistic pathway of the aforementioned [3+2+1] process and provide 
alternative formation of tricyclic derivatives, as outlined in Scheme 1.23.61
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Scheme 1.23. Different mechanistic pathways in the Rh-catalysed cycloaddition of VCP-
ynes.
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Scheme 1.24. Mechanistic pathway of the Rh-catalysed [5+l]/[2+2+l] cycloaddition 
reactions of yne-vinylcyclopropanes.
V
The initial step involved coordination of the rhodium catalyst i to the ene-cyclopropane ii and 
oxidative addition into the VCP moiety to afford iii. Subsequent alkyne and CO insertion 
provided metallacycle v. Reductive elimination of v afforded [3+2+1] bicyclic adduct xi
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whereas alternative aikene insertion provides metallacycle vii. This latter intermediate is 
amenable to CO msertion and reductive elimination to afford angular tricyclic derivative ix. 
Studies by Wang outlined the investigation of cyclopropenes as an alternative reactive [3C25] 
component in the Rb-catalysed [3+2+1] cycloaddition (Eq. 1.21-1.22).62
[RhCI(CO)2]2 (5 mol%) 
DCE, CO (1 atm) 
--------------------------- ^
80 °C
74%
69
Ph
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[RhCl(CO)2]2 (5 mol%) 
DCE, CO (1 atm)
80 °C
f 54% \
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Higher strain energy of cyclopropenes compared to the parent cyclopropane and VCP allowed 
the cyclopropenes to react efficiently with an aikene and alkyne counterpart and thereby 
furnish bicyclohexenone or phenol-type derivatives (Eq. 1.21-1.22). An intriguing feature of 
this approach involved the exclusive formation of frawj-fused bicyclic adducts and 
antithetical cA-stereochemistry of the corresponding [3+2] derivatives.62 This interesting 
dichotomy provided the basis for a working hypothesis for the divergent [3+2] and [3+2+1] 
cycloaddition reactions of cyclopropen-ene substrates (Scheme 1.25). Initial coordination of 
cyclopropen-ene ii to the rhodium catalyst, followed by oxidative addition into the 
cyclopropene provides common metallacyclobutane iv. Aikene insertion in the [3+2] pathway 
affords cA-metallacyclopentene ix which imdergoes reductive elimination to provide adduct 
x. In the [3+2+1] pathway, on the contrary, aikene insertion is preceded by CO insertion and 
formation of intermediate v. Stereospecific aikene insertion provides the P^ms-bridged 
metallacycle vii and subsequent reductive elimination supplies bicyclohexenone adduct viii 
(Scheme 1.25).62
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Scheme 1.25. Mechanistic pathways for [3+2] and [3+2+1] cycloaddition reactions of
cyclopropene-enes.
The development of the metal-catalysed [3+3+1] carbocylisation reactions has not been 
investigated extensively due to the low reactivity of cyclopropanes. Nonetheless, a unique 
report by Chung demonstrated the ability of unsymmetrical biscylopropanes to undergo a 
carbocyclisation reaction and provide synthetically useful bicycloheptanone derivatives (Eq. 
1.23).63
TsN.
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100 °c
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73
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1.3.4. [4+1] and [5+1] Cycloadditions.
Early studies by Eaton64 reported the ability of iron carbonyl complexes to catalyse [4+1] 
cycloadditions of conjugated allenes under a carbon monoxide atmosphere. Inspired by these
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studies, Murakami and Ito probed the feasibility of a Rh-catalysed [4+1] carbonylative 
cyclisation of vinylallenes derivatives.65 A postulated mechanism involved initial r|4 
coordination of the vinylallene moiety to the rhodium centre and subsequent oxidative 
addition for the formation of metallacycle iii (Scheme 1.26). Subsequent CO insertion and 
reductive elimination provides dienone vi. This mechanistic hypothesis rationalised the 
development of the Rk-catalysed [4+1] cycloaddition (Eq. 1.24).65 A significant drawback 
with the methodology was the concomitant formation of an isomeric mixture of 
cyclopentenones 75a and 75b. Further optimisation of the methodology demonstrated that 
bisphospholane ligand DuPhos and high CO pressure exerts a beneficial effect and prevents 
the isomerisation process, thus providing the exclusive formation of dienone 75a.66
Scheme 1.26. Putative mechanism of the Rh-catalysed [4+1] cycloaddition of vinylallenes.
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Later studies by Liebeskind described the Rh-catalysed [5+1] cycloaddition of conjugated 
cyclopropene derivatives under a carbon monoxide atmosphere.67 This protocol provided an
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interesting methodology for the regioselective synthesis of functionalised phenol and pyrone 
adducts (Scheme 1.27).
Scheme 1.27. Rh-catalysed [5+1] cycloaddition reaction of conjugated cyclopropenes.
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The proposed mechanism for this process is thought to involve the initial formation of the 
metallocyclobutene ii and regiospecific CO insertion, which results in metallacyclopentenone 
iii (Scheme 1.28). Subsequent alkene insertion and reductive elimination provides the 
corresponding pyrone v or phenol vi.
Scheme 1.28. Mechanistic pathway of the Rh-catalysed [5+1] cycloaddition reaction.
vi
Additional investigations prompted the De Meijere group to expand the strategy to 
vinylcyclopropanes and develop a convergent approach to cyclohexanone derivatives,
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although the crucial requirement of an additional cyclopropane moiety partially limited the
synthetic utility of the process (Eq. 1.25).68
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Recent work by Malacria and Fensterbank disclosed the opportunity to carry out a [5+1] 
cycloaddition without the necessity of a cyclopropane-type 5C component. Treatment of 3- 
acyloxy-1,4-enyne 81 under carbonylative conditions resulted in a regioselective synthesis of 
resorcinol derivative 82 (Eq. 1.26).69
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Scheme 1.29. Postulated mechanism of the Rh-catalysed [5+1] cycloaddition reaction of 3- 
acyloxyenynes.
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Additional studies supported an unusual mechanistic pathway, which involves formation of a 
conjugated ketene intermediate v to permit a thermal 6k electrocyclisation, which delivers the 
aromatic adduct vi (Scheme 1.29).69
1.3.5. [5+2+1] Cycloadditions.
Extensive studies by Wender highlighted the ability of VCP to undergo Rh-catalysed [5+2] 
cycloaddition with a wide variety of 2C synthons, thus providing a valuable approach for the 
construction of cycloheptane scaffolds.48 In this context, it was envisioned that the 
incorporation of a carbon monoxide unit in the cycloaddition could deliver a powerful method 
for the construction of cyclooctenone derivatives. Preliminary studies revealed the intrinsic 
instability of the cyclooctenone ring, which resulted in the formation of bicyclic derivatives.70 
Hence, the appropriate choice of alkyne counterpart with hydrolytic work-up allowed the 
exclusive formation of transannular adducts (Scheme 1.30). A remarkable feature with the 
process includes the high regioselectivity in the alkyne insertion step and the latent 
functionalities in the cycloadducts.
Scheme 1,30. Intermolecular Rh-catalysed [5+2+1] cycloaddition reaction of 
vinylcyclopropanes, alkynes and CO.
O
83 84 85
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Previous studies on the [5+2] cycloaddition of VCP/ene substrates demonstrated that 
[RJiC1(CO)2]2 failed to efficiently promote the process (Scheme 1.31).71 The lack of reactivity 
was attributed to the low aptitude of the catalyst to promote reductive elimination (RE) and 
consequent C(sp3)-C(sp3) bond formation (Scheme 1.31). On the other hand, the mechanistic 
pathway of the corresponding [5+2+1] involved migratory reductive elimination (MRE) and 
C(sp2)-C(sp3) bond formation. Related computational studies indicated a lower activation 
energy for this step, thereby assessing the ability of [RhCl(CO)2]2 to promote a [5+2+1] 
carbocyclisation reaction.
Scheme 1.31. Reductive elimination step in Rh-catalysed [5+2] and [5+2+1] cycloadditions.
[RhCI(CO)2]2 
-------------------- *
i
Hence, the theoretical findings provided the impetus to develop a new method for the 
construction of bicyclooctenone derivatives (Eq. 1.28).72
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Further studies by the Yu group broadened the scope of this methodology with the highly
stereoselective assembly of complex tricyclic scaffolds (Eq. 1.29).73
[RhCI(CO)2]2 (5 mol%)
N2:CO = 4:1 (1 atm) 
dioxane
(1.29)
1.3.6. [6+1] and [7+1] Cycloadditions.
The role of the vinylcyclopentane moieties as a 5C synthon, prompted the Wender group to 
evaluate the reactivity of the homologous vinylcyclobutane group as a 6C component in the 
context of a Rh-catalysed carbonylative cycloaddition.74a,b Preliminary studies on a [6+l]-type 
process of vinylcyclobutanes under carbonylative conditions demonstrated an overall lack of 
reactivity. In light of this result, it was envisioned that the allene moiety would promote an 
effective coordination and enhance the rate of the oxidative addition step. The Rh-catalysed 
[6+1] cycloaddition of allenylcyclobutanes enabled the desired ring expansion, thereby 
providing an efficient approach to cycloheptenone derivatives (Eq. 1.30).74b
OTBS
[RhCI(CO)232 (10 mol%) 
CO (2 atm), toluene
80 °C OTBS
92 93
(1.30)
A putative mechanism involved initial 2jt coordination of the allene moiety, oxidative 
addition of the cyclobutane ring and formation of metallacycle ii (Scheme 1.32). Subsequent 
CO insertion and reductive elimination afforded the desired cycloheptenone adduct vi.
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Scheme 1.32. Mechanistic pathway of the Rli-catalysed [6+2+1] cycloaddition reaction.
Additional studies by the Yu group envisaged that an additional alkene moiety in the 
vinylcyclopropane building block, namely dienylcyclopropanes, would permit a novel Rh- 
catalysed [7+1] cycloaddition process.75 In this context, they provided the synthetically 
challenging construction of cyclooctenone rings (Eq. 1.31), which effectively overcame the 
inability of the intermolecular Rh-catalysed [5+2+1] cycloaddition to deliver eight-membered 
rings. Although high catalyst loading was required to promote useful rates and the reaction 
provides an isomeric mixture of 95a and 95b, the isolated adduct 95b readily undergoes Rh- 
catalysed isomerisation to provide enone 95a as the exclusive product.75
[RhCI(CO)2]2 (10 mol%) 
dioxane, CO (1 atm) J
f 74% \
95a :95b = 6:1 J
1.3.7. [m+n+o+1] Carbocyclisations.
The development of Rh-catalysed carbocyclisations has clearly estabilished the merit of the 
metal to coordinate a wide array of ji-components and thereby promote the convergent
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synthesis of complex polycyclic scaffolds. From a conceptual standpoint, the synthetic utility 
of this strategy could be further broadened to many multiple components, to increase the 
structural complexity of the carbocyclisation adducts. A major breakthrough in the 
application of the strategy was achieved by Ojima who developed a remarkable 
multicomponent RJh-catalysed [2+2+2+1] carbocyclisation reaction (Eq. 1.32).76a
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RT
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Scheme 1.33. Postulated mechanism of the silicon-initiated RJh-catalysed [2+2+2+!] 
cycloaddition reaction of ene-diynes and CO.
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The proposed mechanism for the novel silicon-initiated carbotricyclisation is outlined in 
Scheme 1.33.76a,b Oxidative addition of the silane into the [Rh(acac)(CO)2] catalyst provides 
reactive complex ii. Further alkene insertion into the Rh-Si bond and an ene-type 
cycloisomerisation process afforded intermediate iv. Steric hindrance in iv between the 
vinylsilane and vinylrhodium moiety promoted isomerisation to vi through an Ojima-Crabtree 
mechanism. Cyclisation and CO insertion provided acylrhodium intermediate viii. The 
carbometallation and (3-silyl elimination of intermediate ix afforded the [5-7-5] tricyclic 
derivative x. Further optimisation of this intriguing strategy provided the opportunity to 
achieve analogue scaffolds in the absence of silane initiators (Eq. 1.33).76c
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Scheme 1.34. Postulated mechanism of the Rh-catalysed [2+2+2+1] cycloaddition reaction of 
ene-diynes and CO.
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The alternative mechanistic pathway involved two consecutive migratory insertion steps via 
the formation of metallacycle iv (Scheme 1.34). Subsequent CO insertion and reductive 
elimination to provide the fused tricyclic adduct vii. The overall efficiency of both
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methodologies relies on the exquisite reactivity of rhodium catalysts under mild conditions 
and the regioselective OC bond formation between multiple n components. The 
demonstration of the synthetic potential of the method was further highlighted in the highly 
stereoselective assembly of complex tetracyclic scaffolds (Eq. 1.34).76d
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Optimisation studies on the intermolecular Rh-catalysed [5+2+1] of vinylcyclopropanes, 
alkynes and CO revealed that a different substitution pattern on the alkyne counterpart leads 
to divergent mechanistic pathway (Scheme 1.35).
Scheme 1.35. Mechanistic pathway of the Rh-catalysed [5+1+2+1] cycloaddition reaction.
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Employment of phenylacetylene substrates promotes a dicarbonylative process with the 
formation of the unstable dienone 103. Subsequent tautomerisation to triene 104 and 
electrocyclic ring closure provided unstable diene 105. Hence, the final elimination delivers 
the aromatic adduct 106 in excellent yield.77 Despite the moderate synthetic utility and lack of 
stereogenic centres in the hydroxyindanone derivative, this methodology provided a rare 
example of Zus-carbonylative multi-component process.
1.4 Diastereoselective Pauson-Khand Reactions.
1.4.1. Introduction.
The discovery of the Pauson-Khand cyclocarbonylation methodology highlighted the ability 
of transition metals to facilitate the simultaneous formation of multiple C-C bonds in a single 
operation step from readily available materials. Nonetheless, the impact of the original 
methodology was dramatically affected by the necessity to employ strained alkenes and the 
limited synthetic value of the cycloadducts. The introduction of tethered enynes for the 
intramolecular Pauson-Khand provided a new paradigm for the rapid construction of 
polycyclic structures. In this context, the ability to understand the stereochemical outcome of 
these reactions provided a formidable challenge for the exploitation of its synthetic utility.
1.4.2. Cobalt-catalysed Diastereoselective Pauson-Khand Reaction.
As a part of a program directed towards the synthesis of triquinanes, studies by Magnus 
explored the stereochemical outcome of the cobalt-mediated PK reaction and rationalisation 
of the experimental findings provided the current model for the stereocontrol in this process.6 
The cobalt-mediated thermal PK reaction of substituted 1,6-enynes provided complete 
diastereocontrol and resulted in the preferential formation of 6/5-fused bicyclopentenone 
adducts (Eq. 1.35-1.36). The observed 1,2- and 1,3-stereoselectivity could be explained in
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terms of steric interactions in the alkene insertion step and corresponding formation of the 
cobalt metallacycle (Eq. 1.37-1.38).6 Metallacycle 111a can effectively minimise the 
interactions between the bulky C-3 substituent and TMS moiety on the alkyne terminus, 
whereas formation of metallacycle 111b is disfavoured due to 1,3-pjewt/o-axial interaction on 
the ew^fo-face.
Analogous steric implications can rationalise the preferential fonnation of metallacycle 112a 
in order to minimise 1,4-pseudoaxial interactions between the TMS group and the C2 allylic 
substituent (Eq. 1.38). Additional studies demonstrated that the bulky alkyne dramatically 
enhances the stereocontrol in process, thereby supporting the validity of the mechanistic 
hypothesis.
H
111b
disfavoured
MOMO
109
TMS Co'TMS Co'
MOMOMOMO
disfavouredfavoured
(1.37)
(1.38)
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Nonetheless, additional investigations revealed how the stereochemical outcome of the 
process was dramatically affected by the nature of the tethering group and substituents on the 
enyne. In a program directed towards the total synthesis of picrotoxanes, Mukai and Hanaoka 
explored the feasibility of tartrate-derived 1,7-enyne in the PK reaction and to provide the 
highly functionalised bicyclo[4.3.0]nonanes (Eq. 1.39-1.40).78 Previously invoked 1,3- 
pseudoaxial steric interactions between the protected hydroxyl group and phenyl substituent 
provided a rationale for the stereoselective formation of adduct 114, albeit with the 
unexpected stereocomplementary formation of the corresponding dihydroxy derivative 116, 
which prompted additional investigation into the nature of the reactive conformers.
(1.39)
(1.40)
Scheme 1.36. Reactive conformers in the PK reaction of tartrate-derived 1,7-enynes.
TBSO
OTBS
117a
favoured
1
TBSO
OTBS
118b
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118a
disfavoured
117b
disfavoured
116
Analysis of conformers of both reactions rationalised the observed diastereocontrol on the 
basis of reduced steric interactions between the axial H4 and the olefinic proton HI in 117a
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and 118b. This revealed that the orientation of the hydroxyl groups was responsible for the 
stereocomplementary formation of 114 and 116 (Scheme 1.36).78 For instance, hydrogen­
bonding interactions in 115 generate a five-membered transient ring, wherein the vicinal 
hydroxyl groups are diequatorial, which contrasts the axial orientation of TBS ethers in 117 
(Scheme 1.36). Additional studies revealed the key role of conformational restriction in the 
enyne substrates for the enhancement and control of the stereoselectivity.78 Nonetheless, the 
application of this methodology towards to the synthesis of polycyclic alkaloid-type scaffolds 
provided poor diastereocontrol in the cobalt-mediated PK reaction of C2-substituted nitrogen- 
tethered enynes (Eq. 1.41).79
(1.41)
In contrast, incorporation of a C2 substituent and nitrogen tether inside a rigid cyclic structure 
drastically reduced the conformational mobility of the enyne substrate and provided a high 
level of diastereocontrol in the cycloaddition process (Eq. 1.42).80
(1.42)
The aforementioned studies by Magnus confirmed the crucial role of bulky functional groups 
in the reaction with respect to diastereocontrol. In light of these observations, Carretero 
envisioned that incorporation of a bulky group on the alkene counterpart would provide 
additional steric interactions and enhance the level of stereoinduction in the metal lacy cle 
formation, thereby providing stereoselectivity in the process. The vinylsulfone moiety proved
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to be optimal in this regard (Eq. 1.43), in which the 1,2-cw diastereoselectivity could be 
switched to facilitate the synthesis of 1 ^-rrara-substituted bicyclopentenone rings.
MOMO
^^-^^S02Ph Co2(CO)8, NMO 
------------------ >-
123
cp=°
MOM(5 h S02Ph
(1.43)
124
The observed /raws-1,2 diastereoselectivity was explained in terms of 1,3-steric interactions in 
the alkene insertion step between the C2-substituent and bulky sulfone moiety in the 
formation of the cobalt metallacycle 125a (Eq. 1.44).81
C02(C0)8
NMO
*wS02Ph
MOMO
123
<4
MOM<? H SOoPh
125a
favoured
'A,
k
MOM5) h ^02Ph 
125b
disfavoured
(1.44)
Additionally, the sulfone moiety provides a removable stereodirecting group in order to 
circumvent the poor diastereocontrol in the nitrogen-tethered PK reaction of 1,6-enynes 
(Scheme 1.37).82
Scheme 1.37. Sulfone group as a removable stereodirecting group in the PK reaction.
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The high level of diastereocontrol in the cycloaddition was rationalised in terms of increased 
steric pseudo-<xx\d\ interactions between the C2 methyl substituent and olefin group in 130a, 
which enhanced the formation of 130b and the stereoselective formation of adduct 129 (Eq.
H H
Ts H
Me
129 (1.45)
130a
disfavoured favoured
130b
1.5. Diastereoselective PK and Related Cyclocarbonylation Reactions in Total Synthesis.
1.5.1. Introduction.
Since its inception in 1971, the PK reaction has undergone extensive development as 
highlighted by the persistent exploitation of the methodology in the context of the total 
synthesis of complex natural products. The employment of a wide variety of transition metals 
broadened the substrate scope using mild operating conditions. Moreover, elegant theoretical 
and mechanistic studies provided additional insights into the reaction, thus enhancing 
understanding and the factors that control the stereochemical outcome. Finally, these 
investigations have provided a wide range of Ji-components to assemble distinctive molecular 
architectures, as outlined in Figure 1.1. The outstanding synthetic value of the PK reaction is 
clearly epitomised by the number of total synthesis involving that utilise this methodology. 
The structural complexity of the cycloadducts has prompted the employment of this strategy 
in the total synthesis of terpene and terpinoid-type natural products. Moreover, the ability to 
incorporate nitrogen tethers permits the construction of nitrogen-containing polycyclic 
scaffolds, relevant to the synthesis of biologically active alkaloids. Additionally, the ability of 
the intermolecular manifold provides cyclopentane rings, which were utilised in the synthesis 
of natural prostaglandins. The present section will highlight the application of the PK reaction
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and related metal-catalysed cyclocarbonylations in the total synthesis of challenging bioactive 
natural products.
Figure 1.1. Synthetic utility of the PK reaction in the construction of polycyclic scaffolds.
1.5.2. Terpenes.
1.5.2.1 Monoterpenes.
Pauson and Kerr outlined the problems83 with the intermolecular PK reaction in the total 
synthesis of Japanese hop ether84, which resulted in low regioselectivity and preferential 
formation of undesired butenolides. Nevertheless, the intramolecular manifold to overcame 
the abovementioned issues and resulted in an efficient synthesis of the monoterpene.85 Other 
key issues with the methodology include enhanced reactivity of brucine iV-oxide as a 
promoter in the cobalt-catalysed PK reaction (Scheme 1.38).
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Scheme 1.38. Kerr’s total synthesis of (±)-Japanese hop ether.
131 132
OTHP
Co2(CO)a
CO
-----------^
8%
Co2{CO)8 
promoter 
CO (1 atm)
O » + butenolides
H
133
°: J
H
Q±)^apanes^io^ether^
134
The development of the first Mo-catalysed hetero-PK reaction by Carretero36 {vide section 
1.2.4.1.2) provided an optimal approach for the construction of butenolide-containing natural 
products. A straightforward five-step synthesis of epi-dihydrocanadensolide demonstrated the 
synthetic potential of this methodology (Scheme 1.39).36 An analogue approach was applied 
by Gao in the construction of (-)-mintlactone A.86
Scheme 1.39. Hetero-PK reaction-mediated total synthesis of epi-dihydrocanadensolide.
O H
137
O
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"Bu
u s-
f^^^lh^rocanadensoiid^
I.5.2.2. Sesquiterpenes.
I.5.2.2.I. Diquinanes.
Additional studies by Kerr and Pauson87a described the ability of vinyl esters to behave as a 
2jt component in the intermolecular PK reaction, followed by the reductive loss of the ester
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moiety, to provide an ethylene surrogate. A key advantage of this strategy is the ability to 
avoid the utilisation of an autoclave apparatus for the, previously required, high pressure of 
ethylene. This was successfully demonstrated in the total synthesis of (+)-taylorione and (+)- 
nortaylorione (Scheme 1.40).87b
Scheme 1.40. Kerr’s total synthesis of (+)-taylorione and (+)-nortaylorione.
1.5.2.2.2 Linear Triquinanes.
Development of the intramolecular PK reaction9 in 1981 delivered a versatile platform for the 
total synthesis of cyclopentenone derivatives. In this regard, Magnus recognised the 
opportunity to utilise this approach for total synthesis of coriolin.88
Scheme 1.41. Magnus’ PK reaction-mediated total synthesis of the sesquiterpene coriolin.
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The associated high antitumor activity and the structural complexity of this sesquiterpene 
generated a wide interest in its construction, which is evident from the six completed total 
syntheses between 1980 and 1982.88b’89 The development of a PKR-mediated total synthesis 
of coriolin demonstrated the synthetic potential of this carbocyclisation and provided 
preliminary support for the Magnus-type mechanism of Co-catalysed PK reaction (Scheme 
1.41).90 The validity of the approach prompted additional investigations into the construction 
of analogous linear triquinanes. Greene et al. described a mild coupling of chiral alcohols 
with terminal alkynes to afford chiral acetylenic ethers,91 which provided the opportunity to 
utilise this functionality as a 2tc component in the PK reaction and thereby provide 
asymmetric induction in the carbocyclisation. This resulted in the first asymmetric approach 
to the sesquiterpene hirsutene (Scheme 1.42).92,93 The remarkable key advantage of this 
approach included the separation of the diastereoisomers and recover the chiral auxiliary, 
albeit the stereochemical outcome of the process was moderate.
Scheme 1.42. Greene’s asymmetric synthesis of hirsutene.
The development of Mo-mediated allenyne PK reactions31 (vide section 1.2.4.1.1) to provide 
bicyclo[4.3.0]nonane scaffolds was also utilised in the total synthesis of sesquiterpene natural 
products. Biological studies by MacDonald and Kelner94 demonstrated that HMAF 
(hydroxymethylacylfulvene) sesquiterpene has outstanding antitumoral activity and 
concomitant low toxicity. Hence, the development of an asymmetric process was desirable 
since natural (^-enantiomer has two-fold increase in activity.94
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Scheme 1.43. Total synthesis of HMAF by Mo-mediated allenynes PK reaction.
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In this context, Brummond utilised a Mo-mediated PK reaction of allenynes in the racemic 
total synthesis of HMAF (Scheme 1.43) and additionally developed a synthetic route to 
enantiopure intermediate (f?,/?)-144, thus providing the first enantioselective route to 
HMAF.32 The excellent antileukemial activity and the highly functionalised 
bicyclo[4.3.0]nonane architecture of Jatropha neopaaciflora95 sesquiterpenes prompted the 
Mukai group to investigate the Rh-catalysed PKR of allenyne 147 to assemble the complex 
scaffold 148 in a stereoselective fashion (Scheme 1.44).
Scheme 1.44. Total synthesis of Jatropha neopaaciflora sp. by Rh-catalysed allenenes PK 
reaction.
TBSO* X
C02Me
147
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This approach provided an elegant strategy for the construction of the bicyclic scaffold with
concomitant formation of two stereogenic centres (Scheme 1.44).96
Scheme 1.45. Total synthesis of achalensolide by Rh-catalysed allenynes PK reaction.
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Mukai also examined the homologous allenyne to provide the bicyclo[5.3.0]nonane 
scaffolds53a’b in the enantioselective synthesis of guaianolide (+)-achalensolide (Scheme 
1.45).97,98 Interestingly, the employment of dppp ligand is critical for the Rh-catalysed 
cycloaddition, in the context of yield.
Scheme 1.46. Total synthesis of (±)-hirsutene and (±)-1-desoxhypnophylin.
c (±)-1-Desoxyhypnophylin J
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Recently developed Rh-catalysed [m+n+1] cycloadditions reactions have emerged as a 
powerful tool for the expeditious construction of a wide variety of polycyclic scaffolds. In this 
context, the Yu group developed a highly convergent synthesis of triquinane scaffolds using a 
tandem Rh-catalysed [5+2+1] cycloaddition/aldol reaction (Scheme 1.46)." A key feature of 
the strategy involved the ability to generate three rings and four stereogenic centres in a single 
operational step. Concise and stereoselective syntheses of (±)-hirsutene and (±)-l- 
desoxhypnophylin highlighted the synthetic utility of this approach (Scheme 1.46)." The 
strategy was also applied in the total synthesis of (±)-hirsutic acid, albeit the quaternary 
stereocentre on the carbon tether was too remote to induce effective diastereocontrol in the 
cycloaddition reaction (Scheme 1.47).100,101
Scheme 1.47. Yu’s total synthesis of (±)-hirsutic acid.
[RhCI(CO)2]2,
N2:CO = 4:1 (1 atm) 
dioxane, 80 °C
then H+, RT
OTBS
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1.5.2.2.3 Angular Triquinanes.
The exploitation of the intramolecular PK reaction in the total synthesis of linear triquinane 
involved an obvious extension of the strategy for the construction of angular analogues. The 
recent isolation of several pentalenoids, which have marked antibiotical activity, provided an 
optimal scaffold for probing the synthetic potential of the carbocyclisation. Extensive studies 
by Schore led to the development of useful approaches to the (±)-pentalenene, (±)-pentalenic 
acid and (±)-silphinene angular triquinanes (Eq. 1.45).102,103 The construction of the tricyclic
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scaffold involved a Co-catalysed PK reaction of a 1,6-enyne bearing a cyclopentene moiety as 
a 2n component. Nevertheless, a major drawback with the approach was the inability of the 
remote methyl substituent to direct the stereochemical outcome of the process.103
(1.45)
Additional investigations by Pericas and Moyano on the PKR-mediated construction of 
pentalenoid derivatives provided the first enantioselective synthesis of (+)-15- 
norpentalenene.104 The bulky camphor-derived chiral auxiliary confers enhanced stereocontrol 
in the alkene insertion step and thereby promote a diastereoselective cyclisation (Scheme 
1.48).
Scheme 1.48. PK reaction-mediated asymmetric synthesis of (+)-15-norpentalenene.
(+)-15-Norpentalenene
dr= 9:1
Recent studies by Fox employed cyclopropenes to act as a reactive 2n component in the 
cobalt-catalysed PK reaction.l05a The methodology was successfully applied in the 
enantioselective synthesis of (-)-pentalenene (Scheme 1.49).105b As previously observed in
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Schore’s pentalenoid synthesis,103 substituents on the cyclic ring do not effectively direct the 
stereochemical outcome of the Pauson-Khand reaction. Hence, the poor diastereocontrol in 
the total synthesis of angular triquinanes provided the impetus to explore alternative 
methodologies.
Scheme 1.49. Fox’s asymetric total synthesis of (-)-pentalenene.
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An early total synthesis of (±)-pentalenene by Pattenden revealed that final BFa-catalysed ring 
closure of bicyclooctadiene derivative 166 promoted a highly stereoselective formation of the 
angular triquinane (Scheme 1.50).106 The disclosed ability of Rh-catalysed [5+2+1] 
cycloaddition to generate bicyclooctenone scaffolds72 was promptly exploited by Yu group in 
the synthesis of intermediate 166, thereby providing a stereoselective formal synthesis of (±)- 
pentalenene (Scheme 1.51).107
Scheme 1.50. Pattenden’s total synthesis of (±)-pentalenene.
■Pentalenene
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Scheme 1.51. Yu’s formal total synthesis of (±)-pentalenene.
Cedrene sesquiterpenes108 gained particular interest among the synthetic organic community 
in light of the unusual tricyclic structural core and wide utilisation as deodorant components. 
In this context, Kerr and Pauson reported an intramolecular PK reaction for the synthetically 
challenging construction of the fused tricyclic scaffold and thereby provide an efficient 
synthesis of (±)-a and (3-cedrene (Scheme 1.52).109 The acknowledged ability of sulfides to 
act as promoters15 conferred optimal reactivity to the Co-catalysed carbocyclisation reaction.
Scheme 1.52. Kerr and Pauson formal total synthesis of (±)-a and |3-cedrene.
The isolation and characterisation of asteriscanolide by the San Feliciano group110 provided a 
novel sesquiterpene architecture, which consists of a bicyclo[6.3.0]undecane scaffold bearing 
a bridged lactone and five stereocentres. An intriguing stereoselective total synthesis by 
Krafft involved an initial regioselective inteimolecular PK reaction to provide a highly
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functionalised cyclopentenone 174a (Scheme 1.53).111 The appropriate choice of the alkyne 
substituents facilitates a lactonisation/ring opening sequence and then the construction of the 
eight-membered ring by a RCM reaction.
Scheme 1.53. Krafft’s PKR-mediated total synthesis of (±)-asteriscanolide.
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In an alternative enantioselective total synthesis of (+)-asteriscanolide by the Yu group the 
Rh-catalysed [5+2+1] cycloaddition of chiral ene/VCP 175 provided the corresponding 
bicyclooctenone 176 (Scheme 1.54) as route to the natural product.112 The radical annulation 
then provided the requisite bridging butyrolactone ring. Nevertheless, the efficiency of both 
strategies was partially diminished by the requirement of additional synthetic steps, in order 
to achieve optimal stereoselectivity for the bridging C3 centre.111,112
Scheme 1.54. Yu’s PKR-mediated total synthesis of (+)-asteriscanolide.
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The development of the Rh-catalysed [3+2+1] cycloaddition of VCP-ynes provided a new 
approach for the construction of 6-6 bicyclic scaffolds. The exploitation of this strategy 
provided an efficient synthesis of antifeedant sesquiterpene (±)-a-agarofuran (Scheme
56
1.55).60 The excellent stereocontrol was rationalised by favourable frara-equatorial 
configuration of the ester and vinyl substituents in the alkyne insertion transition state 177- 
TS.
Scheme 1.55 Rh-catalysed [3+2+1] cycloaddition-mediated total synthesis of (±)-a- 
agarofuran.
[RhCi(CO)2]2 (5 mol%) 
toluene, CO (1 atm) Me02Cj
80 °C
177-TS
I.5.2.2.4. Tetracyclic Sesquiterpenes.
Terashima et al. reported the first total synthesis of enantiopure natural (-)- 
tricycloillicinone5u3 using a diastereoselective Co-catalysed PK reaction of enyne 179 
(Scheme 1.56).114 A remarkable feature of the carbocyclisation included the ability to exploit 
a generally unreactive bulky enones as a 2k component.
Scheme 1.56. Terashima’s PK reaction-mediated approach to (-)-tricycloillicinone.
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Co2(CO)8
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Paecilomycine A115 has an unusual trichotechane-type architecture, which is characterised by 
a fused tetracyclic core and three contiguous quaternary stereogenic centres. Supplemental 
biological studies115 revealed astonishing neurotrophic activity and, thus, identified this 
sesquiteipene as a candidate for the treatment of neurodegenerative diseases.
Scheme 1.57. Danishefsky’s total synthesis of paecilomycine A.
TBSOTBSO‘
^ Paecilomycine A
The structural complexity and intrinsic biological activity inspired the development of an 
efficient synthetic strategy. Elegant studies by Danishefsky led to the development of the first 
total synthesis of paecilomycine A (Scheme 1.57).116 In this context, the utilisation of an 
intramolecular PK reaction afforded the desired tricyclic scaffold 182 in a stereoselective 
fashion.
I.5.2.3. Diterpenes.
The discovery of the beneficial effect of amine 7V-oxides as promoters11,12 in the Co-catalysed 
PK reaction provided an opportunity to employ this process in the total synthesis of diterpene 
(+)-epoxydictymene117 by Schreiber et al. (Scheme 1.58).118 The initial Nicholas reaction of 
alkyne 183, followed by Lewis acid-catalysed Sakurai cyclisation delivered a stereoselective 
construction of bicyclooctane derivative 184, which prompted the Co-mediated PK reaction 
to afford the tetracyclic core. The NMO additive proved to be essential in order to enhance 
the stereochemical outcome of the cyclisation.118 Hence, the sequential cobalt-mediated
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process provided the direct assembly of three fused rings and two stereogenic centres in a 
single operation.
Scheme 1.58. Schreiber’s total synthesis of (+)-epoxydictymine.
a) Co2(CO)8
Q+)-Epoxydctyrnen^ 186
1.5.2.4 Nortriterpenes.
A recent total synthesis of the nortriterpinoid (±)-schindilactone A119 embodies the enabling 
role of PK methodology for the expeditious construction of complex molecular architectures 
(Scheme 1.59).,2° The synthetic challenge associated with the cyclisation of enyne 187 is 
highlighted by the cycloaddition of the cyclooctene with an alkynoate moieties, which 
required the TMTU additive to facilitate the Co-mediated reaction to afford the 
bicyclopentenone 188 with cA-stereochemistry of the bicyclo[6.3.0]undecanone bridge. A 
key advantage of the strategy included the possibility to employ the ester moiety as a 
temporary tether, which, upon reduction, unveiled the functionalised cyclopentenone 189, 
thereby serving as a “masked” stereo- and regioselective directing group.120
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Scheme 1.59. PK reaction-mediated total synthesis of nortriterpinoid (±)-schindilactone A.
1.5,3 Alkaloids.
1.5.3.1 Monocyclic Alkaloids.
The important medicinal role of (~)-a-kainic acid121 due to its anthelmintic and 
neurotrasmitting activity make it an important synthetic target.122 The problem with supply 
and the excessive price has prompted renewed interest in the synthesis of this bioactive 
monocyclic alkaloid. Yoo and coworkers envisioned the opportunity to install all the three 
contiguous stereogenic centres through a diastereoselective PK reaction/hydrogenation 
sequence.79 Further functionalisation of the cyclopentanone and ring opening would facilitate 
the introduction of the required methallyl and carboxylic side-chains. Interestingly, the cobalt- 
mediated PK reaction proceeds with poor diastereocontrol (Scheme 1.60). Moreover, 
alternative nitrogen protecting groups did not improve the selectivity of the process.79 The 
examination of the crystal structure of hydrogenated bicyclopentenone offered an explanation 
for the neglegible stereochemical outcome (Eq. 1.46).123
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Scheme 1.60. Yoo’s PK reaction-mediated total synthesis of (-)-a-kainic acid.
The spatial disposition of tosyl group under the bicyclic core leads to unfavourable steric 
interactions with methyl group on the alkyne terminus in 190, while, in contrast, the 
stereocomplementary intermediate model 191 has a steric clash between the methyl group and 
MOM group on the C2-side chain. Hence, the comparable steric interactions in both 
intermediate configurations account for the poor stereochemical outcome of the process (Eq. 
1.46). As previously discussed in section 1.4.2, conformational locking by formation of a 
rigid oxazolidinone ring enhanced facial discrimination, thus providing excellent 
diastereoselectivity (Scheme 1.61).123
Scheme 1.61. Yoo’s optimised PK reaction-mediated total synthesis of (-)-a-kainic acid.
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In a related process, Helmchen outlined that stereocontrol of the process could be otherwise 
improved by utilisation of a bulky C2 side-chain in conjunction with a Boc protecting group 
(Scheme 1.62).124
Scheme 1.62. Helmchen’s PK reaction-mediated approach to (-)-a-kainic acid.
194 195
^ (-)-q-Kainic aciti
1.5.3.2. Bicyclic Alkaloids.
Despite the modest structural complexity, natural monoterpene alkaloids exhibit a wide range 
of biological and pharmacological activities such as analgesic, hypoglycaemic and anti­
inflammatory (Figure 1.2).125
Figure 1.2. Bicyclic monoterpene alkaloids.
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Although optimal reaction conditions required stoichiometric cobalt with sulfides as 
additives, high reactivity and diastereoselectivity could be accomplished in this process. From 
a conceptual standpoint, the PK reaction of nitrogen-tethered 1,7-enynes provided an optimal 
manifold for the straightforward construction of bicyclic piperidine units. Nonetheless, 
experimental studies towards the total synthesis of (±)-tecomanine126 delineated several 
drawbacks with this strategy. As reported by Schore, the Co-mediated carbonylative 
cyclisation of 1,7-enynes afforded poor yields of the tecomanine precursor. Employment of 
alternative nitrogen protecting groups afforded comparable yields.127 Additional studies by 
Honda demonstrated the possibility of applying a PK strategy for an efficient assembly of the 
bicyclopiperidine ring as outlined in the total synthesis of bicyclic alkaloid (-)-incarvilline 
(Scheme 1.63).l28a The extension of the methodology to the total synthesis of the 
deoxygenated congener (-t-)-a-skytanthine served to illustrate the generality of this strategy 
(Scheme 1.64)128b
Scheme 1.63. PK reaction-mediated total synthesis of bicyclic alkaloid (-)-incarvilline.
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Scheme 1.64. PK reaction-mediated total synthesis of (+)-a-skytanthine.
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Although the utilisation of promoters provided a beneficial influence on the reaction rate, the 
efficacy of the strategy was lowered by poor stereoselectivity. In this context, the recent 
synthesis of kinabalurine derivatives82 demonstrated the synthetic utility of the sulfone {vide 
section 1.4.2) as a removable stereodirecting group (Scheme 1.65).82
Scheme 1.65. PK reaction-mediated total synthesis of kinabalurine derivatives.
I.5.3.3. Tricyclic alkaloids.
Extensive studies by Mukai demonstrated the formidable reactivity of the allene moiety in the 
context of metal-catalysed [2+2+1] carbocyclisations.53 From a theoretical perspective, Mukai 
envisaged that the allene moiety could be exchanged with an equally reactive heteroallene 
moiety and thereby enable a hetero-PK-type process. In this regard, the utilisation of the 
carbodiimide moiety as reactive 2n component provided the first example of cobalt-catalysed 
hetero-PK reaction.129 This methodology is particularly significant in light of the abundance 
of pyrrolo[2,3-Z>]indole scaffolds in bioactive natural alkaloids (Figure 1.3).
Figure 1.3. Pyrrolo[2,3-6]indole scaffolds in complex natural products.
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Mukai sought to exploit this enabling methodology in the total synthesis of (±)-physostigmine 
(Scheme 1.66).130,131 The cobalt-catalysed hetero-PK reaction of the carbodiimide 201 
provided the tricyclic core 202 of the parasympathomimetic alkaloid. Reductive aldol reaction 
generated the c is-con fi g urati o n on the ring junction, which ultimately resulted in an eight-step 
total synthesis of the alkaloid.129
Scheme 1.66. Hetero-PK reaction-mediated total synthesis of the tricyclic core of (±)- 
physostigmine.
MeO
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1.5.3.4. Polycyclic alkaloids.
Ogawasara reported the first application of a PKR-based approach for the assembly of 
polycyclic alkaloid scaffolds. Co-mediated carbonylative cyclisation of an enyne afforded a 
tricyclic intermediate, which was converted in a straightforward manner in the (-)-dendrobine 
core. Remarkably, this approach allowed the diastereoselective formation of three 
contiguous stereogenic centres with the appropriate cis relationship. A decade later, the Zard 
group successfully exploited the original strategy for the total synthesis of (-)-dendrobine
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(Scheme 1.67).l33a Notably, coordinating solvent acetonitrile, was necessary in order to 
achieve high reactivity in the cycloaddition process.
Scheme 1.67. PK reaction-mediated total synthesis of (-)-dendrobine.
The Zard group also applied the Co-mediated carbocyclisations for the construction of 
bicyclo[4.3.0]nonane scaffold 207 , which was then converted to the tetracyclic alkaloid (±)- 
13-deoxyserratine (Scheme 1.68)133b by radical cyclisation and silyl group removal.
Scheme 1.68. PK reaction-mediated total synthesis of (±)-13-deoxyserratine.
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Co2(CO)g, NMO 
DCM/THF
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The enabling role of this methodology was further highlighted by several synthetic 
approaches towards related Lycopodium alkaloids. For example, the magellanines skeleton134 
provided an ideal system to demonstrate the versatility of the PK cyclisation towards for 
different bicyclic and tricyclic sections of the alkaloid core. The first total synthesis of (±)- 
magellanine by Ishizaki applied the Co-mediated process to the diastereoselective assembly 
of rings B and C,135 wherein 1,3-pseudoaxial interaction between a hydroxyl group and the 
alkyne side chain accounted for the lower reactivity of 208 (Scheme 1.69). Nonetheless,
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epimerisation at C3 by a Mitsunobu/hydrolysis sequence provided the required intermediate
213.
Scheme 1.69. PK reaction-mediated formation of ring B and C of magellanine.
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Comprehensive studies by Mukai provided an elegant approach to alkaloids (-)-magellanine, 
(+)-magellaninone and (+)-paniculatine (Scheme 1.70).06 The synthetic strategy involved a 
Co-mediated PK reaction to construct the AB ring portion of the tetracyclic core and an 
additional Co-mediated cyclocarbonylation of a subsequent intermediate to efficiently 
assemble the remaining CD rings. This approach highlighted the key role of bulky enyne 
substituents to generate steric interactions and maximise the facial discrimination in the 
cobaltacycle formation step, thus conferring a high degree of stereoinduction in the 
carbocyclisation.136
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Scheme 1.70. PK reaction-mediated total synthesis of magellanine-type natural alkaloids.
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Prominent bioactivity137 and unique complex structural features, such as adjacent quaternary 
stereocentres and spirominal moieties prompted wide interest towards the total synthesis of 
lycopodine alkaloids.138 In this context, Takayama reported the first asymmetric total 
synthesis of related alkaloids lycoposerramine A and phlegmariurine A (Scheme 1.71).139
Scheme 1.71. Employment of PKR in the total synthesis of lycopodium alkaloids.
^I^coposerramin^^
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A diastereoselective Co-mediated PK reaction delivered a highly functionalised 
bicyclo[4.3.0]nonane framework in excellent yield,140 thereby enabling the strategy to be 
profitably reiterated in the asymmetric total synthesis of the related alkaloid, huperzine Q 
(Scheme 1.72).141
Scheme 1.72. Effect of the conformational restriction in the enyne substrates in the 
stereochemical outcome of the PKR.
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Nevertheless, the ability to achieve optimal stereocontrol in the carbocyclisation process 
provided an intriguing synthetic challenge. Preliminary experimental investigation on enyne 
220 demonstrated the preferential formation of the undesired adduct 221 (Scheme 1.72). 
Mechanistic considerations postulated a chair-like conformation in the intermediate 220-TS 
and that the side-chain at C15 controlled the stereochemistry in the alkene insertion step, thus 
providing 221 as the major diastereoisomer. Based on the previous works by Mukai using
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tartrate-derived 1,7-enynes78 (vide section 1.4.2), Takayama postulated that conversion of the 
diol moiety into a silicon-tethered cyclic silaketal could alter the conformation of the related 
cobaltacycle 222-TS, and thereby reverse the stereochemistry in the alkene insertion step. 
This aforementioned structural modification effectively reversed the stereochemical outcome 
of the reaction and, after silyl deprotection, allowed the exclusive formation of the desired 
adduct 223 (Scheme 1.72).141
Scheme 1.73. PKR-mediated construction of (--)-alstonerine core.
N-Cbz
The synthetic potential of the PK carbocyclisation also has additional applicability within the 
unprecedented formation of azabridged bicyclic motifs. A synthetic approach to the macrolide 
alkaloid (-)-alstonerine142 by Martin described an efficient assembly of the tetracyclic core 
using a challenging Co-mediated carbocyclisation of tryptophane-derived 1,7-enynes.143 
Derivatisation of the pentenone ring then permitted the completion of the total synthesis 
(Scheme 1.73). Despite the wide substrate scope and the ability of the PK reaction to generate 
a wide variety of polycyclic motifs, the utilization of activated alkenes and alkynes as 2jc 
components has remained unexplored. The PKR-mediated total synthesis of (±)-meloscine144 
provided a formidable synthetic challenge, which addressed this issue by exploiting ynamine, 
enamine and propiolamide moieties. A recent total synthesis of (±)-meloscine by Mukai 
successfully accomplished this goal with a remarkable Co-mediated cyclocarbonylation 
reaction of propiolamide and enamine 2ix, components, thereby allowing the expeditious 
formation of the fused tetracyclic core in a single operation step (Scheme 1.74).145
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Scheme 1.74. Mukai’s PK reaction-mediated approach to (±)-meloscine.
1.5.4. Prostanoids.
1.5.4.1. Prostaglandins.
The examination of prostaglandin lipids146 highlights an opportunity to assemble the 
cyclopentanone motif with an intennolecular PK cycloaddition (Figure 1.4).
Figure 1.4. Natural prostaglandines.
The feasibility of this approach relies on the intrinsic control of the regioselectivity and 
challenging exploitation of the reactivity of unstrained alkenes. In view of these issues, the 
development of the directed PK reaction by the Krafft group provided a major breakthrough
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and therefore enhanced the synthetic potential of the intermolecular manifold (Scheme
1.75). 14
Scheme 1.75. Directed intermolecular PK reaction.
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As outlined in Scheme 1.75, heteroatom substituted alkenes coordinate the cobalt metal 
centre and thereby provide a dual role for enhancing the metal reagent ‘s reactivity and direct 
the regiochemical outcome of the process.
Scheme 1.76. Utilisation of the directed PK reaction in the total synthesis of PGA2.
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This enabling methodology was successfully exploited in the formal total synthesis of 
prostaglandine PGA2 and outlined the ability of homoallylic sulfides to enhance regio- and 
diastereoselective formation of cyclopentenone derivatives (Scheme 1.76).147 
Greene and Pericas capitalised on the ability of chiral acetylenic ethers91 to exert high levels 
of stereocontrol, thereby providing a key step in an elegant asymmetric total synthesis of 
natural Brefeldin A.148
Scheme 1.77. Asymmetric total synthesis of brefeldin A.
The employment of the bulky mercaptoisoborneol auxiliary proved essential to promote a 
highly diastereoselective transformation (Scheme 1.77). The subsequent reh'o-Diels-Alder 
cleavage of norbomene ring149 then allowed further derivatisation of the cyclopentanone 
scaffold and completion of the synthesis. The use of norbornadiene as removable strained 
alkene was further exploited by the Riera group in the PK-mediated total synthesis of anti- 
HIV carbonucleosides, (-)-carbovir and (-)-abacavir (Scheme 1.78).150 For example, chiral 
PNSO ligands facilitated the formation of the PK adduct 242 with high enantioselectivity.
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Scheme 1.78. Enantioselective total synthesis of (-)-carbovir and (-)-abacavir.
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In contrast to the above approaches, a structural examination of 15-Deoxy-D12’14- 
prostaglandin (Figure 1.4) indicated the difficulty in applying an intermolecular 
cyclocarbonylation between alkene and alkyne units, in light of the exocyclic olefin moiety 
on the cyclopentenone ring. From a conceptual standpoint, the substitution of the alkene for 
an allene would furnish the required exocyclic olefin functionality (Scheme 1.79).
Scheme 1.79. Intermolecular PKR of allenes and alkynes.
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Nonetheless, the intermolecular cyclocarbonylation of alkynes and allenes is very synthetic 
challenging. Early reports by Narasaka151 and Gazes152 revealed on overall lack of 
regioselectivity in the process and the inability to control EIZ selectivity of the resulting 
exocyclic alkene (Scheme 1.79). The inherent reactivity of allenynes in the intramolecular 
manifold30 inspired Brummond to connect the reactive 2ji components by the means of a 
temporary silicon tether.153 This strategy favourably overcame regioselectivity issues and, 
additionally, the increased coordinative aptitude of the 2jz components to the metal centre 
enhanced the overall reactivity of the process (Scheme 1.80).
Scheme 1.80. Employment of temporary tethers in the Mo-catalysed PKR.
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The examination (vide section 1.2.4.1.1)) of the intramolecular PK reaction with allenynes 
highlighted the unique ability of molybdenum catalysts to promote an exclusive formation of 
bicyclopentenones derivatives bearing an exocyclic alkene.30 Hence, Brummond postulated 
that a Mo-catalysed PKR of temporary-tethered allenynes could promote an optimal 
cycloaddition process and further provide the desired a-methylene cyclopentenone, upon 
removal of the tether. The testing of the aforementioned hypothesis resulted in the first total 
synthesis of 15-Deoxy-A12’14-prostaglandin J2 (Scheme 1.81),154 Mo-mediated 
cyclocarbonylation of silicon-tethered allenyne provided the desired bicyclic adduct in 
moderate yield and with low F/Z selectivity, albeit the yield of desired E'-adduct could be 
improved via a Lewis acid-catalysed isomerisation. The removal of the silicon tether and side 
chain derivatisation completed the synthesis of the natural prostaglandin.
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Scheme 1.81. Utilisation of Si-tethered enynes PKR for the total synthesis of 15-Deoxy- 
D12’14-prostaglandin /2-
toluene
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I.5.4.2. Prostacyclins.
The key role of the intramolecular PK process for the construction of sesquiterpene-type 
natural products revealed the possibility to extend the valuable methodology towards the total 
synthesis of carbacyclins and isocarbacyclins (Figure 1.5).155
Figure 1.5. Natural prostacyclins.
^Carbacyclir^^ Qlsocarbacyclin
Moreover, this synthetic approach could install the required \,2-cis diastereoselectivity in the 
corresponding bicyclic adducts, as previously observed in the total synthesis of coriolin. 
Seminal studies by Magnus explored the feasibility of the strategy towards the construction of 
carbacyclin analogues (Scheme 1.82).156 Preliminary mechanistic studies hypothesised that
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incorporation of the secondary hydroxyl group and C2 substituent into a rigid lactone 
structure could enhance steric interactions between the ring and acetylenic TMS, thus 
enhancing 1,2-cis diastereoselectivity of the cyclisation adduct. Unfortunately, PK reaction of 
enyne 254 showed and overall lack of reactivity due to the strained nature of the lactone and 
the inability for the alkene to insert. In contrast, the unstrained acetonide ring provided 
optimal reactivity for 255 and the desired 1,2-cis diastereoselectivity in the bicyclic adduct 
256 (Scheme 1.82),
Scheme 1.82. Magnus’s synthesis of carbacyclin derivatives.
Medicinal studies on stable prostacyclin surrogates revealed prominent antithrombotic 
activity of isocarbacyclin and relative synthetic analogues.157 Hence, in view of their 
widespread therapeutic utility, Saito and coworkers examined the viability of a synthetically 
valuable PK-mediated approach (Scheme 1.83).158
Scheme 1.83. PK reaction-mediated construction of isocarbacyclin.
258
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Treatment of L-ascorbic acid-derived enyne 258 under Co-mediated carbonylative conditions 
furnished the desired bicyclic core 259 as a single stereoisomer (Scheme 1.83). Further 
introduction of aliphatic side chains enabled the total synthesis of isocarbacyclin and provided 
a potential route for related bioactive analogues. For example, prostacyclins are used for the 
treatment of pulmonary hypertension. The aqueous sodium salt solution (Flolan®) provided 
the most effective therapy for the disease. Nonetheless, the moderate biological half-life and 
degradation upon transit through lungs159,1 prompted an examination of potential bioactive 
suiTogates. In this context, treprostinil displayed improved in vitro and in vivo stability and 
subsequently marketed under the trade name Tremodulin® and Tivaso®.159b'159c The increasing 
demand for an efficient and scalable synthetic approach, prompted the Moriarty group to 
employ the PK methodology in an expeditious synthesis of the tricyclic core, which was 
converted to treprostinil in a concise manner (Scheme 1.84).160
Scheme 1.84. PK reaction-mediated construction of the tetracyclic core of treprostinil.
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Co-mediated cyclocarbonylation of enyne 260 delivered the tricyclic core in high yield and 
with excellent diastereocontrol. Enone reduction and side chains derivatisation delivered a
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concise 15-step synthesis of the prostacyclin analogue from inexpensive 3-methoxybenzyl
alcohol.160
1.6. Investigation of the Rhodium-catalysed Diastereoselective PK Reaction.
1.6.1. Introduction.
The development of the Rh-catalysed PK reaction by Narasaka49 provided initial insight into 
the diastereoselectivity for this process. In this context, the reaction is stereo specific for the 
formation of the cis- and trans- bicyclopentenone derivatives 263 and 264, depending on 
which geometrical isomer is employed (Eq. 1.47).
[RhCI(CO)2]2 (1 mol%)
CO (1 atm), dibutyl 
ether
263:264 = 95:5
Ph
Et02C
Et02C O
264
(1.47)
Low concentration of carbon monoxide and high substrate molarity was necessary for optimal 
reactivity in the process and thereby avoid the competitive ene-type cycloisomerisation 
reaction.
[RhCI(CO)2l2 (5 mol%)
In light of Magnus’ observations on the diastereoselective Co-catalysed PK reaction in the 
total synthesis of coriolin {vide section 1.5.2.2.2), analogous studies on the Rh-catalysed 
manifold demonstrated that the reaction proceeds with high 1,3-cw-stereoselectivity, despite
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the moderate 1,3-jasewfifo-axial interactions between C3-substituent and methyl group on the 
alkyne terminus (Eq. 1.48).6 In contrast, the examination of 1,2-diastereoselectivity in this 
process was surprisingly unexplored. In this context, an unprecedented sequential Rh- 
catalysed allylic alkylation/PK reaction161 process, developed by Evans and Robinson, 
estabilished the opportunity to conduct a highly diastereoselective Rli-catalysed PK reaction 
using C2-substituted 1,6-enynes. Moreover, this study provided the basis for additional 
mechanistic investigations to rationalise the stereochemical outcome of these reactions.162 The 
enabling role of the metal-catalysed allylic alkylation163 process to promote the formation 1,6- 
enynes coupled with the exquisite reactivity of these substrates in the PK carbocyclisation 
reactions provided the ability to merge these two strategies in a metal-catalysed domino-type 
process. Hence, this could either be accomplished using two metal catalysts or a single 
catalyst that is capable of catalysing both reactions.
Scheme 1.85. Jeong’s sequential allylic alkylation/PK annulation strategy.
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In this context, Jeong disclosed the first sequential allylic alkylations/PK carbocyclisation 
(Scheme 1.85).164 Detailed optimisation studies revealed that a combination 
Pd2(dba)3(CHCl3) and [RhCl(CO)(dppp)]2 promotes the domino process without any 
modification of the solvent system and temperature. Nonetheless, the synthetic value of this 
strategy was reduced by the inability to conduct the transformation in presence of a single
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metal catalyst. Additionally, oxygen nucleophiles as propargyl alcohols displayed no 
reactivity in the process and regioselectivity issues in the Pd-catalysed alkylation step 
required the simple unsubstituted allyl acetate (Scheme 1.85). In contrast, Evans and 
Robinson reported a sequential Rh-catalysed allylic alkylation/PK reaction, which utilises a 
single precatalyst and deals with regio- and diastereocontrol (Scheme 1.86).161
Scheme 1.86. Evans’ tandem allylic alkylation/PK annulation strategy.
XH
[RhCI(CO)(dppp)]2 
,R (5 mol%), LiHMDS
+ °^0Me CO (1 atm), MeCN
A ------------------------ ►-
°Y^
R1
X “ C(C02Et)2, NTs, O 
R= Me, H, Ph
30 °C
IV
Xv ^-Rir*
R'
80 °C
Ml
The observed cA-diastereoselectivity in the PK process was initially rationalised through 
reversible metal binding which results in the preferential formation of iv, due to the steric 
interactions between C2-substituent and bulky rhodium catalyst (Scheme 1.87).161 Evans and 
coworkers group developed a highly regioselective Rh-catalysed alkylation reaction166 and the 
ability of rhodium catalysts to promote regioselective formation of C2-substituted enynes 
outlined the opportunity to conduct a novel diastereoselective tandem reaction. Hence, 
optimisation studies showed that the utilisation of [RhCl(CO)(dppp)]2 in acetonitrile 
efficiently promoted both the allylic alkylation and PK reaction with high levels of regio- and 
diastereoselectivity, thus leaving temperature as the sole parameter to be modulated for the 
optimal reactivity of the domino process (Scheme 1.86).161 Remarkable features of the 
strategy included the ability to employ propargyl alcohols as nucleophiles and a wide range of 
substituents on the alkyne terminus.
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Scheme 1.87. Proposed origin of diastereoselectivity in the Rh-catalysed PK reaction.
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Moreover, the level of diastereoselectivity in this process was dramatically influenced by the 
nature of the enyne tether (Table 1.1).161
Table 1.1. Influence of the tether nature on the diastereoselectivity of the Rh-catalysed 
tandem allylic alkylation/PK reaction.
XH
268
[RhCI(CO)(dppp)]2 
(5 mol%), Li HMDS 
CO (1 atm), MeCN
30 to 80 °C
entry X Alkyne Yield (%) cis trans dr (cis\trans)
1 0 269 63 272 273 ^19:1
2 NTs 270 79 274 275 3:1
3 C(C02Me)2 271 82 276 277 5:1
Supplementary studies revealed that the employment of high CO pressure in the tandem 
reaction could reverse the stereochemical outcome of the process, thus favouring the 
preferential formation of /raws-bicyclopentenone adducts (Scheme 1.88).165
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Scheme 1.88. Effect of the CO pressure on the diastereoselectivity of the Rh-catalysed 
tandem allylic alkylation/PK reaction.
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In light of the prominent influence of the tether and carbon monoxide pressure, steric 
arguments could not account for the stereochemical outcome of the reaction. Additional 
mechanistic investigations were therefore required in order to gain an optimal understanding 
into the origin of selectivity. This prompted the Evans and Baik groups to employ a synergic 
combination of computational and experimental studies in order to garner further insights into 
the diastereochemical outcome of the Rh-catalysed PK reaction.162
1.6.2. Effect of the CO Concentration on the Diastereoselective Rh-catalysed PK 
Reaction.
Initial computational studies focused on the analysis of the Rh-catalysed PK reaction of 1,6- 
enyne 279 and related formation of bicyclopentenone adducts 280 and 281 (Eq. 1.49).
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The objective of the computational study was the identification of the active catalytic species 
and the formulation of a mechanistic pathway that could explain the observed stereochemical 
outcome.162 Additionally, the study allowed further insights to be gained into the role of the 
CO ligand in the carbocyclisation.
Scheme 1.89. Putative mechanistic pathways of the diastereoselective Rh-catalysed PK 
reaction under carbon monoxide atmosphere.
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The generally accepted mechanism for the Rh-catalysed PKR involves initial ji coordination 
of the alkene and alkyne to the rhodium metal centre, followed by the oxidative addition and 
formation of a five-membered rhodium metallacycle. Subsequent CO insertion and final 
reductive elimination provides desired bicyclopentenone adduct with regeneration of the
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rhodium catalyst. Although the formulation of a detailed reaction mechanism was partially 
precluded by their limited knowledge of the catalytically active rhodium species, the authors 
envisaged two plausible mechanistic pathways for catalysts [Rh^^CO)] (Scheme 1.89, 
pathway A) and [RhICl(CO)2] (Scheme 1.89, pathway B).162 Hence, depending on the nature 
of the catalytic active species, Jt coordination of 1,6-enyne x would provide either the 16- 
electron square planar complex ii or 18-electron trigonal bipyramidal analogue iii. 
Computational analysis examined the relative reaction energy profdes for each complex, in 
the context of the aforementioned mechanistic pathway.167
Scheme 1.90. Energy profile for mechanistic pathway A.
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Scheme 1.90 outlines the computed solution-phase free-energy reaction profile employing 
[Rh'C^CO)] as the catalytically active species (pathway A). Upon initial ji coordination of the 
enyne to the rhodium centre and formation of the square planar complex i, subsequent 
oxidative addition could generate two possible diastereoisomeric rhodium metallacycles, in 
which the C3 hydrogen atom is either anti (Scheme 1.90, complex ii’) or syn to the C2- 
substituent R1 (Scheme 1.90, complex ii). Examination of the solution-phase activation free
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energies of related transition states i-TS’ (28.82 Kcal mol'1) and i-TS (27.59 Kcal mol'1) 
indicated a difference of 1.2 Kcal mol1, which can be equated of an approximate 
diastereomeric ratio {dr) of 10:1 in favour of cis adduct 280. Hence, the computed energetic 
difference between transition states i-TS’ and i-TS could not efficiently rationalise the 
experimentally high diastereoselectivity in the carbocyclisation process (Eq. 1.49).
Scheme 1.91. Energy profile for mechanistic pathway B.
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As the rhodium centre accepts a electron density from the additional CO ligand, the 
antibonding interaction of the trigonal-bipyramidal complex with the original enyne becomes 
more prominent. Thus, axial coordination of an additional CO ligand to the /Tsewafo-square- 
planar rhodium centre forces the chlorine ligand to adopt a trans axial spatial disposition into 
trigonal-bipyramidal complex vi. Coordination of an additional CO ligand and the resulting 
formation of a five-coordinate rhodium complex did not provide a substantial variation in 
activation energy for the formation of the syn metallacycle (27.59 Kcal mol1 for i-TS, 
Scheme 1.90 vs 26.57 Kcal mol1 for vi-TS, Scheme 1.91). On the contrary, activation energy
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for the formation of anti metallacycle was dramatically influenced by the geometry of the 
catalytically active rhodium complex (28.82 Kcal mof1 for i’-TS, Scheme 1.90 vs 33.56 Kcal 
mof1 for vi’-TS, Scheme 1.91). Examination of the solution-phase activation free energies of 
transition states vi-TS’ (33.56 Kcal mof1) and vi-TS (26.57 Kcal mof1) in pathway B 
indicated a difference of 7.0 Kcal mof1, thereby predicting an approximate diastereomeric 
ratio {dr) of >99:1 in favour of the cis PKR adduct 280, Hence, formation of the trigonal- 
bipyramidal complex vi (pathway B, Scheme 1.88) as the prevalent catalytically active 
species accounted for the experimentally observed cis diastereoselectivity in the PK reaction 
(Eq. 1.49). The equilibrium between square-planar complex 1 and trigonal bipyramidal vi is 
clearly dependent on CO concentration in the system, whereas complex vi will be prevalent at 
relatively high CO concentration and complex i will be the predominant species at lower CO 
concentration. Therefore, the computational investigations predicted a relative loss of 
diastereoselectivity in the Rh-catalysed PK reaction at low CO concentration, in view of the 
shift in equilibrium towards the formation of the square planar complex i.
Table 1.2. Influence of the CO concentration in the Rh-catalysed PK reaction of enyne 279.
Rh catalyst (3 mol%) 
p-xylene 
CO/Ar (1 atm)
entry
CO
Pressure
Ar
Catalyst Yield (%) dr
280:281
1 1.00 0.00 [RhCI(CO)2]2 81 22:1
2 0.10 0.90 [RhCI(CO)2]2 64 10:1
3 0.05 0.95 [RhCI(CO)2]2 57 6:1
4 1.00 0.00 [RhCI(CO)(dppp)]2 88 *99:1
5 0.10 0.90 [RhCI{CO)(dppp)]2 51 58:1
6 0.05 0.95 [RhCI(CO){dppp)]2 44 57:1
280 281
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Exploitation of the theoretical findings prompted the experimental correlation study between 
CO concentration and related diastereochemical outcome of the Rh-catalysed PK reaction 
system (Table 1.2, entries 1-3).162 As outlined in Table 1.2 (entry 2 and 3) the employment of 
low CO concentration resulted in a significant reduction in the diastereoselectivity of the 
process, thus endorsing the validity of the aforementioned computational predictions. 
Additionally, Baik and Evans envisaged that utilisation of metal-binding phosphine ligands 
could enforce the aptitude of Rh complexes to adopt trigonal bipyramidal geometry, thus 
providing enhanced diastereoselectivity in the reaction. Ligand optimisation studies 
estabilished that [RhCl(CO)(dppp)] imparts a high degree of diastereoselectivity, regardless 
of the CO concentration in the reaction (entries 4-6).
In summary, a combination of high-level density functional theory calculations and 
experimental studies disclosed fundamental mechanistic insights into the rhodium-catalysed 
Pauson-Khand reaction. Additionally, this work highlighted the powerful influence of CO 
concentration to promote the formation of trigonal bipyramidal catalytic species and enhance 
the diastereoselectivity of the process, thus disproving the original hypothesis of a purely 
sterically driven model for stereocontrol.
Table 1.3. Diastereoselective Rh-catalysed PK reaction of nitrogen and carbon-tethered 
enynes 282 and 283.
[RhCI(CO)2]2 (3mol%) 
p-xylene 
CO/Ar (1 atm)
O0OV
-----
4 H H
entry Pressure X Enyne Yield (%) cis trans dr
CO Ar cis:trans
1 1.00 0.00 NTs 282 77 284 285 3:1
2 0.10 0.90 » " 69 1:1
3 1.00 0.00 C(C02Me)2 283 80 286 287 5:1
4 0.10 0.90 11 " 64 ■I ii 2:1
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Nevertheless, low degree of diastereoselectivity in the Rh-catalysed PK carbocyclisation of 
nitrogen and carbon-tethered enynes 282 and 283 remained a barrier for a highly general and 
selective carbocyclisation strategy (Table 1.3).168 In light of the success with high-level 
density functional theory (DPT)56,72,169’170 to predict and rationalise the stereochemical 
outcome of metal-catalysed carbocyclisation reactions, we decided to undertake additional 
computational and experimental studies and provide a new hypothesis to attain high 
diastereoselectivity in the rhodium(I)-catalysed PK reaction,169 irrespectively from the nature 
of the tether.
1.6.3. Computational and Experimental Investigation of the Substitution Pattern 
on the Alkyne Terminus.
The computed solution-phase free-energy reaction profile for the rhodium trigonal 
bipyramidal species (Scheme 1.89) revealed a notable activation energy difference (7 Kcal 
moll) for the formation of syn (complex iii) and anti (complex in’) metallacycles and 
consequent high diastereoselectivity in the process.162 Hence, in collaboration with the Baik 
group, we aimed to investigate the origin of the high diastereoselectivity in the oxidative 
addition step by computational analysis of transition states la-TS-1 and la-TS-2 which 
further furnish the cis- and trans- PK adducts, respectively (Scheme 1.92).171 Examination of 
the partial charges172 of the carbon atoms forming the C-C bond revealed an intriguing 
electronic feature. Although, both transition states are highly charge polarised, they displayed 
opposite direction of polarisation at the distal carbon atoms in the metallacyclic intermediates, 
as outlined by the partial charges in the transition states (Scheme 1.92). The computed partial 
charge for the C3-position is positive for la-TS-1 (+0.34) and negative for la-TS-2 (-0.34). 
Furthermore, the C3’ in la-TS-1 and la-TS-2 is polarised with opposite sign (-0.10 and 
+0.11 respectively), which suggests that the oxidative addition is best conceptualised as a 
heterolytic cleavage of the Ji-bonds followed by an electronic reorganisation (Scheme 1.92).
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Scheme 1.92. Computational analysis of partial charges of transition states la-TS-1 and la- 
TS-2.
-0.10 0.11
0.34 -0.34
1a-TS-1 1a-TS-2
Conformational analysis of la-TS-1 and la-TS-2 provides a rationale for the observed charge 
polarisation pattern and the origin of stereocontrol in this process. As illustrated by the 
Newman projections (Figure 1.6), the methyl group at the C2-position is in a tram- 
disposition relative to the sp~-hybridised orbital on C3, which will form a new 6-bond with 
the C3’-carbon in la-TS-1.
Figure 1.6. Newman projections of la-TS-1 and la-TS-2.
This orientation is necessary for obtaining the c/s-adduct, since it provides the necessary syn- 
orientation of the C3-hydrogen relative to the C2-methyl group. Similarly, formation of the 
trans-PKR product results from the sp2-hybridised orbital becoming syn to the C2-methyl in 
la-TS-2 (Figure 1.6). Considering the structural requirements in the transition state, the 
electronic consequences are evident. In la-TS-1 hyperconjugation amplifies the +1 effect of 
the methyl group, which stabilises the developing positive charge on C3. Alternatively, in la- 
TS-2 the methyl group is orthogonal to the sp'-orbital on C3, which reduces the electronic 
communication between the methyl group and the C3 sp2-orbital. With the charge directing
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effect of the methyl group reduced by this structural arrangement, the -I effect of the 
methylene moiety (blue in Figure 1.6) stabilises the developing negative charge on the sp2- 
orbital on C3. This in turn causes a reversal of the charge polarisation in the metallacycle la- 
TS-2 compared to la-TS-1 (Scheme 1.92).
As previously discussed, the employment of [RhCl(CO)] as catalytically active species 
displayed moderate activation energy difference (1.2 Kcal mof1) for the formation of syn 
(complex ii) and anti (complex ii’) metallacycles, thereby predicting low diastereocontrol in 
the process (Scheme 1.89).162 Hence, we were prompted to perform computational analysis of 
the partial charges of 2a-TS-l and 2a-Ts-2 in order to assess the origin of the lower 
diastereoselectivity provided by square-planar rhodium species (Scheme 1.93).
Scheme 1.93. Computational analysis of partial charges of transition states 2a-TS-l and 2a- 
TS-2.
2a-TS-1 2a-TS-2
Examination of the partial charges of the relevant carbon atoms forming the C-C bond 
exhibited a divergent polarisation pattern, in which both transition states showed moderate 
charge and displayed a similar direction of polarisation at the distal carbon atoms in the 
metallacyclic intermediates, as outlined by the partial charges in the transition states (Scheme 
1.93). The computed partial charge for the C3-position is both positive and similar for 2a- 
TS-1 (+0.04) and 2a-TS-2 (+0.05). Furthermore, the C3’ in 2a-TS-l and 2a-TS-2 is only 
slightly polarised with the opposite sign (-0.04 and +0.10, respectively), which suggests that 
the oxidative addition is best conceptualised as a radical recombination-type mechanism 
(Scheme 1.92).
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Figure 1.7. MO of square planar Rh-fragment (A), trigonal-bipyramidal Rh fragment (B) and 
oxidative addition process for trigonal-bypiramidal Rh species (Bl).
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In summary, the oxidative addition process for square planar and trigonal bipyramidal 
involves different mechanisms, namely a closed-shell electron-pair polarisation-type (Scheme 
1.92) and a radical recombination-type mechanism, respectively (Scheme 1.93). Analysis of 
molecular fragments ol rhodium trigonal bipyramidal and square planar coordination 
complexes clarifies the varying nature of their subsequent oxidative addition process. As 
outlined in Figure 1.7, the HOMO of the rhodium atom in square planar (A) and trigonal 
bipyramidal (B) have different shapes, respectively d(z2) and d(x2-y2). Therefore, in the 
subsequent oxidative addition step, orbital d(x2-y2) of trigonal bipyramidal rhodium complex 
is occupied and points directly towards the direction where the two new Rh-C bonds will be 
formed (Figure 1.7, Bl). This orbital promotes a “push-pull” type of reaction that leads to the 
oxidative addition of the closed-shell electron-pair polarisation type. Hence, the distorted 
trigonal-bipyramidal complex promotes a stereoselective oxidative addition process in view
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of the ability of the Rh centre to direct the charge polarisation as to match the heterolytic 
charge redistribution of the reactant. In contrast, the d(x2-y2) orbital is empty in the 
corresponding square-planar rhodium system, thus the complex can not efficiently control the 
diastereoselectivity in the following oxidative addition step. A summary of the divergent 
mechanistic pathways is outlined in Figure 1.8.
Figure 1.8. Oxidative addition mechanism for trigonal-bipyramidal and square-planar RIi 
complexes.
high CO concentration
trigonal bipyramidal
closed-shell electron-pair 
polarization
high diastereoselectivity
low CO concentration 
square planar 
radical recombination 
low diastereoselectivity
The discussed computational analysis of the charges of distal carbon atoms of intermediate 
rhodium metallacycles provided an intriguing paradigm for the augmentation of reactivity and 
diastereocontrol in the Rh-catalysed PK reaction. From a conceptual standpoint, mimicking of 
the theoretical charges in transition state la-TS-1 (Scheme 1.92) by means of an enyne 
prepolarisation could efficiently serve this purpose (Scheme 1.94).
Scheme 1.94. Prepolarisation of 1,6-enynes by modification of the alkyne terminus.
prepolarysed
enyne ii
improved reactivity 
and diastereocontrol
R2
X 0
* H
R1
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Theoretical analysis of several electron withdrawing groups (R2 = aryl, ester and halide 
groups) indicated that the addition of a halogen to the alkyne terminus173 should induce a 
positive partial charge at the C4’-position (Table 1.4), and thereby decrease the energy barrier 
foi the rate-determining step to provide the conditions for a spontaneous room temperature 
reaction.174
Table 1.4. Effect of the C4’ substituent on the computed barrier for the metallacycle 
formation (Scheme 1.91, R1 = Me).a
entry r2 enyne 4Gca/csynb AGca/canti*3
1 H 288 28.4 31.1
2 Cl 289 24.5 29.3
3 Br 290 24.5 29.5
4 I 291 25.7 30.3
3 Jaguar 7.0, Schrodinger, LLC, New York, NY, 2007. b Kcal mo|-1.
Hence, we elected to examine the predicted reactivity of halogenated 1,6-enynes by means of 
a challenging room temperature diastereoselective PK reaction. As predicted by the computed 
activation energy barriers, the unsubstituted enyne 296 did not display any reactivity in the 
PK process at room temperature (entry 1, Table 1.5). Replacement of the alkyne moiety with 
a biomine unit (entry 3) provided moderate reactivity in the carbocyclisation, albeit the 
resulting adduct 298 was prone to undergo decomposition after isolation. Gratifyingly, the 
chloride substituted alkyne conferred optimal reactivity at room temperature and allowed for 
the formation of bicyclopentenone derivative 305 in good yield (entry 2, Table 1.5). Similar 
investigation on nitrogen-tethered enynes confirmed the outstanding ability of chlorinated 
1,6-enynes to promote Rh-catalysed PK reaction under extremely mild operating conditions 
(entry 7), while analogous bromine and iodine derivative displayed an overall lack of 
reactivity. Finally, the carbon-tethered bicyclopentenone adduct could also be obtained in 
good yield at room temperature (entry 10). In light of these promising results, we decided to
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investigate the reactivity and stereochemical outcome of a wide variety of C2-substituted 1 }6- 
enynes under carbonylative conditions.
Table 1.5. Effect of the C45 halogen substituent on the Rh-catalysed PK reaction.”
Rh-catalysed
PKR
R
O
entry X R Enyne Yield (%)b Product
1 0 H 296 NR 305
2 " Cl 297 74 306
3 Br 298 39 307
5 " 1 299 NR 308
6 NTs H 300 NR 309
7 ti Cl 301 81 310
8 Br 302 NR 311
9 '■ 1 303 NR 312
10 C(C02Me)2 Cl 304 74 313
a Ail reactions were carried out on a 0.2 mmol scale utilizing 5 mol% 
[RhCi(CO)2]2 in p-xylene (0.1 M) at 25 °C under CO atmosphere (1 
atm). b Isolated yields.
1.6.4. Scope of the Room Temperature Diastereoselective PK Reaction of 1,6- 
Chloro Enynes.
An initial optimization study on the reactivity of C2“substituted halogenated enynes 
confirmed the ability of the chloride moiety to confer excellent reactivity for this process 
(entry 1, Table 1.6). Moreover, the observed excellent reactivity and stereoselectivity for 
enyne 314 is particularly significant in view of the poor diastereoselectivity displayed by 
nitrogen-tethered enynes in previous rhodium 161 and cobalt-catalysed11 PK reactions.
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Table 1.6. Room temperature Rh-catalysed diastereoselective PK reaction of C2-methyl- 
substituted haiogenated l,6-enynes.a
entry X Enyne Yield (%)b CIS trans cis\transc
1 Cl 314 80 317 318 97:3
2 Br 315 NR 319 320 ll
3 I 316 NR 321 322 »
aAH reactions were carried out on a 0.2 mmol scale utilizing 5 mol% 
[RhCI(CO)2]2 in p-xylene (0.1 M) at 25 °C under CO atmosphere (1 atm). 
b Isolated yields. c Ratios of diastereoisomers were determined by 
HPLC or GC analysis of the crude products.
Table 1.7 illustrates the scope of the diastereoselective room temperature PK methodology. 
Treatment of nitrogen and oxygen-tethered enynes under the actual conditions provided the 
corresponding bicyclopentenone adducts in good overall yield. Remarkably, the nature of the 
tether and the employment of benzyl, alkyl and hydroxymethyl C2 substituent provided a 
highly diastereoselective Rh-catalysed carbocyclisation. In this context, a benzyl substituent 
(entry 3 and 7, Table 1.7) proved to exert a beneficial effect in the process, thus allowing 
complete diastereocontrol and excellent yield. An additional key feature of the methodology 
included the exceptionally mild operating conditions and the ability to conduct the process at 
ambient temperature with a low catalyst loading. The aforementioned computational studies 
highlighted the ability of a trigonal bypiramidal rhodium species to exert a dramatic influence 
on the activation energy for the formation of syn- and anti- metallacycles, thereby conferring 
enhanced diastereoselectivity in the overall carbocyclization process. Hence, the employment 
of a high concentration of carbon monoxide proved to be of fundamental to enable the 
coordination of an additional CO ligand and achieve the required geometry.
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Table 1.7. Scope of the RT diastereoselective Rh-catalysed PK reaction of chlorinated 1,6- 
enynes.a
entry X R Enyne Yield (%)b CIS trans cis:transc
1 NTs Me 314 80 317 318 97:3
2 " CH2OBn 319 73 323 324 *99:1
3 If Bn 320 84 325 326 *99:1
4 O Me 289 82 327 328 98:2
5 M CH2OBn 321 84 329 330 *99:1
6 M Bn 322 87 331 332 *99:1
a All reactions were carried out on a 0.2 mmol scale utilizing 5 moI% 
[RhCI{CO)2]2 in p-xylene (0.1 M) at 25 °C under CO atmosphere (1 atm). b 
Isolated yields. c Ratios of diastereoisomers were determined by HPLC or 
GC analysis of the crude products.
In view of the computationally predicted and experimentally confirmed role of the CO 
concentration, we elected to examine the influence of the carbon monoxide concentration in 
the room temperature PK reaction of chlorinated 1,6-enynes and thereby examine its 
influence on the diastereoselectivity of the process. Table 1.8 outlines the reactivity and 
stereochemical outcome of the carbocyclization under reduced CO concentration (Ar:CO - 
10:1). As predicted, oxygen-tethered enynes furnish the corresponding bicyclopentenones 
derivatives with a high level of stereoselectivity, albeit with a slight reduction in the overall 
yield (entries 4-6, Table 1.8 and, entries 4-6, Table 1.7). In contrast, the variation of the CO 
atmosphere provided diminished reactivity and diastereocontrol for the analogous nitrogen- 
tethered substrates (entries 1-3, Table 1.8 and entries 1-3, Table 1.7). Hence, the reduction in 
diastereoselectivity supports the hypothesis that square-planar rhodium complexes, prevalent 
species imder reduced CO concentration, proceed through a different TS which is suboptimal 
for obtaining high level of diastereoselectivity in the oxidative addition step.162
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Table 1.8. Room temperature RJh-catalysed diastereoselective PK reaction of chlorinated 1,6- 
enynes at low CO concentration (Ar:CO = 10:1),
entry X R Enyne Yield (%)b cis trans cis:transc
1 NTs Me 314 69 317 318 85:15
2 " CH2OBn 319 59 323 324 87:13
3 II Bn 320 63 325 326 76:23
4 O Me 289 76 327 328 96:4
5 II CH2OBn 321 64 329 330 99:1
6 11 Bn 322 65 331 332 £=99:1
aAll reactions were carried out on a 0.2 mmol scale utilizing 5 mol% 
[RhCI(CO)2]2 in p-xylene {0.1 M) at 25 °C under Ar:CO atmosphere (10:1,1 
atm). b Isolated yields.0 Ratios of diastereoisomers were determined by 
HPLC or GC analysis of the crude products.
1.6.5. Limitations of the Reaction.
As discussed, the installation of a chloride unit on the alkyne terminus reduces the activation 
energy in the oxidative addition step and confers enhanced reactivity in the process, thus 
enabling the accomplishment of a mild and stereoselective PK reaction. Nonetheless, 
additional experimental investigations revealed that prominent reactivity of chlorinated 1,6- 
enynes was largely affected by the size of substituent on the C2 position. In this context, 
substrates containing cyclic C2 substituents whether aliphatic or aromatic, display no 
reactivity in the Rh-catalysed carbocyclisation (Eq. 1.50). A plausible rationale for the 
observed behaviour could involve the steric effect exerted by the cyclic C2 moiety and the 
inability of the enyne substrate to efficiently coordinate to the metal centre. Hence, as 
described in previous studies on the diastereoselective Rh-catalysed PKR with enynes bearing 
cyclic C2 substituents require harsh thermal conditions in the process (T = 110 °C).168
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[RhCI(CO)2]2 (5 moI%)
NR
R enyne
Cy 333
2-furyl 334 
p-F-C6H4 335
(1.50)
The sequential Rli-catalysed tandem allylic alkylation/PK reaction developed by Evans and 
Robinson highlighted the effect of the tether nature on the diastereoselectivity of the reaction. 
Nonetheless, the employment of thermal conditions (80 °C) provided excellent reactivity rates 
for nitrogen, oxygen and carbon-tethered enynes.162 In contrast, the development of the Rli- 
catalysed methodology with chlorinated 1,6-enynes demonstrates a remarkable influence of 
the tether on the reactivity at ambient temperature. As highlighted in Table 1.9, oxygen and 
nitrogen-tethered enynes 289 and 314 displayed high reactivity towards the carbocyclisation 
reaction whereas the analogous carbon-tethered substrate 336 displayed on overall lack of 
reactivity even after prolonged reaction time (48 h).
Table 1.9. Effect of tether nature on the reactivity of the RT Rh-catalysed diastereoselective 
PK reaction of chlorinated 1,6-enynes.a
entry X Enyne Time (h) Yield (%)b cis trans cis:transc
1 0 289 20 82 327 328 98:2
2 NTs 314 27 80 317 318 97:3
3 C(C02lVle)2 336 48 NR 337 338 '■
a All reactions were carried out on a 0.2 mmol scale utilizing 5 mol% 
[RhCI(CO)2]2 in p-xylene (0.1 M) at 25 °C under CO atmosphere (1 atm). b 
Isolated yields.0 Ratios of diastereoisomers were determined by HPLC or GO 
analysis of the crude products.
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Interestingly, in a related development in the group, the novel [2+2+2] Rh-catalysed 
carbocyclisation of diene-ynes175 also suffers from low reactivity with carbon-tethered 
precursors in the formation of bicyclic and tricyclic scaffolds under mild thermal conditions 
(Table 1.10).
Table 1.10. Effect of tether nature on the Rh-catalysed [2+2+2] cycloaddition reaction of 
diene-ynes.
)r~ '
OHC
NTs
J
[Rh(cod)CI]2 (5 moI%) 
dppp (12 mol%), benzene 
- ------------------------------►
60 °C
NTs
H
CHO
entry X Enal Yield (%) Product dr
1 0 339 76 342 :>19:1
2 NTs 340 73 343 &19:1
3 C(C02Me)2 341 NR 344 —
Scheme 1.95. Oxidative addition process for enynes and diene-ynes.
Me02C-
Me02C‘
Rh cat.
oxidative addition
MeOaC-
Nie02C'
^~CI Rh cat.
oxidative addition
336
A common feature in the Rh-catalysed carbocyclisation of enynes 336 and 341 is the 
attempted construction of a malonate-containing five-membered rings (Scheme 1.95). The 
oxidative addition step involves a distortion of the enyne substrate in order to achieve an 
optimal coordination to the metal centre to undergo C-C bond formation. Hence, we
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envisioned that the employment of malonate tethered enynes 336 and 341 might provide an 
energetically disfavoured distortion of the enyne substrate, thus lowering the aptitude of the 
alkene and alkyne counterparts to coordinate to the metal centre and undergo further oxidative 
addition (Scheme 1.95). In order to gain additional insights into the aforementioned 
theoretical hypothesis we performed a computational analysis of the C-X-C (X = NTs, O, 
C(CC>2Me)2 bond angle variation in both initial substrates and related PK adducts (Figure 
1.9).176 Initial computational examination of oxygen-tethered enynes and their related PK 
adduct predicted an overall angle variation of 4.42 °, whereas investigation of the nitrogen- 
and carbon-tethered enynes indicated a larger angle variation, respectively 6.27 ° and 7.27 °. 
In light of the higher reactivity of oxygen-tethered enyne 289 with respect to the nitrogen- and 
carbon-tethered enynes 314 and 304 we envisioned that a wide angle variation could result in 
a higher energy for the enyne coordination step and the following oxidative addition step, 
with consequent lower reactivity in the PK reaction.
Figure 1.9. Examination of C-X-C (X = O, NTs, C(C02Me)2) in 1,6-enynes and related PK 
adducts.
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Analysis of malonate-tethered substrate 336 corroborated the hypothesised relationship and 
predicted a wide angle variation between enyne and related PK adduct (8.79 °). Hence, we 
believe that to the energy required for the distortion of the initial enyne geometry during the 
corresponding Ji-coordination Rh complex is too high for enyne 336 and this is indicated by 
the wide angle variation between starting material 336 and PK adduct 337 (Figure 1.9).
1.6.6. Proof of Stereochemistry in the Rh-catalysed Diastereoselective PK 
Reaction.
NOE analysis of the PK reaction adducts 317 and 327 confirmed the predicted cis 
stereochemistry of the bicyclopentenone derivatives (Figure 1.10).
Figure 1.10. NOE analysis of PK reaction adducts 327 and 317.
Figure 1.11. Homodecoupling experiments on C2-substituted PK reaction adducts.
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Further homodecoupling experiments on the related nitrogen and oxygen-tethered PK adducts 
confirmed the overall cis diastereoselectivity in the carbocyclisation process. Irradiation of 
the NMR signal corresponding to the methyl or methylene moiety adjacent to the C2 position 
demonstrated similar coupling constants between vicinal protons Ha and Hb, thereby denoting 
uniform cis stereochemistry in the bicyclopentenone adducts (Figure 1.11).
We envisaged that further functionalisation of the chlorine moiety could enhance the 
synthetic utility of the diastereoselective methodology and, moreover, provide additional 
proof of stereochemistry by correlation to previously characterised compounds in the 
literature. In this context, we elected to derivatise the chlorine moiety by means of a 
dechlorination process or Suzuki coupling (Scheme 1.96).
Scheme 1.96. Derivatisation of PK reaction adducts.
. _ dechlorination
’Vl>° -—
R H
Suzuki coupling
R
O
Experimental investigation of a challenging and relatively unexplored dechlorination of a- 
chloro-enones revealed the challenges of this process. Dechlorination under reductive (A-B, 
Eq. 1.51) and radical (C-F, Eq. 1.51) conditions provided recovered starting material and 
decomposition of enone 317.
317 272
Conditions
(Eq. 1.51)
A) Zn, MeOH, NH4CI, RT: no reaction
B) Zn, MeOH, NH4CI, reflux : decomposition
C) TTMSS, TEB, benzene (0.1 M): decomposition
D) TTMSS, TEB, benzene (0.02 M): no reaction
E) Bu3SnH, ABCN, benzene, reflux: decomposition
F) Bu3SnH, ABCN, benzene, 65 °C : decomposition
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These disappointing results prompted us to investigate functionalisation of the vinyl chloride 
moiety by Pd-catalysed Suzuki coupling of a-chloro-enones with boronic acids, thereby 
installing an aliphatic and aromatic substituent at the a position of the enone moiety (Eq. 
1.52).177 Initial Pd-mediated coupling of bicyclopentenone 317 with methyl boronic acid 
revealed the inability of teh'akis(triphenylphosphine)palladium (0) catalyst to promote the 
desired transformation. However, a literature survey highlighted the opportunity to conduct 
the desired transformations under conditions developed by Buchwald and coworkers.178
(Eq. 1.52)
A) MeB(OH)2, Pd(PPh3)4, Na2C03, benzene, reflux: no reaction
B) MeB(OH)2, Pd(PPh3)4, Na2C03, toluene, 100 °C: no reaction
C) MeB(OH)2) Pd(OAc)2, dpdb, K3PO4, H20, THF, 100 °C: decomposition 
D) MeB(OH)2, Pd(OAc)2, dpdb, K3PO4, H20, Toluene, 100 °C: decomposition 
E) MeB{OH)2, Pd(OAc)2, dpdb, K3PO4, H20, Toluene, 65 °C: 62% yield
Gratifyingly, the employment of palladium acetate as catalyst with the monophosphine dpdb 
allowed the desired Suzuki-type coupling in good yield and with complete retention of 
stereochemistry (Eq. 1.52).178 An essential requirement for the optimal exploitation of the 
transformation involved elimination of moisture and air from the reaction solvent by freeze- 
thaw degassing. Enone 284, obtained by a PK reaction/Suzuki coupling sequence was further 
correlated with the compound prepared by carbocyclisation of enyne 282. As predicted, the 
two synthetic pathways led to the formation of c/.s-enone 284 as the major diastereoisomer 
(Scheme 1.97). Additionally, the low diastereoselectivity obtained in the PK carbocyclisation 
of enyne 282 provided additional evidence for the ability of chlorinated 1,6-enynes to 
enhance the reactivity of the PK reaction and allow a highly diastereo selective annulation 
process.
104
Scheme 1.97. Diasteroeselective syntheses of enone 284.
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1.6.7. Conclusions.
As discussed in section 1.6, initial computational and experimental studies on the 
diastereoselective Rh-catalysed Pauson-Khand reaction highlighted the ability of trigonal 
bipyramidal rhodium species to promote the stereoselective formation of syn rhodium 
metallacycles and the subsequent highly diastereoselective synthesis of cis bicyclopentenone 
derivatives.162 In this context, a high concentration of carbon monoxide proved to be of 
fundamental importance in order to achieve the requisite trigonal-bypiramidal geometry in the 
metal catalyst. In order to garner additional insights into the carbocyclisation process, we 
performed detailed computational examination of the partial charges of the transition states 
intermediates of syn- and anti- rhodium metallacycles.169 This study revealed a highly charge 
polarised metallacycle intermediate and the opposite direction of polarisation at the distal 
carbon atoms in the these species. Those theoretical findings prompted the investigation of 
substituted 1,6-enynes by mimicking the charge pattern on the syn metallacycle intermediate. 
Hence, theoretical predictions highlighted that favourable prepolarisation could be achieved 
by replacement of the alkyne terminus with a halogen moiety, thereby conferring enhanced
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reactivity to the enyne substrate in the oxidative addition step. Consequent experimental 
investigations validated the outstanding reactivity of chlorinated 1,6-enynes and thereby 
facilitate a highly diastereoselective Rh-catalysed PK reaction under exceptionally mild 
operating conditions.169 Remarkably, the methodology could deliver an unprecedented 
stereoselective carbocyclization of nitrogen-tethered enynes. Finally, the possibility to 
functionalise a-chloro-enone adducts by means of Pd-catalysed coupling reactions showcase 
the synthetic potential of this strategy. In this context, Chapter 2 will describe the additional 
exploitation of chlorinated enynes in the development of a unique room temperature 
enantioselective Pauson-Khand carbocyclisation process.
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1.7. Experimental
1.7.1 General.
Unless otherwise indicated, all reactions were carried out in flame-dried glassware under an 
atmosphere of carbon monoxide (CO balloon, 1 atm). Xylene and toluene were distilled from 
CaHj and kept over sieves, under an Ar atmosphere, and THF was distilled from 
benzophenone ketyl. All other starting materials and solvents were purchased from Acros, 
Aldrich, Alfa Aesar, Fluorochem or Strem and used without further purification. Catalyst 
[R1iC1(CO)2]2 was purchased by Strem, kept in the glove box at -35 °C and entirely utilized in 
the glove box. Carbon monoxide gas and mixture of Ar:CO (10:1) gas were purchased by CK 
Gas (CO purity = 99.97%). High purity of CO (>99.95) proved to be essential for the optimal 
exploitation of the PK reaction.
Thin layer chromatography (TLC) was performed on Whatman F254 precoated silica gel 
plates. Visualisation was accomplished with a UV light and/or KMn04 solution. Flash 
chromatography (FC) was performed using either Merck Silica Gel 60 (230-400 mesh) or 
Whatman Silica Gel Purasil® 60 (230-400 mesh). Solvents for extraction and FC were 
analytical grade. Reported solvent mixtures for TLC and FC are volume/volume mixtures. 
Infrared spectra were obtained on a Perkin-Elmer spectrum 100 series FTIR spectrometer. 
Peaks are reported in cm"1 with the following relative intensities: vs (very strong), s (strong), 
m (medium) and w (weak). Mass spectra were performed at either the University of Liverpool 
Mass Spectrometry Center or the EPSRC National Mass Spectrometry Service Centre, 
Swansea. High resolution electron-impact (El, ionization voltages of 70 eV), chemical 
ionization (Cl, reagent gas CFI4 or NH3) were obtained on either an Autospec ZAB 2SE, 
Rratos MS-80, VG 7070E double focusing magnetic sector mass spectrometer equipped with 
a solid probe inlet, a QUATRO II, MAT 95, or MAT 900. The electrospray ionization (ESI) 
and mass spectra were obtained on a Waters micromass and LCT mass spectrometer, ’ll and
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13C NMR were recorded on a Bruker AV 500 MHz NMR spectrometer in the indicated 
deuterated solvent, which were obtained from Cambridge Isotope Labs. For lH NMR, CDCl3 
was set to 7.26 ppm (CDC13, singlet). For 13C NMR, CDC13 was set to 77.16 ppm (CDC13, 
centre of triplet), ’ll data are reported in the following order: chemical shift in ppm (5) 
(multiplicity, which are indicated by br (broadened), s (singlet), d (doublet), t (triplet), q 
(quartet), m (multiplet)); assignment of 2nd order pattern, if applicable; coupling constant {J, 
FIz); integration values for all 13C NMR spectra data using the descriptor o and e refer to 
whether the peak is odd or even, respectively, and correlate to an attached proton test (APT) 
experiments. All liquid chi'omatograms were obtained on a HPLC Agilent 1200 machine with 
a variable UV detector. The instrument was fitted with a ZORBAX RX-SIL analytical 
column (4.6 mm x 250 mm, 5 p) or semipreparative column (9.4 x 250 mm, 5 p). All the gas 
chromatograms were obtained on GC Agilent 7890A machine. The instrument was fitted with 
a HP-1 19091Z-433 analytical column (length = 30 m, I.D. = 0.25 mm, film = 0.25 pm).
1.7.2. Experimental Procedures.
General Procedure for the Preparation of Tethered l-Chloro-l,6-enynes (Method A): 
Cesium carbonate (4 mmol) and tetra-»-butylammonium fluoride trihydrate (1 mmol) were 
added to a solution of the requisite 1,6-enyne (2 mmol) in CCI4 (3 mL) and the reaction 
mixture stirred for ca. 20-40 minutes at room temperature. The resulting mixture was then 
diluted by the addition of dichloromethane (25 mL), filtered through a short pad of celite and 
the filtrate concentrated in vacuo to afford a crude oil. Purification by flash chromatography 
(silica gel, eluting with diethyl ether/hexanes) afforded the desired 1-chloro-1,6-enyne.
General Procedure for the Preparation of Tethered 1-Chloro-l,6-enynes (Method B): a 
solution of the requisite 1,6-enyne (2 mmol) in THF (4 mL) was cooled to -78 °C under an 
argon atmosphere. LiHMDS (2.2 mL, 2.2 mmol, 1M solution in hexane) was added dropwise 
and the resulting suspension stirred for 20 minutes at -78 °C. Then, a solution of p-
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toluenesulfonyl chloride (2.2 mmol) in THF (2 mL) was added dropwise and reaction stirred 
for 4 hours at -78 °C. The resulting suspension was allowed to warm at RT and quenched with 
brine (10 mL) and diethyl ether (10 mL) and extracted with diethyl ether (3x15 mL). The 
organic layer was dried over MgS04> filtered and concentrate in vacuo to afford a crude oil. 
Purification by flash chromatography (silica gel, eluting with diethyl ether/hexanes) afforded 
the desired l-chloro-l,6-enyne
General Procedure for the Preparation of Tethered l-Bromo-l,6-enynes: N-
bromosuccinimide (1.3 eq.) and silver nitrate (0.13 mmol) were added to a solution of the 
requisite 1,6-enyne (1 mmol) in acetone (3 mL) and the reaction mixture stirred for ca. 3 
hours minutes at room temperature. The resulting white suspension was filtered through a 
short pad of celite and the filtrate concentrated in vacuo to afford a crude oil. Purification by 
flash chromatography (silica gel, eluting with diethyl ether/hexanes) afforded the desired 1- 
bromo-1,6-enyne.
General Procedure for the Preparation of Tethered l-Iodo-l,6-enynes: yV-iodosuccinimide 
(1.2 eq.) and silver nitrate (0.12 mmol) were added to a solution of the requisite 1,6-enyne (1 
mmol) in acetone (7 mL) and the reaction mixture stirred for ca. 2 hours at room temperature. 
The resulting white suspension was filtered through a short pad of celite and the filtrate 
concentrated in vacuo to afford a crude oil. Purification by flash chromatography (silica gel, 
eluting with diethyl ether/hexanes) afforded the 1-iodo-1,6-enyne.
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3-(Prop-2-ynyloxy)prop-l-ene.179
Colour and State: Pale yellow liquid.
‘H NMR (500 MHz, CDC13) 8 5.89 (ddt, 17.2, 10.4, 5.8 Hz, 1H), 5.30 {app. dq, J= 17.3, 
1.6 Hz, 1H), 5.21 {app. dq, J= 10.4, 1.4 Hz, 1H), 4.14 (d, /= 2.4 Hz, 2H), 4.06 {app. dt, J = 
5.8, 1.3 Hz, 2H), 2.42 (t, J= 2.4 Hz, 1H).
13C NMR (125 MHz, CDC13) 5 133.94 (o), 118.10 (e), 79.75 (e), 74.52 (e), 70.68 (e), 57.16 
(e).
IR (Neat) 3298 (w), 2856 (w), 2118 (w), 1648 (w), 1443 (w), 1075 (s), 925 (m) cm-1.
HRMS (Cl, [M+NH4]+) calcd for C6H12NO 114.0913, found 114.0912.
■Cl
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3-(3-Chloroprop-2-ynyloxy)prop-l-ene.
Synthesised by the general procedure for the preparation of tethered l-chloro-l,6-enynes 
(Method A, yield = 53%).
Colour and State: Pale yellow liquid.
ln NMR (500 MHz, CDC13) 5 5.90 (ddt, /= 16.5, 10.8, 5.5 Hz, 1H), 5.32 (d, J= 17.2 Hz, 
1H), 5.23 (d, 10.4 Hz, 1H), 4.16 (s, 2H), 4.05 (d, J= 5.7 Hz, 2H).
13C NMR (125 MHz, CDC13) 5 133.87 (o), 118.19 (e), 70.84 (e), 65.55 (e), 64.56 (e), 57.60 
(e).
IR (Neat) 2854 (w), 2239 (w), 1648 (w), 1353 (m), 1096 (s), 924 (s) cm-1.
HRMS (Cl, [M+NHtD calcd for C6HU35C1N0 148.0524, found 148.0524.
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298
3-(3-Bromoprop-2-ynyloxy)prop-l-ene.180
Synthesised by the general procedure for the preparation of tethered 1 -bromo-1,6-enynes 
(yield = 74%).
Colour and State: Pale yellow liquid.
^ NMR (500 MHz, CDC13) 5 5.90 (ddt, J= 17.2, 10.5, 5.8 Hz, 1H), 5.32 (app. dq, 7= 17.2, 
1.6 Hz, 1H), 5.23 {app. dq, J= 10.4, 1.3 Hz, 1H), 4.18 (s, 2H), 4.06 {app. dt, 7= 5.8, 1.3 Hz, 
2H).
13C NMR (125 MHz, CDC13) 6 133.86 (o), 118.23 (e), 76.30 (e), 70.87 (e), 58.20 (e), 46.12 
(e).
IR (Neat) 2852 (w), 2214 (w), 1648 (w), 1351 (m), 1090 (vs), 926 (s) cm-1.
HRMS (Cl, [M+NH4]+) calcd for C6Hu79BrNO 129.0019, found 129.0020.
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3-(3-Iodoprop-2-ynyloxy)prop-l-ene.
Synthesised by the general procedure for the preparation of tethered l-iodo-l,6-enynes (yield
= 82%).
Colour and State: yellow liquid.
lJl NMR (500 MHz, CDC13) 5 5.87 (ddt, 17.2, 10.6, 5.7 Hz, 1H), 5.29 {app. dq, J= 17.2, 
1.4 Hz, 1H), 5.20 {app. dq, J= 10.4, 1.1 Hz, 1H), 4.27 (s, 2H), 4.03 (d, J= 5.8 Hz, 2H).
13C NMR (125 MHz, CDC13) 8 133.77 (o), 118.13 (e), 90.48 (e), 70.74 (e), 58.73 (e), 3.14
(e).
IR (Neat) 3081 (w), 2850 (w), 2185 (w), 1711 (w), 1647 (w), 1349 (m), 1071 (s), 924 (m) 
cm-i.
Ill
HRMS (Cl, [M+NH4]+) calcd for CgHn'^INO239.9880, found 239.9881.
TsN
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Ar-Allyl-4-methyl-Ar-(prop-2-ynyl)benzenesulfonamide.181
Colour and State: White crystalline solid; mp = 60-62 °C.
NMR (500 MHz, CDC13) 8 7.73 (d, 8.3 Hz, 2H), 7.29 (d, J= 8.2 Hz, 2H), 5.70 (ddt, J
= 16-9, 10.3, 6.6 Hz, 1H), 5.29 (dd, /= 17.1, 1.4 Hz, 1H), 5.24 (dd, J = 10.1, 1.1 Hz, 1H), 
4.09 (d, J= 2.5 Hz, 2H), 3.82 (d, J= 6.5 Hz, 2H), 2.42 (s, 3H), 2.00 (t, J= 2.5 Hz, 1H).
13C NMR (125 MHz, CDC13) 5 143.70 (e), 136.14 (e), 132.00 (o), 129.61 (o), 127.88 (o), 
120.13 (e), 76.62 (e), 73.84 (e), 49.11 (e), 35.88 (e), 21.67 (o).
IR (Neat) 3269 (m), 2908 (w), 2118.85 (w), 1644 (w), 1599 (w), 1325 (m), 1157 (s), 929 (s) 
cm-1.
HRMS (ESI, [M-t-Na]+) calcd for C13H15NNa02S 272.0721, found 272.0721.
TsN
7V-Allyl-7V-(3-chloroprop-2-ynyl)-4-methylbenzenesulfonaniide.
Synthesised by the general procedure for the preparation of tethered l-chloro-l,6-enynes 
(Method A, yield = 84%).
Colour and State: White crystalline solid; mp = 39-41 °C.
^ NMR (500 MHz, CDC13) 8 7.71 (d, /= 8.1 Hz, 2H), 7.31 (d, J= 8.0 Hz, 2H), 5.70 (ddt, J 
= 17.0, 10.2, 6.5 Hz, 1H), 5.26 {app. dq, J= 17.1, 1.5 Hz, 1H), 5.22 {app. dq, J = 10.1, 1.3 
Hz, 1H), 4.05 (s, 2H), 3.76 (d, 7= 6.5 Hz, 2H), 2.41 (s, 3H).
13C NMR (125 MHz, CDC13) 8 143.81 (e), 135.63 (e), 131.90 (o), 129.57 (o), 127.76 (o), 
120.10 (e), 63.46 (e), 62.34 (e), 49.39 (e), 36.25 (e), 21.58 (o).
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IR (Neat) 2907 (w), 2856 (w), 2244 (w), 1645 (w), 1598 (w), 1334 (s), 1163 (s), 933 (s) cm-1. 
HRMS (ESI, [M+Na]+) calcd for C^Hu^ClNNaOjS 306.0331, found 306.0320.
TsN
iV-Allyl-Ar-(3-bromoprop“2-ynyI)-4-metliylbenzenesulfonamide.
Synthesised by the general procedure for the preparation of tethered l-bromo-l,6-enynes 
(yield = 89%).
Colour and State: Yellow crystalline solid; mp = 63-65 °C.
lB. NMR (500 MHz, CDC13) 6 7.68 (d, J= 8.3 Hz, 2H), 7.28 (d, 7= 8.2 Hz, 2H), 5.67 (ddt, J 
= 16.9, 10.2, 6.6 Hz, 1H), 5.24 (dd, 7- 17.0, 1.2 Hz, 1H), 5.20 (d, 7- 10.0 Hz, 1H), 4.04 (s, 
2H), 3.74 (d, 7= 6.5 Hz, 2H), 2.39 (s, 3H).
13C NMR (125 MHz, CDCl3) 5 143.71 (e), 135.47 (e), 131.78 (o), 129.49 (o), 127.66 (o), 
119.99 (e), 72.76 (e), 49.30 (e), 45.01 (e), 36.87 (e), 21.48 (o).
IR (Neat) 2907 (w), 2856 (w), 2220 (w), 1645 (w), 1597 (w), 1423 (m), 1331 (s), 1161 (s), 
891 (s) cm-1.
HRMS (ESI, [M+Na]+) calcd for C13H1479BrNNa02S 349.9826, found 349.9828.
TsN
iV-Allyl-iV-(3-iodoprop-2-ynyl)-4-methylbenzenesulfonamide.
Synthesised by the general procedure for the preparation of tethered l-bromo-l,6-enynes 
(yield = 88%).
Colour and State: White crystalline solid; mp = 73-75 °C.
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NMR (500 MHz, CDC13) 5 7.71 (d, J= 8.1 Hz, 2H), 7.31 (d, 8.0 Hz, 2H), 5.70 (ddt, J
= 17.0, 10.2, 6.5 Hz, 1H), 5.26 (app. dq, J = 17.1, 1.5 Hz, 1H), 5.22 (app. dq, J = 10.1, 1.3 
Hz, 1H), 4.05 (s, 2H), 3.76 (d, J= 6.5 Hz, 2H), 2.41 (s, 3H).
13C NMR (125 MHz, CDC13) 5 143.76 (e), 135.42 (e), 131.80 (o), 129.60 (o), 127.77 (o), 
120.15 (e), 86.60 (e), 49.37 (e), 37.71 (e), 21.64 (0), 2.04 (e).
IR (Neat) 2912 (w), 2860 (w), 2184 (w), 1645 (w), 1648 (w), 1429 (m), 1318 (s), 1151 (s), 
898 (s) cm-1.
HRMS (ESI, [M+Na]+) calcd for C^HnlNNaOzS 397.9688, found 397.9688.
M ci
MeOzCrV-"^
304
Dimethyl 2-allyl-2-(3-chloroprop-2-ynyl)malonate.
Synthesised by the general procedure for the preparation of tethered l-chloro-l,6-enynes 
(Method B, yield = 91%).
Colour and State: Colourless oil.
lH NMR (500 MHz, CDC13) 6 5.58 (ddt, J= 17.2, 10.0, 7.5 Hz, 1H), 5.15 {app. dq, 17.0, 
1.3 Hz, 1H), 5.11 {app. dq, J = 10.1, 1.0 Hz, 1H), 3.72 (s, 6H), 2.77 (s, 2H), 2.75 (d, 7= 7.5 
Hz, 2H).
13C NMR (125 MHz, CDCI3) 6 170.14 (e), 131.63 (0), 120.10 (e), 64.26 (e), 60.65 (e), 56.94 
(e), 52.91 (o), 36.79 (e), 23.13 (e).
IR (Neat) 2955 (w), 2247 (w), 1735 (vs), 1642 (w), 1436 (m), 1200 (s) cnT1.
HRMS (ESI, [M+Naf) calcd for C11H1335ClNa04 267.0400, found 267.0397.
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A^-(But-3-en-2-yl)-Ar-(3-chloroprop-2-ynyl)-4-methylbenzenesulfonamide.
Synthesised by the general procedure for the preparation of tethered l-chloro-l,6-enynes 
(Method A, yield = 79%).
Colour and State: colourless oil.
^ NMR (500 MHz, CDC13) 8 7.76 (d, J= 8.1 Hz, 2H), 7.28 (d, J= 7.9 Hz, 2H), 5.70 (ddd, J 
- 17.3, 10.6, 4.6 Hz, 1H), 5.15 (d, 10.5 Hz, 1H), 5.12 (d,J= 17.3 Hz, 1H), 4.58-4.54 (m,
1H), 4.11 (d, Aof AB, JAb = 18.4 Hz, 1H), 3.85 (d, B of AB, JAB= 18.4 Hz, 1H), 2.41 (s, 3H), 
1.21 (d, 7=7.0 Hz, 3H).
13C NMR (125 MHz, CDC13) 8 143.48 (e), 137.72 (e), 137.35 (o), 129.53 (o), 127.50 (o), 
117.18 (e), 65.67 (e), 62.31 (e), 54.68 (o), 32.66 (e), 21.61 (o), 16.91 (o).
IR (Neat) 2983 (w), 2243 (w), 1639 (w), 1597 (w), 1351 (m), 1331 (s), 1145 (s) cm"1.
HRMS (Cl, [M+H]4^) calcd for Ci4Hi735ClN02S 298.0669, found 298.0659.
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Ar-(But-3-en-2-yl)-A-(3“bromoprop-2-ynyl)-4-methylbenzenesulfonainide.
Synthesised by the general procedure for the preparation of tethered l-bromo-l,6-enynes 
(yield = 89%).
Colour and State: off-white solid, mp = 54-56 °C.
^ NMR (500 MHz, CDC13) 8 7.76 (d, 7= 8.0 Hz, 2H), 7.29 (d, 7= 8.0 Hz, 2H), 5.70 (ddd, 7 
= 17.2, 10.8,4.7 Hz, 1H), 5.15 (d,7= 10.1 Hz, 1H), 5.13 (d,7= 17.1 Hz, 1H), 4.59-4.52 (m, 
1H), 4.13 (d, A of AB, 7Ab = 18.5 Hz, 1H), 3.87 (d, B of AB,7Ab= 18.5 Hz, 1H), 2.41 (s, 3H), 
1.21 (d, 7-7.0 Hz, 3H).
115
13C NMR (125 MHz, CDC13) 5 143.45 (e), 137.73 (e), 137.38 (o), 129.52 (o), 127.55 (o), 
117.17 (e), 76.20 (e), 54.73 (o), 44.06 (e), 33.38 (e), 21.62 (o), 16.92 (o).
IR (Neat) 2981 (w), 2926 (w), 2218 (w), 1639 (w), 1597 (w), 1351 (m), 1330 (s), 1143 (s) 
cm-1.
HRMS (ESI, [M+Na]+) calcd for C14Hi679BrNNa02S 363.9983, found 363.9988.
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iV-(But-3-en-2-yl)-Ar-(3-iodoprop-2-ynyl)-4-methylbenzenesulfonamide.
Synthesised by the general procedure for the preparation of tethered l-iodo-l,6-enynes (yield 
= 83%).
Colour and State: white solid, mp = 69-71 °C.
^ NMR (500 MHz, CDC13) 8 7.75 (d, J= 8.4 Hz, 2H), 7.29 (d, ,7=8.1 Hz, 2H), 5.70 (ddd, J 
- 17.3, 10.6, 4.6 Hz, 1H), 5.16-5.09 (m, 2H), 4.59-4.52 (m, 1H), 4.24 (d, A of AB, JAB = 18.6 
Hz, 1H), 3.98 (d, B of AB, Tab = 18.6 Hz, 1H), 2.41 (s, 3H), 1.20 (d, .7=7.0 Hz, 3H).
13C NMR (125 MHz, CDC13) 8 143.39 (e), 137.65 (e), 137.36 (o), 129.52 (o), 127.57 (o), 
117.13 (e), 90.03 (e), 54.73 (o), 34.13 (e), 21.63 (o), 16.90 (o), 1.26 (e).
IR (Neat) 2980 (w), 2929 (w), 2188 (w), 1598 (w), 1351 (m), 1324 (s), 1154 (s), 893 (s) cm"1. 
HRMS (ESI, [M+Na]+) calcd for CnHielNNaCbS 411.9844, found 411.9846.
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iy-(l-(Benzyloxy)but-3-en-2-yI)-AL(3-chloroprop-2-ynyl)-4-metIiylbenzenesulfonamide.
Synthesised by the general procedure for the preparation of tethered l-chloro-l,6-enynes 
(Method A, yield = 75%).
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Colour and State: Pale yellow oil,
'H NMR (500 MHz, CDC13) 5 7.78 (d, 8.3 Hz, 2H), 7.38-7.25 (m, 5H), 7.22 (d, /= 8.1
Hz, 2H), 5.81 (ddd, J = 17.4, 10.6, 5.4 Hz, 1H), 5.26 {app. dt, J = 10.3, 1.2 Hz, 1H), 5.23 
(app. dt, J= 17.2, 1.3 Hz, 1H), 4.72-4.68 (m, 1H), 4.48 (d, A of AB, JAB - 11.8 Hz, 1H), 4.43 
(d, B of AB, = 11.8 Hz, 1H), 4.24 (d, A of AB, yAB = 18.5 Hz, 1H), 4.06 (d, B of AB, JAB 
= 18.5 Hz, 1H), 3.69-3.64 (m, 2H), 2.42 (s, 3H).
13C NMR (125 MHz, CDC13) S 143.39 (e), 137.78 (e), 137.50 (e), 133.16 (o), 129.34 (o), 
128.45 (o), 127.83 (o), 127.79 (o), 127.74 (o), 119.00 (e), 73.25 (e), 70.45 (e), 65.44 (e), 
62.19 (e), 58.98 (o), 34.04 (e), 21.67 (o).
IR (Neat) 3028 (w), 2862 (w), 2244 (w), 1598 (w), 1336 (s), 1157 (s), 1092 (s) cm"1.
HRMS (ESI, [M+Na]+) calcd for C21H2235ClNNa03S 426.0907, found 426.0914.
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Ar-(3-ChIoroprop-2-ynyl)-4-methyl“Ar-(l-phenyIbut-3-eii-2-yl)benzenesulfonamide.
Synthesised by the general procedure for the preparation of tethered l-chloro-l,6-enynes 
(Method A, yield = 86%).
Colour and State: Pale yellow oil.
^ NMR (500 MHz, CDC13) 5 7.64 (d, J= 8.2 Hz, 2H), 7.28-7.14 (m, 5H), 7.22 (d, 8.1
Hz, 2H), 5.77 (ddd, J = 17.3, 10.5, 5.8 Hz, 1H), 5.15 (d, J= 10.5 Hz, 1H), 5.10 (d, J= 17.3 
Hz, 1H), 4.71 (app. q, J= 1A Hz, 1H), 4.17 (d, A of AB, JAB = 18.5 Hz, 1H), 3.95 (d, B of 
AB, JAB= 18.5 Hz, 1H), 2.96 (d, A of AB, JAB = 14.3 Hz, 1H), 2.92 (d, B of AB, JAB = 14.0 
Hz, 1H), 2.40 (s, 3H).
I3C NMR (125 MHz, CDC13) 8 143.47 (e), 137.68 (e), 137.53 (e), 134.81 (o), 129.49 (o), 
129.42 (o), 128.57 (o), 127.66 (o), 126.67 (o), 118.72 (e), 65.48 (e), 62.80 (e), 61.31 (o), 
38.98 (e), 33.60 (e), 21.65 (o).
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IR (Neat) 3028 (w), 2925 (w), 2245 (w), 1598 (w), 1496 (w), 1337 (s), 1164 (s), 1093 (s), 
700 (m) cm-1.
HRMS (ESI, [M+Na]+) calcd for C2oH2o35ClNNa02S 396.0801, found 396.0815.
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3-(3-Chloroprop-2-ynyloxy)but-l-ene.
Synthesised by the general procedure for the preparation of tethered l-chloro-l,6~enynes 
(Method A, yield = 61%).
Colour and State: Pale yellow liquid.
lU NMR (500 MHz, CDC13) 8 5.68 (ddd, 17.5, 10.1, 7.6 Hz, 1H), 5.23 (d, J= 17.3 Hz, 
1H), 5.19 (d, 10.4 Hz, 1H), 4.16 (d, A of AB, JAB = 15.5 Hz, 1H), 4.04 (d, B of AB, JAB =
15.6 PIz, 1H), 4.03-4.00 (m, 1H), 1.27 (d, J= 6.4 Hz, 3H).
13C NMR (125 MHz, CDC13) 8 139.06 (o), 117.47 (e), 76.18 (o), 65.96 (e), 63.93 (e), 55.62 
(e), 21.30(o).
IR (Neat) 2980 (w), 2857 (w), 2239 (w), 1372 (w), 1085 (s), 928 (m) cm"1.
HRMS (Cl, [M+NH4]+) calcd for C7H1335C1N0 162.0680, found 162.0679
Cl
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((2-(3-Chloroprop“2-ynyloxy)but-3-enyloxy)methyl)benzene.
Synthesised by the general procedure for the preparation of tethered 1-chloro-1,6-enynes 
(Method A, yield = 81%).
Colour and State: Pale yellow oil.
118
^ NMR (500 MHz, CDC13) 5 7.36-7.26 (m, 5H), 5.74 (ddd, J= 17.5, 10.3, 7.5 Hz, HI), 5.36 
(app. dt, J = 17.3, 1.4 Hz, 1H), 5.32 (d, /= 10.5 Hz, 1H), 4.61 (d, A of AB, JAB = 12.2 Hz, 
1H), 4.57 (d, B of AB, JAB = 12.1 Hz, 1H), 4.27 (d, A of AB, JAB = 15.6 Hz, 1H), 4.14 (d, B 
of AB, JAB= 15.6 Hz, 1H), 4.18-4.12 (m, 1H), 3.57 (dd, A of ABX, JAB = 10.4 Hz, JAX = 6.3 
Hz, HI), 3.53 (dd, B of ABX, /AB = 10.4 Hz, JBX = 4.2 Hz, 1H).
13C NMR (125 MHz, CDC13) 8 138.21 (e), 134.68 (o), 128.48 (o), 127.82 (o), 127.73 (0),
119.58 (e), 79.11 (o), 73.51 (e), 72.75 (e), 65.79 (e), 64.28 (e), 56.30 (e).
IR (Neat) 3030 (w), 2857 (w), 2238 (w), 1496 (w), 1362 (w), 1087 (s), 930 (m), 736 (m) cnT 
1
HRMS (ESI, [M+Na]^ calcd for C14H,535ClNa02 273.0658, found 273.0656.
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(2-(3-Chloroprop-2-ynyloxy)but-3-enyl)benzene.
Synthesised by the general procedure for the preparation of tethered l-chloro-l,6-enynes 
(Method A, yield = 87%).
Colour and State: Yellow liquid.
^ NMR (500 MHz, CDC13) 8 7.30-7.20 (m, 5H), 5.67 (ddd, J= 17.3, 10.0, 7.5 Hz, 1H), 5.21 
(dd, J = 10.4, 1.0 Hz, 1H), 5.17 (dd, ^ = 17.3, 0.8 Hz, 1H), 4.16 (d, A of AB, JAB = 15.7 Hz, 
1H), 4.10 {app. q, J= 6.9 Hz, 1H), 4.02 (d, B of AB, JAB= 15.6 Hz, 1H), 2.96 (dd, A of ABX, 
dm = 13.8 Hz, JAX = 6.8 Hz, 1H), 2.80 (dd, B of ABX, JAB = 13.8 Hz, JBX = 6.4 Hz, 1H).
13C NMR (125 MHz, CDC13) 8 137.86 (e), 137.10 (o), 129.68 (0), 128.27 (o), 126.38 (o), 
118.68 (e), 81.08 (0), 65.85 (e), 63.95 (e), 55.94 (e), 42.02 (e).
IR (Neat) 3029 (w), 2855 (w), 2238 (w), 1605 (w), 1496 (w), 1081 (s), 699 (s) cm-1.
HRMS (ESI, [M+Na]+) calcd for C13H1335ClNaO 243.0553, found 243.0564.
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iV-(3-Chloroprop-2-ynyl)-iV-(l-cyclohexylallyl)-4-methylbenzenesulfonamide.
Synthesised by the general procedure for the preparation of tethered l-chloro-l,6-enynes 
(Method A, yield = 80%).
Colour and State: colourless oil.
^ NMR (500 MHz, CDC13) 5 7.71 (d, J= 8.3 Hz, 2H), 7.25 (d, /= 8.2 Hz, 2H), 5.66 (ddd, J 
= 17.2, 10.2, 8.7 Hz, 1H), 5.05 (dd, J= 10.4, 0.5 Hz, 1H), 4.94 (d, J= 17.1 Hz, 1H), 4.05 (d, 
A of AB, JAB - 18.5 Hz, 1H), 3.99 (app t, J= 9.5 Hz, 1H), 3.93 (d, B of AB, JAb= 18.5 Hz, 
1H), 2.40 (s, 3H), 1.92-1.48 (m, 6H), 1.28-0.77 (m, 5H).
13C NMR (125 MHz, CDC13) 5 143.26 (e), 137.76 (e), 134.00 (o), 129.30 (o), 127.75 (o), 
119.33 (e), 66.40 (o), 65.26 (e), 62.36 (o), 38.86 (o), 33.45 (e), 30.65 (e), 30.39 (e), 26.35 (e), 
26.17 (e), 25.99 (e), 21.61 (o).
IR (Neat) 2924 (w), 2852 (w), 2245 (w), 1598 (w), 1336 (m), 1333 (s), 1092 (s) cm"1.
HRMS (ESI, [M+Na]^ calcd for C19H2435ClNNa02S 390.1084, found 390.1092.
Cl
334
iV-(3-Chloroprop-2-ynyl)-iV-(l-(furaii-2“yl)allyl)-4-methylbenzenesulfonamide.
Synthesised by the general procedure for the preparation of tethered l-chloro-l,6-enynes 
(Method A, yield — 86%).
Colour and State: off-white solid, mp = 60-62 °C.
^ NMR (500 MHz, CDC13) 5 7.77 (d, J= 8.3 Hz, 2H), 7.30-7.22 (m, 3H), 6.26 (dd, J= 3.2, 
2.0 Hz, 1H), 6.17 (d, J= 3.4 Hz, 1H), 6.04 (ddd, J= 16.6, 10.9,5.5 Hz, 1H), 5.73 (d,J=5.3
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Hz, 1H), 5.36-5.30 (m, 2H), 3.99 (d, A of AB, Jab = 18.5 Hz, 1H), 3.94 (d, B of AB, JAB = 
18.4 Hz, 1H), 2.40 (s, 3H).
13C NMR (125 MHz, CDC13) 8 150.46 (e), 143.49 (e), 142.84 (o), 137.24 (o), 132.35 (o), 
129.25 (o), 127.82 (o), 119.24 (o), 110.39 (o), 109.90 (o), 64.29 (e), 61.82 (e), 56.99 (o), 
34.05 (e), 21.55 (o).
IR (Neat) 2925 (w), 2246 (w), 1598 (w), 1498 (w), 1334 (m), 1157 (s), 1091 (m) cm"1.
HRMS (ESI, [M+Na]+) calcd for Cl7H1635ClNNa03S 372.0437, found 372.0430.
F
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iV-(3-chloroprop-2-ynyI)-A“(l-(4-fluorophenyI)allyI)-4-methylbenzenesulfonamide.
Synthesised by the general procedure for the preparation of tethered l-chloro-l,6-enynes 
(Method A, yield = 72%).
Colour and State: pale yellow oil.
!H NMR (500 MHz, CDCl3) S 7.77 (d, J - 8.3 Hz, 2H), 7.28-7.20 (m, 4H), 6.99-6.96 (m, 
2H), 6.04 (ddd, J = 17.2, 10.2, 7.0 Hz, 1H), 5.58 (d, J= 7.1 Hz, 1H), 5.24 (d, J= 10.4 Hz, 
lH),5.12(d, J= 17.1 Hz, 1H), 4.04 (d, A of AB, JAB - 18.5 Hz, 1H), 3.81 (d, B of AB, JAB = 
18.4 Hz, 1H), 2.39 (s, 3H).
13C NMR (125 MHz, CDC13) 5 162.32 (e, d, JCF= 252.8 Hz), 143.53 (e), 137.25 (e), 133.55 
(e, d, JCf= 3.2 Hz), 133.42 (o), 132.35 (o), 129.86 (o, d, JCf= 8.1 Hz), 127.64 (o), 119.45 (e), 
115.27 (o, d, JCF - 21.4 Hz), 64.77 (e), 62.67 (e), 62.55 (o), 34.04 (e), 21.40 (o).
IR (Neat) 2925 (w), 2245 (w), 1601 (w), 1508 (w), 1349 (m), 1157 (s), 1092 (m), 906.75 cm"
i
HRMS (ESI, [M+Na]+) calcd for C19H1735ClFNNa03S 400.0550, found 400.0544.
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Dimethyl 2-(but-3-en-2-yl)-2-(3-chloroprop-2-ynyl)malonate.
Synthesised by the general procedure for the preparation of tethered l-chloro-l,6-enynes 
(Method B, yield = 92%).
Colour and State: pale yellow oil.
^ NMR (500 MHz, CDC13) 5 5.67 (ddd, J= 17.0, 10.2, 8.7 Hz, 1H), 5.12-5.06 (m, 1H), 5.02 
(dd, J = 10.3, 1.5 Hz, 1H), (3.70, s, 3H), (3.69, s, 3H), 3.04-2.97 (m, 1H), 2.75 (d, A of AB, 
Jab = 17.1 Hz, 1H),2.71 (d, B of AB, Jab= 16.9 Hz, 1H), 1.09 (d, J=7.0Hz, 3H).
13C NMR (125 MHz, CDC13) 5 169.95 (e), 169.82 (e), 138.24 (o), 116.85 (e), 64.89 (e), 60.32 
(e), 60.24 (e), 52.42 (o), 41.40 (o), 24.05 (e), 16.36 (o).
IR (Neat) 2954 (w), 2247 (w), 173l(s), 1435 (m), 1270 (s), 1226 (s), 1202 (m), 1055 (m), 922 
(m) cm-1.
HRMS (Cl, [M+H]^ calcd for Ci2Hi635C104 259.0670, found 259.0664.
General Procedure for the Room Temperature Rhodium(I)-Catalysed Pauson-Khand 
Reaction (Method A, CO:Ar = 100:0, 1 atm): [Rh(CO)2Cl]2 (3.9 mg, 0.01 mmol) was 
weighed into a 10 mL round bottom flask under an atmosphere of argon and the flask was 
evacuated and backfilled three times with carbon monoxide. Freshly distilled />xylene (2 
mL) was added to the flask fitted with a carbon monoxide balloon (1 atm.) and the resulting 
solution stirred in a preheated 25 °C bath for ca. 10 minutes. The requisite l-halo-l,6-enyne 
was added in one portion via a tared syringe and the mixture was allowed to stir at 25 °C until 
the reaction was complete (t.l.c. control). The reaction mixture was concentrated in vacuo 
and purified by flash chromatography (silica gel, eluting via a gradient 15-40% diethyl 
ether/hexane) to furnish the desired PK adduct.
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General Procedure for the Room Temperature Rhodiam(I)-Catalysed Pauson-Khand 
Reaction (Method B, CO:Ar = 10:90, 1 atm): [Rh(CO)2Cl]2 (3.9 mg, 0.01 mmol) was 
weighed into a 10 mL round bottom flask under an atmosphere of argon and the flask was 
evacuated and backfilled three times with a balloon containing a mixture of CO:Ar = 10:90. 
Freshly distilled /?-xylene (2 mL) was added to the flask fitted with a balloon containing a 
mixture of CO:Ar - 10:90 (1 atm) and the resulting solution stirred in a preheated 25 °C bath 
for ca. 10 minutes. The requisite i-halo-l,6-enyne was added in one portion via a tared 
syringe and the mixture was allowed to stir at 25 °C until the reaction was complete (t.l.c. 
control). The reaction mixture was concentrated in vacuo and purified by flash 
chromatography (silica gel, eluting via a gradient 15-40% diethyl ether/hexane) to furnish the 
desired PK adduct.
Cl
306
6-Chloro-3a,4-dihydro-lJEf-cyclopenta[c]furan-5(3L0"OIie*
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Khand reaction (Method A, CO:Ar = 100:0, 1 atm, t = 22 h, yield = 74%).
Colour and State: pale yellow oil.
NMR (500 MHz, CDC13) 5 4.67 (d, A of AB, JAB = 16.6 Hz, 1H), 4.57 (d, B of AB, JAB - 
16.5 Hz, 1H), 4.36-4.34 (m, 1H), 3.35-3.26 (m, 2H), 2.82 (dd, A of ABX, JAB = 18.1 Hz, Tax 
- 5.7 Hz, 1H), 2.28 (dd, B of ABX, JAB - 18.2 Hz, JBx = 1.8 Hz, 1H).
13C NMR (125 MHz, CDC13) 5 200.45 (e), 175.60 (e), 127.26 (e), 71.99 (e), 65.22 (e). 43.44 
(o), 37.96 (e).
IR (Neat) 2919 (w), 2251 (w), 1729 (s), 1662 (m), 1024 (s), 952 (s) cm"1.
HRMS (Cl, [M+H]4) calcd for C7H835C102 159.0207, found 159.0203.
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6-Bromo-3a,4-dihydro-Lff-cyclopenta[c]furan-5(3JHr)-one.
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Khand reaction (Method A, CO:Ar = 100:0, 1 atm, t = 24 h, yield = 39%).
Colour and State: Yellow oil.
‘H NMR (500 MHz, CDC13) 5 4.66 (d, A of AB, = 16.7 Hz, 1H), 4.50 (d, B of AB, JAB = 
16.6 Hz, 1H), 4.40-4.35 (m, 1H), 3.33-3.29 (m, 2H), 2.85 (dd, A of ABX, JAB = 18.2 Hz,
= 5.3 Hz, 1H), 2.29 (dd, B of ABX, JAB - 17.8 Hz, JAx = 1.8 Hz, 1H).
13C NMR (125 MHz, CDC13) 5 201.10 (e), 180.00 (e), 117.01 (e), 72.03 (e), 66.04 (e). 45.33 
(o), 37.90 (e).
IR (Neat) 2911 (w), 2852 (w), 1723 (s), 1655 (s), 1407 (w), 1122 (in), 1025 (s), 904 (m) cm-*. 
HRMS (ESI, [M+Naf) calcd for C7H779BrNa02 224.9527, found 224.9528.
Cl
310
6-Chloro-2-tosyl-2,3,3a,4-tetrahydrocyclopenta[clpyrrol-5(l^T)-one.
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Kliand reaction (Method A, CO:Ar = 100:0, 1 atm, t - 27 h, yield = 81%).
Colour and State: pale yellow oil.
^ NMR (500 MHz, CDC13) 8 7.72 (d, /= 8.2 Hz, 2H), 7.35 (d, 7= 8.1 Hz, 2H), 4.34 (d, A 
of AB, Tab - 17.2 Hz, 1H), 4.06-4.03 (m, 1H), 4.03 (d, B of AB, JAB = 17.4 Hz, 1H), 3.21- 
3.15 (m, 1H), 2.76 (dd, A of ABX, JAB = 18.2 Hz, JAX = 6.4 Hz, 1H), 2.62 (dd, B of ABX, JAB 
= 11-0 Hz, JBX = 9.6 Hz, 1H), 2.44 (s, 3H), 2.18 (dd, B of ABX, JAB = 18.2 Hz, JBX = 2.9 Hz,
1H).
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l3C NMR (125 MHz, CDC13) 8 199.09 (e), 170.70 (e), 144.53 (e), 133.26 (e), 130.25 (o), 
128.69 (e), 127.59 (o), 52.69 (e), 47.17 (e), 41.60 (o), 38.50 (e), 21.71 (o).
IR (Neat) 2923 (w), 1732 (vs), 1667 (s), 1597 (m), 1345 (vs), 1161 (vs) cm”1.
HRMS (Cl, [M+H]4) calcd for C14H1535C1N03S 312.0456, found 312.0461.
Cl
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Dimethyl 6-chloro-5-oxo-3,3a,4,5-tetrahydropentalene-2,2(l£0-dicarboxylate.
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Khand reaction (Method A, CO:Ar = 100:0, 1 atm, t = 44 h, yield = 74%).
Colour and State: yellow oil.
^ NMR (500 MHz, CDC13) 8 3.80 (s, 3H), 3.77 (s, 3H), 3.38 (d, A of AB, JAb = 19.7 Hz, 
1H), 3.31 (d, B of AB, JhB - 19.6 Hz, 1H), 3.16-3.10 (m, 1H), 2.84 (dd, A of ABX, JhB = 
12.9 Hz, Tax = 7.3 Hz, 1H), 2.81 (ddd, A of ABMX, JAB = 18.2 Hz, JAM = 6.3 Hz, JAX = 0.8 
Hz, 1H), 2.25 (dd, B of ABX, /AB - 18.2 Hz, = 2.9 Hz, 1H), 1.78 (app. t, J- 12.8 Hz, 
1H).
13C NMR (125 MHz, CDC13) 8 200.78 (e), 176.93 (e), 171.68 (e), 170.86 (e), 127.81 (e), 
60.60 (e), 53.61 (o), 53.46 (o), 42,59 (o), 40.55 (e), 39.36 (e), 34.56 (e).
IR (Neat) 2956 (m), 2925 (w), 1733 (vs), 1655 (s), 1262 (s), 955 (m) cm"1.
HRMS (Cl, [M+H]4) calcd for C^Hi^ClOs 273.0524, found 273.0531.
Cl
O
317
(3RA,3a6'*)-6-ChIoro-3-methyl-2-tosyl-2,3,3a,4-tetrahydrocyclopenta[c]pyrrol-5(lH)-
one.
125
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Kliand reaction (Method A, CO:Ar = 100:0, 1 atm, t = 27 h, yield = 80%). Selectivity: 
317/318 = 97:3.
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Khand reaction (Method B, CO:Ar = 10:90, 1 atm, t = 27 h, yield = 69%). Selectivity: 
317/318 = 85:15.
Colour and State: pale yellow oil.
HPLC analysis (25 cm x 9.4 mm ZORBAX RX-SIL), 7% isopropanol/hexane at 1.5 mL/min, 
230 run, T = 20 °C; tR {major) 29.5 min, tR {minor) 30.5 min.
NMR (500 MHz, CDCR) 5 7.74 (d, 8.3 Hz, 2H), 7.32 (d, 8.2 Hz, 2H), 4.33-4.27
(m, 1H), 4.28 (d, A of AB, JAB - 17.6 Hz, 1H), 4.20 (d, B of AB, JAB - 17.5 Hz, 1H), 2.90 
(dddd, J = 9.6, 6.5, 3.3, 1.6 Hz, 1H), 2.54 (dd, A of ABX, /AB - 18.6 Hz, JAX = 6.6 Hz, 1H), 
2.41 (s, 3H), 2.20 (dd, B of ABX, JAB = 18.6 Hz, JBX = 3.0 Hz, 1H), 1.01 (d, .7=6.8 Hz, 3H). 
13C NMR (125 MHz, CDC13) 5 199.95 (e), 170.82 (e), 144.22 (e), 135.52 (e), 130.20 (o), 
128.11 (e), 127.12 (o), 56.85 (o), 45.76 (e), 45.01 (o), 36.02 (e), 21.62 (o), 16.05 (o).
IR (Neat) 2978 (w), 2929 (w), 1731 (vs), 1669 (m), 1598 (m), 1346 (s), 1162 (s), 1094 (s)
cm .
HRMS (Cl, [M+NH4]+) calcd for C15H2o35C1N203S 343.0883, found 343.0876.
Cl
323
(3£*,3aN*)-3-(Benzyloxymethyl)-6-chloro-3a,4-dihydro-lEr-cyclopenta[c]furan-5(3/7)-
one.
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Khand reaction (Method A, CO:Ar = 100:0, 1 atm, t = 27 h, yield = 73%). Selectivity: 
323/324 = >99:1.
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Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Khand reaction (Method B, CO:Ar = 10:90, 1 atm, t = 27 h, yield = 59%). Selectivity: 
323/324 = 87:13.
Colour and State: Yellow oil.
HPLC analysis (25 cm x 4.9 mm ZORBAX RX-SIL), 2% isopropanol/hexane at 1 mL/min, 
230 nm, T = 22 °C; tR {major) 37.5 min, tR {minor) 13.5 min.
NMR (500 MPIz, CDC13) 5 7.75 (d, J = 8.3 Hz, 2H), 7.34-7.27 (m, 5H), 7.12-7.11 (m, 
2H), 4.35 (d, A of AB, JAB = 17.4 Hz, 1H), 4.34 (d, A of AB, JAB = 11.5 Hz, 1H), 4.30 (d, B 
of AB, JAB = 11.6 Hz, 1H), 4.25-4.22 (m, 1H), 4.21 (d, B of AB, JAB - 17.7 Hz, 1H), 3.60 
(dd, A of ABX, Jab = 10.3 Hz, Jax = 2.5 Hz, 1H) 3.56 (dd, B of ABX, JAb = 10.3 Hz, JBX = 
5.3 Hz, 1H), 2.91 (dddd, J = 10.0, 6.7, 3.4, 1.7 Hz, 1H), 2.58 (dd, A of ABX, JAB = 18.3 Hz, 
Jax = 6.4 Hz, 1H), 2.49 (dd, B of ABX, JAb = 18.3 Hz, JBX = 3.4 Hz, 1H), 2.43 (s, 3H).
13C NMR (125 MHz, CDC13) 5 200.10 (e), 171.66 (e), 144.39 (e), 137.18 (e), 135.40 (e), 
135.37 (e), 130.28 (o), 128.65 (o), 128.07 (o), 127.64 (o), 127.24 (o), 73.74 (e), 70.13 (e), 
60.09 (o), 47.67 (e), 44.11 (o), 36.70 (e), 21.72 (o).
IR (Neat) 2862 (w), 1726 (s), 1670 (m), 1598 (w), 1346 (m), 1161 (s), 1093 (s), 679 (m) cnf
HRMS (ESI, [M+Na]^ calcd for C22H2235ClNNa04S 454.0856, found 454.0848.
Cl
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325
(3if*,3aiS'*)-3-Benzyl-6-chloro-3a,4-dihydrO“lEf-cyclopenta[c]furan-5(3Jr)-one 2ai.
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Khand reaction (Method A, CO:Ar = 100:0, 1 atm, t = 27 h, yield = 84%). Selectivity: 
325/326 = >99:1.
127
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Khand reaction (Method B, CO:Ar = 10:90, 1 atm, t = 27 h, yield = 63%). Selectivity: 
325/326 = 76:23.
Colour and State: Yellow oil.
HPLC analysis (25 cm x 4.9 mm ZORBAX RX-SIL), 2% isopropanol/hexane at 0.8 mL/min, 
230 nm, T = 22 °C; tR {major) 21,9 min, tR {minor) 19.4 min.
^ NMR (500 MHz, CDC13) 8 7.67 (d, J= 8.3 Hz, 2H), 7.38-7.17 (m, 5H), 7.32 (d, J= 8.1 
Hz, 2H), 4.62 {app. q, 7.4 Hz, 1H), 4.33 (d, A of AB, Ab = 17.7 Hz, 1H), 4.22 (d, B of 
AB, JAB - 17.7 Hz, 1H), 3.02 (dddd, J = 9.7, 7.9, 3.7, 2.0 Hz, 1H), 2.81-2.72 (m, 2H), 2.56- 
2.50 (m, 2H), 2.45 (s, 3H).
13C NMR (125 MHz, CDC13) 8 199.85 (e), 171.44 (e), 144.30 (e), 136.53 (e), 135.53 (e), 
130.23 (o), 129.36 (o), 128.87 (o), 128.37 (e), 127.34 (o), 127.13 (o), 61.54 (o), 46.33 (e), 
45.57 (o), 36.86 (e), 36.26 (e), 21.72 (o).
IR (Neat) 3029 (w), 2925 (w), 1728 (s), 1668 (m), 1598 (w), 1347 (m), 1160 (s), 1093 (m), 
671 (m) cm-1.
HRMS (ESI, [M+Na]+) calcd for C2,H2oClNNa03S 424.0750, found 424.0741.
Cl
327
(3i?*,3a)S'*)-6-Chloro-3-methyl-3a,4-dihydro-lJH-cyclopenta[c]furan-5(3J0-one*
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Khand reaction (Method A, CO:Ar = 100:0, 1 atm, t = 24 h, yield = 82%). Selectivity: 
327/328 = 98:2.
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Khand reaction (Method B, CO:Ar = 10:90, 1 atm, t = 24 h, yield = 76%). Selectivity: 
327/328 = 96:4.
128
Colour and State: Yellow oil.
GC analysis (HP-1 19091Z-433 analytical column), 4 °C/min, 50 to 200 °C; tR {major) 18.1 
min, tR {minor) 18.9 min.
lK NMR (500 MHz, CDC13) 8 4.74 (d, A of AB, JAB = 16.8 Hz, 1H), 4.58 (d, B of AB, Jab = 
16.8 Hz, 1H), 3.55 {app dq, J= 1U, 5.9 Hz, 1H), 2.86-2.81 (m, 1H), 2.76 (dd, A of ABX, 
Jab = 17.9 Hz, JAX = 6.3 Hz, 1H), 2.21 (dd, B of ABX, Jab = 17.9 Hz, JBX = 2.5 Hz, 1H), 1.40 
(d, J= 6.0 Hz, 3H).
13C NMR (125 MHz, CDC13) 5 200.32 (e), 176.67 (e), 126.88 (e), 79.96 (o), 65.64 (e). 49.78 
(o), 37.25 (e), 18.98 (o).
IR (Neat) 2974 (m), 2928 (w), 2854 (w), 1732 (s), 1661 (s), 1389 (w), 1067 (m), 965 (s) cm'1. 
HRMS (Cl, [M+H]4) calcd for CgH^CKX 173.0364, found 173.0369.
Cl
(35*,3aY*)-3-(Benzyloxymethyl)-6-chloro-3a,4-dihydro-liJ-cyclopenta[c]furan-5(3JJ)-
one.
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Khand reaction (Method A, CO:Ar = 100:0, 1 atm, t = 24 h, yield - 84%). Selectivity: 
329/330 = >99:1.
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Kliand reaction (Method B, CO:Ar = 10:90, 1 atm, t = 24 h, yield = 64%). Selectivity: 
329/330 = 99:1.
Colour and State: Yellow oil.
HPLC analysis (25 cm x 4.9 mm ZORBAX RX-SIL), 2% isopropanol/hexane at 0.3 mL/min, 
230 nm, T = 22 °C; tR {major) 28.7 min, tR {minor) 31.0 min.
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‘H NMR (500 MHz, CDC13) 5 7.38-7.29 (m, 5H), 4.77 (d, A of AB, JAB = 16.5 Hz, 1H), 4.65 
(d, B of AB, JAB =16.5 Hz, 1H), 4.63 (d, A of AB, Jab — 11.8 Hz, 1H), 4.59 (d, B of AB, JAB 
= 12.1 Hz, 1H), 3.75-3.66 (m, 3H), 3.17 (dddd, 11.6, 6.5, 3.3, 1.7 Hz, 1H), 2.76 (dd, A of 
ABX, JAB = 18.2 Hz, JAX = 6.4 Hz, 1H), 2.29 (dd, B of ABX, JAB = 18.2 Hz, JBX - 3.1 Hz, 
1H).
13C NMR (125 MHz, CDC13) 5 200.46 (e), 175.49 (e), 137.73 (e), 128.64 (o), 128.04 (o), 
127.83 (o), 127.19 (e), 82.28 (o), 73.79 (e), 70.18 (e), 65.74 (e), 45.36 (o), 37.84 (e).
IR (Neat) 2857 (m), 1730 (s), 1661 (m), 1453 (w), 1100 (m), 958 (m) cm-1.
HRMS (ESI, [M+Na]+) calcd for C15Hl535ClNa03 301.0607, found 301.0609.
Cl
(3i?*,3a1S'*)-3-BenzyI-6-chloro-3a,4-dihydi,o-lEr-cyclopentarc]furan-5(3E?)-one.
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Khand reaction (Method A, CO:Ar - 100:0, 1 atm, t = 24 h, yield = 87%). Selectivity: 
331/332 = >99:1.
Synthesised by the general procedure for the room temperature rhodium(I)-catalysed Pauson- 
Khand reaction (Method B, CO:Ar = 10:90, 1 atm, t - 24 h, yield = 65%). Selectivity: 
331/332 = >99:1.
Colour and State: Yellow oil; Selectivity: 331/332 >99:1
HPLC analysis (25 cm x 4.9 mm ZORBAX RX-SIL), 2% isopropanol/hexane at 0.3 mL/min, 
230 run, T = 22 °C; tR {major') 34.7 min, tR {minor) 22.8 min.
^ NMR (500 MHz, CDC13) 5 7.35-7.23 (m, 5H), 4.78 (d, A of AB, JAB = 16.7 Hz, 1H), 4.64 
(d, B of AB, JAB = 16.7 Hz, 1H), 3.71 (dt, J= 10.4, 6.6 Hz, 1H), 3.21 (dd, A of ABX, JAB = 
13.5 Hz, JAX = 6.0 Hz, 1H), 2.97-2.92 (m, 1H), 2.94 (dd, B of ABX, JAB = 13.4 Hz, Jex = 7.3
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Hz, 1H), 2.44 (dd, A of ABX, JAB = 18.4 Hz, - 6.3 Hz, 1H), 1.84 (dd, B of ABX, Jab = 
18.3 Hz,Jbx = 2.9 Hz, 1H).
13C NMR (125 MHz, CDC13) 5 200.41 (e), 175.93 (e), 136.49 (e), 129.30 (o), 128.78 (o), 
127.13 (o), 127.02 (e), 84.31 (o), 65.67 (e), 48.09 (o), 40.26 (e), 37.92 (e).
IR (Neat) 3027 (w), 2920 (w), 2853 (w), 1729 (s), 1660 (m), 1603 (w), 1497 (w), 1454 (w), 
1011 (m), 959 (s) cm-1.
HRMS (ESI, [M+Na]+) calcd for Ci4H1335ClNa02 271.0502, found 271.0506.
TsN
282
Ar-(but-2-ynyl)-Ar-(but-3-en-2-yl)-4-methylbenzenesuIfonamide.
A flame-dried 100 mL flask was charged with triphenylphosphine (1.18 g, 4.5 mmol) and N- 
(but-2-ynyl)-4-methylbenzenesulfonamide (0.670 g, 3 mmol), evacuated and backfilled with 
argon. Anhydrous THE (12 mL) and 3-buten-2-ol (0.325 g, 4.5 mmol) were added and the 
resulting solution was placed in a ice bath for co 15 minutes. Diisopropyldiazodicarboxylate 
(DIAD) (0.88 mL, 4.5 mmol) then was added drop-wise over 5 minutes via syringe. The 
resultant reaction mixture was stirred for 18 hours, slowly warming to room temperature, then 
a TLC (20% diethyl ether/ petroleum ether) showed complete consumption of the secondary 
amine. The reaction mixture was concentrated in vacuo onto silica gel. Purification via FCC 
on silica gel (petroleum ether-diethyl ether, 95:5) provided the sulfonamide product 282 
(0.706 g, 82%).
Colour and State: Yellow oil.
lH NMR (500 MHz, CDC13) 6 7.80 (d, J= 8.3 Hz, 2H), 7.28 (d, 7= 8.2 Hz, 2H), 5.77 (ddd, J 
= 17.2, 10.8, 4.8 Hz, 1H), 5.14 (s, 1H), 5.12 (dd, 7= 7.9, 1.4 Hz, 1H), 4.59-4.51 (m, 1H), 4.08
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(dq, A of ABX, JAB =18.2 Hz, J/LV= 2.3 Hz, 1H), 3.83 (dq, B of ABX, JAB =18.2 Hz, JBX= 2.3 
Hz, 1H), 2.42 (s, 3H), 1.67 (t, J= 2.4 Hz, 3H), 1.25 (d, J= 7.0 Hz, 3H).
I3C NMR (125 MHz, CDC13) 5 143.08 (e), 138.12 (e), 137.72 (o), 129.26 (o), 127.56 (o), 
116.69 (e), 80.18 (e), 75.28 (e), 54.84 (o), 32.87 (e), 21.51 (o), 17.15 (o), 3.43 (o).
IR (Neat) 2979 (w), 2921 (w), 1598 (w), 1332 (m), 1155 (s), 1093 (s), 1093 (s), 896 (m) cm-1. 
HRMS (ESI, [M+Na]+) calcd for Ci5H19NNa02S 300.1034, found 300.1037.
284
(3i?*,3a.S*)-6-Methyl-3-methyl-2-tosyl-2,3,3a,4~tetraliydrocyclopenta[c]pyrrol-5(li/)-
one.168
Method A (Suzuki-Coupling reaction of a-chloroenone 317): methyl boronic acid (18 mg, 0.3 
mmol), K3PO4 (43 mg, 0.2 mmol), Pd(OAc)2 (4.5 mg, 0.02 mmol) and dpdb (2- 
dicyclohexylphosphino^’-b’-dimethoxybiphenyl) (16.5 mg, 0.04 mmol) were placed in a 15 
mL flame-dried reaction tube under argon atmosphere. The reaction tube was then evacuated 
and backfilled three times with argon. A solution of enone 317 (32 mg, 0.1 mmol) in 
anhydrous toluene (1 mL) was added by tared syringe in the reaction tube, followed by 
addition of water (3 pL). The resulting suspension was placed in a 65 °C bath and allowed to 
stir for 24 h. After completion of the reaction (TLC control), mixture was allowed to cool at 
RT, directly placed on silica gel column and purified (petroleum ether-diethyl ether, 50:50), 
to afford enone 284 as a pale yellow oil (62% yield, dr >19:1 by NMR analysis).
Method B (Rh-catalysed PK reaction of enyne 317): [Rh(CO)2Cl]2 (3.9 mg, 0.01 mmol) was 
weighed into a 15 mL flame-dried reaction tube under an atmosphere of argon. After the flask 
was evacuated and backfilled three times with CO gas, a solution of enyne 282 (55 mg, 0.2
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mmol) in p-xylene (2 mL) was added by tared syringe. The reaction was stirred at room 
temperature for ca. 10 minutes and then heated at 110 °C until the reaction was complete 
(TLC control, t = 20 h). The reaction mixture was allowed to cool down at RT, directly placed 
on silica gel column and purified (petroleum ether-diethyl ether, 50:50), to afford enone 284 
as a pale yellow oil (77% yield, dr = 2:1).
Colour and State: Pale yellow oil.
‘H NMR (500 MPIz, CDC13) 5 7.77 (d, 8.3 Hz, 2H), 7.33 (d, J= 8.1 Hz, 2H), 4.28- 4.16
(m, 2H), 4.09 (d, J= 16.3 Hz, 1H), 2.80-2.72 (m, 1H), 2.43 (s, 3H), 2.42-2.37 (m, 1H), 2.08 
(dd, J= 18.4, 3.3 Hz, 1H), 1.73 (s, 3H), 1.00 (d,/= 6.7 Hz, 3H).
IR (Neat) 2978 (w), 2928 (w), 1717 (vs), 1669 (m), 1598 (m), 1346 (s), 1158 (s), 1089 (s) 
cnT1.
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CHAPTER 2
RHODIUM(I)-CATALYSED [2+2+1] ENANTIOSELECTIVE PAUSON-KHAND 
CARBOCYCLISATIONS OF CHLORINATED 1,6-ENYNES AT ROOM 
TEMPERATURE.
2.1. Enantioselective Pauson-Khand Reactions.
2.1.1. Introduction.
The development of the PK reaction in 1971 provided an innovative strategy for the 
construction of bicyclopentenone derivatives.3,4 The synthetic potential of the process inspired 
the exploration of a wide variety of transition metals in order to enhance the substrate scope 
and the applicability of the process towards the total synthesis of biologically active targets. 
In this context, the enantioselective synthesis of bioactive natural compounds also prompted a 
the investigation of asymmetric PK reactions.2
The development of the Co-catalysed carbocyclisation by Pauson and Khand coincided with 
the concomitant accomplishment of the first asymmetric metal-catalysed hydrogenation 
process. Hence, pioneering studies by Knowles182 and Horner183 demonstrated that chiral 
monophosphine ligands exerted modest enantiocontrol in the hydrogenation of styrene (Eq. 
2.1) and acrylic acid derivatives (Eq. 2.2). Despite the low enantioselectivity and the 
problems associated with the preparation of ligands with chirality on the phosphorous atom, 
these studies outlined the ability of chiral phosphine ligands184 to promote asymmetric metal- 
catalysed reactions. The subsequent development of the C2-symmetric chelating bisphosphine 
DIOP by Kagan outlined the importance of the backbone chirality in the ligand design (Eq. 
2.3). In this context, it was envisaged that a Cj-symmetric ligand with two equivalent P 
atoms reduced the number of possible isomeric metal complexes, as well as the number of
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possible substrate-catalyst arrangements, thus enhancing the enantioselectivity of the 
reaction.
[Rh(1,5-hexadiene)CI]2 
L*, benzene, H2 (1 atm)
342 343 r (S)-(+)-methyl-phenyl-\
^ n-propylphosphine J
344
[RhL3*C]3]( Et3N 
benzene, H2 (20 atm)
60 °C
345 (S)-(+)-methyl-phenyl^V
^ n-propylphosphine J
Further developments to the ligand for the Rli-catalysed hydrogenation of acrylic acids 
provided outstanding enantioselectivity, compared to the previous chiral phosphine ligands 
(Eq. 2,1-2.2).
0=^
NH
co2h
[Rh(Cod)2CI]2 (0.2%) 
(S,S)-DlOP (0.4%) 
C6H6/ethanol (4:1), H2(1 atm)
0=/
jNH 0/„.^pph
o^^PPh
RT
\;o2h
346
r >
96% 1 347
72% ee J [ (S,S)-DIOP
The acknowledged ability of a C2-symmetric bisphosphine to induce high level of 
enantioselectivity in the asymmetric metal-catalysed reactions, prompted Knowles to develop 
the P-chiral bisphosphine ligand DIPAMP (Scheme 2.1).186 Application to the asymmetric 
hydrogenation highlighted the synthetic utility of the ligand in the context of excellent 
enantioselectivity in the reaction and the ability to conduct the reaction with an extremely low 
catalyst loading (Scheme 2.1). The ability of the ligand to provide access to enantiopure 
amino acids was further exploited in the first industrial-scale total synthesis of L-DOPA.186
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Scheme 2.1. Total synthesis of L-DOPA.
Despite the outstanding advancement in the design of bisphosphine ligands and the high level 
of enantioselectivity displayed in the asymmetric hydrogenation of various olefins, the major 
breakthrough in the field of chiral ligands came in 1980 with the development of the BINAP 
bisphosphine by Noyori.187,1 The synergic ability of the ligand and rhodium species to catalyse 
the asymmetric hydrogenation of a-(acylamino)acrylic acids with outstanding 
enantioselectivity, high yields and low catalyst loading provided analogous results, albeit the 
synthesis of biaryl chiral backbones was easily accessible compared to the previously 
employed chiral phosphines (Eq.2.4).187b
/=K P
Ph HN—\ 
Ph 
350
[Rh((R)-BINAP)(nbd)3CI04 (0.05 mol%)
ethanol, H2 (4 atm)
Ph'r"iw-f
351
PPh2
PPh2
[^R)-BINAP^
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The outstanding ability of this ligand to provide high levels of enantioselectivity in metal- 
catalysed reactions was further demonstrated in the asymmetric reduction of carbonyl 
compounds with Ru/BINAP complexes (Eq. 2.5).187c
O O
352
RuCI2[(R)-BINAP] {0.05 mol%)
methanol, H2 (100 atm) OH O
353
(2.5)
O
353
RuCI2[(/?)-BINAP] (0.5 mol%)
An additional feature with this process, is the ability to selectively reduce ketones in presence 
of other carbon-carbon double bonds, which is particularly useful in total synthesis (Eq. 
2.6).187d The enantiofacial discrimination imparted by the BINAP ligand could be explained 
by the “quadrant diagram”, originally developed by Knowles (Figure 2.1).186b
Figure 2.1. Knowles’ quadrant diagram theory. 88
biaryl
atropisomeric
backbone
6: dihedral angle 
P: bite angle
The model highlights the role of the aromatic substituents on the P atom as blocking groups
and their ability to enhance the enantiofacial discrimination in tire hydrogenation process.
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Additionally, a remarkable feature of this atropisomeric ligand resides in the possibility to 
modify the biaryl-type backbone, which impacts the bite angle of the related metal-ligand 
complex, thereby enhancing the reactivity of the metal complex towards the hydrogenation of 
different unsaturated functional groups (Figure 2.1). As a result of this seminal contribution 
to the field of asymmetric catalysis, Noyori187e and Knowles186c were awarded the 2001 Nobel 
Prize. Hence, the outstanding advancements in the field of chiral ligands inspired the design 
and synthesis of many novel chiral bisphosphine ligands in order to improve the reactivity 
and enantioselectivity of asymmetric metal-catalysed reactions. A notable effort was devoted 
to the tuning of the chiral backbone of the atropisomeric ligands and the modification of the 
steric environment around the phosphorous atom. For instance, in 1991, Burk designed a 
series of strongly electron-donating bisphospholane ligands, namely Duphos and BPE, which 
have a rigid chiral backbone.199 The novel ligands provided high enantioselectivity in the 
hydrogenation of a wide range of functionalised olefins (Figure 2.2). Togni and Splinder 
subsequently reported a series of non C2-symmetric ferrocene-based bisphosphines, named 
Josiphos ligands (Figure 2.2).189 Key feature of this class of ligands was the ability to 
introduce a wide range of sterically and electronically different phosphines on the 
cyclopentadienyl moiety.
Figure 2.2. Chiral C2-simmetric bisphosphine ligands.
Burk (1991)
Josiphos j
Togni et al. (1993)
Monodentate Ligands
Pringle, Reetz, Feringa (2000)
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Additionally, these bisphosphine ligands were effective applicability in the commercial 
synthesis of (+)-biotin191 and the herbicide (^-metolachlor.192 Recent work by Pringle,l93a 
Reetz193b and Feringal93c had the merit to introduce monodentate phosphoramidates could 
function as ligands in the Rh-catalysed asymmetric hydrogenation of different olefins, 
providing similar reactivity and levels of enantioselectivity displayed by other bisphosphine 
derivatives (Figure 2.2).
This section provided a summary of the advancements in the design of chiral bisphosphine 
ligands and their application to metal-catalysed hydrogenation reactions. The high levels of 
enantioselectivity imparted by the these chiral ligands coupled with the high reactivity 
prompted the extension of these studies to other metal-catalysed reactions, including the 
Pauson-Khand reaction.
2.1.2. Titanium.
Despite the tremendous advancements in the development of the PK reaction and its 
widespread application in the context of total synthesis, the first asymmetric catalytic version 
was achieved 25 years after the pivotal work of Pauson and Khand. Surprisingly, the 
enantioselective variant involved a chiral titanium catalyst whereas the previous non- 
enantioselective protocols employed cobalt.
•Ph
44
Cp2Ti(PMe3)2 (10 moI%) 
benzene, TMSCN, RT
then
H+
80%
(2.7)
The first report by Buchwald and coworkers described the ability of cyclopentadienyl 
titanium complexes to catalyse the [2+2+1] carbocyclisation of enynes and isocyanides (Eq. 
2.7).t94a The corresponding iminocyclopentenes derivatives undergo in situ hydrolysis, to 
afford the corresponding bicyclopentenone adducts. Hence, this seminal study highlighted the
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opportunity to achieve a direct Ti-catalysed formation of bicyclopentenone adducts under a 
carbon monoxide atmosphere. The employment of thermal conditions and a positive CO 
atmosphere (1.3 atm) allowed the desired transformation in good to excellent overall yield 
(Eq. 2.8).194b,c
■Ph
44
Cp2Ti(PMe3)2 (5 mol%) 
toluene, CO (1.3 atm)
----------------------►
90 °C 
92%
(2.8)
The development of the first Ti-catalysed asymmetric carbonylation was mainly hampered by 
the ability of carbon monoxide to easily dissociate the chiral ligand from the metal centre and 
thereby promote the racemic carbocyclisation. The Buchwald group could easily this problem 
by connecting the chiral ligand and the metal center by an alkyl chain, thereby avoiding the 
formation of an achiral Ti catalyst (Eq. 2.9). Hence, the chiral ligand EBTHI in conjunction 
with high CO pressure provided the desired enantiocontrol and reactivity in the process, albeit 
the catalyst is very sensitive to air and moisture, which required the reaction to be conducted 
in a glovebox.195
(S,S)-(EBTHI)Ti(CO)2 (20 mol%) 
.ph toluene, CO (2.3 atm)
44
90 °C
Ph
<05=°
85% 
96% ee )
H
(SM5
(2.9)
(S,S>(EBTHI)Ti(CO)2j
The proposed mechanism involved the initial formation of the active catalyst ii, followed by 
the displacement of a CO ligand and coordination of the alkyne moiety to provide 
metallacycle iv (Scheme 2.2). Coordination to the alkene and displacement of an additional 
CO ligand generates intermediate v, which undergoes reductive cyclisation and provides Ti-
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metallacycle vi. The catalytic cycle is completed by CO insertion and reductive elimination, 
to afford the desired bicyclopentenone viii.
Scheme 2.2. Mechanism of the Ti-catalysed intramolecular enantioselective PK reaction.
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Scheme 2.3. Origin of enantioselectivity in the Ti-catalysed PK reaction.
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The reductive cyclisation of intermediate v into metallacycle vi is considered to be the 
enantioselective determining step in this process. Hence, unfavourable steric interactions 
between the enyne and the chiral ligand backbone promote the preferential formation of the 
intermediate v\ which explains the absolute configuration of the product (Scheme 2.3).
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2.1.3. Cobalt.
The first example of a Co-catalysed catalytic asymmetric Pauson-Khand reaction was 
described by Hiroi in 2000 (Eq. 2.10).196 The cobalt-catalyst with the atropisomeric 
bisphosphine ligand BINAP facilitated the formation of bicyclopentenone derivatives in 
moderate yield and good enantioselectivity, albeit the methodology was severely affected by 
the limited substrate scope.
Co2(CO)8 (20 mol%) 
(S)-B!NAP (20 mol%)
MeOaC^y ^ co atm)> DME
reflux
Me02C^y^\_
O
H
19 (R)~20
(2.10)
Additional experimental investigations highlighted that the enantioselectivity of the 
transformation was clearly influenced by the ligand loading, since a 1:0.5 and 1:1.5 
metahBINAP ratio decreased the enantioselectivity to 22 and 30%, respectively. An initial 
investigation into the stereoselectivity of the process postulated a hypothetical coordination of 
the BINAP to a single cobalt atom would be largely unfavoured by the bulky nature of the 
ligand and catalyst. Hence, each phosphorous of the BINAP ligand would coordinate to a 
different cobalt-atom, thereby promoting the formation of two possible conformers with a 
boat-like or chair-like conformation (Figure 2.3). In light of the pronounced steric 
interference between phenyl rings on the phosphorus atoms and the naphthyl rings of (S)- 
BINAP in the chair-like conformer, preferential alkene insertion in the boat-like intermediate 
was envisioned to determine a stereoselective cobaltacycle fonnation. Further mechanistic 
studies on the BINAP/Co complexes by the Gibson group confirmed the postulated origin of 
stereoinduction in the reaction,197
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Figure 2.3. Origin of the enantioselectivity in the Co-catalysed PK reaction.
Ph Co-Co'
boat-like conformer 
favoured
)
Buchwald and coworkers exploited triphenylphosphite17 as coligand in the Co-catalysed PK 
reaction and further utilised chiral phosphite ligands in the context of the asymmetric Co­
catalysed carbocyclisation.198 Unfortunately, despite the good reactivity of the C2-symmetric 
binaphthyl-type phosphites, the observed enantioselectivity was poor, particularly with 1,6- 
enynes bearing no substitution on the alkyne terminus (Eq. 2.11).
Me02C'V-'''^
Co2(CO)8 (6 mol%) 
(S,S,S)-355 (10 mol%) 
CO (1 atm), toluene
95 °C
19 87% 
22% ee
In contrast to the intramolecular manifold, the intermolecular Co-catalysed PK reaction 
required a stoichiometric metal complex on the alkyne unit to induce chirality in the 
process.93,199 In this context, studies by Greene demonstrated that an intermolecular 
carbocyclisation of phenylacetylene and norbornene could be achieved in presence of a
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catalytic amount of cobalt catalyst and chiral phosphoramidate ligand MONOPHOS (Eq.
2.12) 200
^Ph ♦ /b
21 22
Despite the moderate enantioselectivity, this work provided the first example of a catalytic 
and asymmetric intermolecular Co-catalysed PK reaction. The discovery of the Co-catalysed 
directed PK reaction by the Krafft group revealed that a sulfur atom on the alkene unit 
efficiently coordinated to the cobalt centre, thereby directing the regiochemistry of the alkene 
insertion.14 These findings inspired Pericas to design a new class of sulfur-containing 
bidentate ligands that could chelate the (alkynyl)-hexacarbonyldicobalt complexes, and 
thereby promote a stereospecific alkene insertion and facilitate the enantioselective 
intermolecular carbocyclisation. In this context, the PuPHOS ligands, which are readily 
accessible from natural (+)-pulegone, confer optimal reactivity and enantioselectivity in the 
intermolecular PK reaction of norbornene and monosubstituted alkynes (Scheme 2.4).201 The 
outstanding efficacy of the PuPhos inspired an additional investigation into the design of 
alternative bidentate PS (phosphorous-sulfm') ligands, in order to enhance the substrate scope 
of the intermolecular Co-catalysed process. An intriguing opportunity for this goal resides in 
the ability to exploit ligands bearing chirality on the phosphorous or sulphur atom. Unlike 
phosphorous, the introduction of chirality on the sulphur atom has become relatively routine, 
as demonstrated by the efficient synthesis of chiral teA-butyl sulfinamides by Ellman.202 The 
scalable synthesis of bidentate A-phosphino sulfinamides ligands (PNSO) bearing a sulfoxide 
moiety as the only source of chirality further exemplifies this idea (Scheme 2.5).203
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Scheme 2.4. PuPhos ligands in the intermolecular Co-catalysed PK reaction.
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Scheme 2.5. PNSO ligands in the intermolecular Co-catalysed PK reaction.
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The extension of the Co-catalysed intermolecular PK reaction to the asymmetric 
intermolecular carbocyclisation of internal alkynes is an impressive demonstration of the 
synthetic utility of these ligands.203c The development of this methodology highlighted the 
key role of NMO for achieving highly enantioselective transformations. Employment, the 
role of the amine iV-oxide is to generate a vacant coordination site on the cobalt centre and 
thereby allow the coordination of the sulfoxide moiety in a bidentate manner, which is
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followed by stereoselective insertion of the alkene (Figure 2.4). In absence of additives, the 
inability to coordinate with a site on the cobalt centre forces the PNSO to behave as a 
monodentate ligand. Hence, the diminished enantiofacial discrimination in the subsequent 
alkene insertion step results in lower stereoselectivity in the carbocyclisation process.2030
Figure 2.4. Role of the NMO additive in the enantioselective Co-catalysed intermolecular PK 
reaction.
with NMO
CO
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Rn> ■HR S*
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2.1.4. Iridium.
The development of the first Rh-catalysed PK reaction by the Jeong group employing 
[RhCl(cod)]2 and bisphosphine ligand dppp,50 inspired the Shibata group to examine the 
feasibility of a novel PK reaction in presence of the congener [IrCl(Cod)]2. The beneficial 
effect of dppp ligand in the former process provided the intriguing opportunity to replace the 
achiral bisphosphine with chiral BINAP-type analogues and carry out an enantioselective 
transformation.
Although the synthetic value of the process was partly affected by the high catalyst loading 
and high temperature, the methodology demonstrated the synergistic role of iridium catalyst 
and chiral atropisomeric binaphthyl ligands to facilitate a highly enantioselective PK reaction 
(Eq. 2.13).204a A putative mechanism for the carbocyclisation involves the initial dissociation 
of [Ir(Cod)Cl]2 complex, complexation with the phosphine ligand and formation of a 
monomeric square-planar iridium complex ii (Scheme 2.6).
159
■Ph
[lr(Cod)CI]2 (10 mol%) 
(S)-to/-BINAP (20 mol%) 
toluene, CO (1 atm)
reflux
Ph
44
83% 
93% ee
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Scheme 2.6. Mechanism of the Ir-catalysed intramolecular enantioselective PK reaction.
[lr(Cod)CI]2
Coordination of the enyne iii to the active catalyst ii, followed by oxidative addition provided 
the iridium metallacycle v. The process is then completed by CO insertion and reductive 
elimination to afford the desired bicyclopentenone derivative vii, Shibata also identified the 
oxidative addition of intermediate iv as the enantioselectivity determining step.204a 
Coordination of the enyne iii to the chiral complex ii forces the alkyne substituent into the 
upper position, in order to prevent steric interactions with the tolyl substituents on the 
phosphorous atom. Thus, the alkene unit can exclusively approach from the lower side, to 
promote enantiospecific oxidative addition. The scope of the process was further extended to 
the corresponding intermolecular manifold, which was applied to a challenging catalytic
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asymmetric cyclocarbonylation of norbornene and internal asymmetrical alkynes (Eq. 2.14). 
Despite the low reactivity, this result is very significant, since it provides a unique example of 
an intermolecular catalytic process with a high level of regio- and enantioselectivity.2041*
^Ph * /b
Me^
[lr(Cod)CI]2 (10 mol%) 
(S)-fo/-BINAP (20 mol%)
toluene, CO (1 atm)
reflux
359 22 32% ^360a:360b = 10:1 1
93% ee 1
L J
u
H Me 
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The ability of the iridium catalysts to promote an efficient cyclocarbonylation prompted the 
Shibata204b and Chan215 groups to examine alternative catalysts and sources of CO, in order to 
avoid the high catalyst loading and the employment of poisonous carbon monoxide gas. 
Gratifiingly, aldehydes provide an excellent alternative, which also allow a reduction in 
catalyst loading from 10 to 5 mol% (Scheme 2.7).
Scheme 2.7. Aldehydes as a CO surrogate in the enantioselective Ir-catalysed PK reaction.
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Pfaltz and coworkers demonstrated that Ir/Phox catalyst also promotes the enantioselective 
hydrogenation of a wide range of unsaturated systems, including imines and unfunctionalised 
olefins.206 Hence, in light of the ability of iridium catalysts to promote the PK reaction, Pfaltz
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examined the efficacy of the Ir/Phox system in the asymmetric cyclocarbonylation of 1,6-
enynes (Eq. 2.15).207
44
[lr(Cod)(Phox)]PF6 (9 mol%)
H
(R)-45
The utilisation of Phox ligands in metal-catalysed cycloaddition reactions was relatively 
unexplored. Additionally, this class of P,N (phosphorous-nitrogen) ligands has divergent 
geometrical and electronic properties compared to the classic BINAP-type ligands. 
Specifically, the PHOX ligands are characterised by a non C2-symmetric backbone, a soft P- 
ligand with jr-acceptor properties and a “hard” N-ligand acting primarily as a a-donor. Thus, 
their ability to affect an array of transformations in a highly enantioselective manner had a 
remarkable significance and provided a novel template for the design of ligands for many 
carbocyclisation reactions.
2.2. Rhodium-catalysed Enantioselective PK Reactions.
2.2.1. Historical Background.
The development of rhodium-catalysed reactions with chiral bisphosphine ligands 
demonstrated that rhodium was a privileged metal for a variety of transformations. 
Additionally, the demonstration of dppp ligand in the Rh-catalysed PK reaction50 provided a 
further evidence of the synergic ability of rhodium catalysts and bisphosphine ligands. Plence, 
shortly after the discovery of the Rh-catalysed PK reaction,50 the Jeong group reported the 
first asymmetric Rh-catalysed manifold.208 The process relied in the outlined the ability of 
BINAP-type ligands to induce chirality, in an analogous manner to HiroiI96a and Shibata2043 in
162
the development of the first Co- and Ir-catalysed PK reactions. Additionally, in contrast the 
cobalt and iridium manifolds, the Rii-catalysed reaction occurs with low catalyst loading.
[RhCI(CO)2]2{3 mol%) 
(S)-BINAP (6 moI%), AgOTf 
THF, CO (1 atm)
90 °C
44
88% 
81 % ee
cCpv>=0
H
(S)-45
(2.16)
Jeong rationalised the carbocyclisation in the following manner. Treatment of the dimeric 
metal-catalyst i with a silver salt and the bisphosphine ligand lead to the formation of the 
cationic chiral rhodium active catalyst ii. Subsequent coordination of the enyne iii and 
oxidative addition provides the corresponding rhodium metallacycle v, which is the 
enantiodetermining step. CO insertion, followed by reductive elimination provides the desired 
enantiomerically enriched bicyclopentenone derivative vii (Scheme 2.8).208
Scheme 2.8. Mechanism of the Rh-catalysed enantioselective PK reaction.
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Similar to the Ir-catalysed methodology, coordination of the enyne iii to the chiral complex ii 
forces the alkyne substituent on the upper position, in order to prevent steric interactions with 
the phenyl substituents on the phosphorous atom. Thus, the alkene unit can exclusively 
approach from the lower side, thereby determining a subsequent enantioselective oxidative 
addition (Figure 2.5).208
Figure 2.5. Origin of the enantioselectivity in the Rh-catalysed PK reaction.
However, the manifolds involve divergent operating conditions, whereas the Ir-catalysed204a 
employed a neutral catalyst in a non-coordinating solvent (toluene) and the analogous Rh- 
catalysed process utilised a cationic catalyst in a coordinating solvent (THF). As postulated 
by Jeong, the coordination of the solvent could force the rhodium metallacycle to adopt an 
octahedral geometry in the oxidative addition (Figure 2.5).208 Additional experimental 
investigations revealed that the use of THF was essential for the achievement of a high degree 
of enantioselectivity and thus confirmed that the coordinating solvent could provide the 
optimal geometry in the Rh-complex for an enantiospecific oxidative addition.
Following studies by the Consiglio group aimed at the identification of the active catalytic 
species in the asymmetric Rh-catalysed PK reaction (Scheme 2.9).209 A series of detailed 
kinetic and mechanistic studies provided an alternative scenario, in which the active catalytic
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Rh-species ii is a square-planar complex bearing two molecules of solvent on the metal 
centre. Hence, the carbon monoxide component is solely involved only the insertion step and 
does not coordinate on the rhodium centre in the oxidative addition step (Scheme 2.9).
Scheme 2.9. Experimentally confirmed mechanism of the Rh-catalysed enantioselective PK 
reaction.
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H
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2.2.2. Effect of the Bisphosphine Ligands.
As highlighted in section 2.1.1, the possibility to alter the backbone and the steric 
environment around the phosphorous atom of the atropisomeric bisphosphines inspired the 
design and optimisation of novel ligands in order to enhance the reactivity and 
enantioselectivity of metal-catalysed reactions. In this context, studies by Genet and Jeong 
examined the relationship between the structural properties of atropisomeric bisphosphines 
and the enantioselectivity conferred by these ligands in the Rh-catalysed PK reaction.210
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Figure 2.6 outlines the electronic and structural profile of a series of atropisomeric 
bisphosphine ligands. Utilising BINAP as a ligand of reference, the electron density on the 
phosphorous can be tuned by the modification of the phenyl ring.
Figure 2.6. Electronic and structural properties of C2-symmetric atropisomeric bisphosphine 
ligands.
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p-OMe-BINAP
SYNPHOS
DIFLUORPHOS
Dihedral Angle (0)
Similarly, the influence of different aromatic substituents on the phosphorous atom electron 
density is evident from the variation of the 31P chemical shift (Parameter C, Table 2.1). 
Hence, the spectroscopic data demonstrate that p-MeO-BINAP (5 = -16.9) and 
DIFLUORPHOS (6 = -12.5) have the highest and lowest electron density on the phosphorous 
atom, respectively. Additionally, the electronic analysis included the examination of IR 
stretching frequency of the CO ligand in the [RhCl(CO)(L*)] complexes, thereby allowing a 
comparison of the Jt-acidic character of the chelating bisphosphines (Parameter D, Table 2.1). 
The high CO stretching in the ^-CFs-BINAP complex illustrates the high jt-acidic character of
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the bisphosphine whereas the low CO stretching frequency in jc-OMe-BINAP complex is 
consistent with low n-acidic character.
Table 2.1. Structural and spectroscopic properties of C2-symmetric atropisomeric 
bisphosphine ligands.
Ligand Ale, °) B (0, °) C (8, ppm) D (tj, cm"1)
p-OMe-BINAP 85.2 78.3 -16.9 1998
BINAP 86.2 78.3 -14.4 2003
P-CF3-BINAP 83.8 78.0 -13.8 2022
SYNPHOS 70.7 73.0 -14.3 2000
DIFLUORPHOS 67.6 72.2 -12.5 2014
A = dihedral angle of the free ligand.
B = dihedral angle of ligand in the [RhCI(CO)L*] complex.
D = 31 P NMR chemical shift.
E = IR carbonyl stretching frequency in [RhCI(CO)L*] complex.
Table 2.2. Effect of the bisphosphine ligand on the enantioselectivity of the Rh-catalysed PK 
reaction.
[RhCI(CO)2]2 (3 mol%)
(S)-Ligand (9 mol%), AgOTf Me
^ THF, CO (1 atm)
n ^~Me _____________________ n r \=n
361
00 0 0 O H
(S)-362
Ligand yield (%) ee (%)
p-OMe-BINAP 53 81
BiNAP 70 83
p-CFg-BINAP 65 84
SYNPHOS 57 93
DIFLUORPHOS 52 89
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Subsequent experimental studies on the asymmetric Rh-catalysed PK reaction in presence of 
atropisomeric bisphosphine ligands provided divergent results in terms of reactivity and 
enantioselectivity. Hence, as illustrated in Table 2.2 the bisphosphines with a reduced 
dihedral angle (SYNPHOS and FLUOROPHOS) provided the highest enantioselectivity in 
the reaction.210 As previously outlined in Figure 2.5, the steric interactions between alkyne 
terminus and aryl substituents on the phosphorous atom account for the high stereoselectivity 
in the oxidative addition step. Additional experimental studies investigated the effect of the 
substitution on the alkyne moiety on the level of enantioselectivity (Table 2.3). The observed 
results demonstrate the dramatic influence of the alkyne substitution pattern and illustrated 
that the electronic nature of the terminus (Me or /?-MeO-C6H4), more than the size impact the 
stereochemical outcome. 210 The outstanding stereoselectivity conferred by binaphthyl- and 
bisphospholane-type bisphophines in the Rh-catalysed PK reaction inspired the design of 
novel chiral scaffolds to analyse the effect of the different backbones on the level of 
enantioselectivity.
Table 2.3. Effect of the alkyne terminus on the Rh-catalysed enantioselective PK reaction.
[RhCI(CO)2]2 (3 mol%) 
(S)-SYNPHOS (9 mol%), AgOTf 
, THF, CO (1 atm)
R
o0o00
....^ \ /
H
Enyne R Product yield (%) ee (%)
361 Me (S)-362 57 93
363 p-OMe-C6H4 (S)-364 64 89
44 Ph (S)-44 65 65
365 p-CF3-C6H4 (S)-366 68 68
For instance, Zhou and coworkers described an efficient asymmetric Rh-catalysed Pauson- 
Khand reaction in presence of SDP ligands, based on the l,l'-spirobiindane scaffold. Which 
has a wide dihedral angle (95 °) (Eq. 2.17).211
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[RhCI(CO)232 (3 mol%) 
(R)-SDP (9 moI%), AgOTf 
DCE, CO (1 atm)
Ph
44
Ph
°C^>=o
H
(S)-45
(2.17)
In view of this result, Zhou investigated the Rh-catalysed cyclocarbonylation of 1,6-enynes in 
presence of monodentate phosphoramidate SIPHOS (Eq. 2.18),212 The resulting methodology 
provided the first example of Rli-catalysed PK reaction in presence of a monodentate 
phosphorous ligand.
•Ph
[RhCI(CO)2]2 (3 mol%) 
(R)-SDP (13 mol%), AgSbF6 
DCE, CO (1 atm)
90 °C
44
56% 
84% ee
(2.18)
2.2.3. Alternative CO Sources.
The aforementioned developments highlight the wide range of different ligands that impart 
optimal reactivity and stereoselectivity in the Rh-catalysed asymmetric manifold. Therefore, 
additional studies focused on the ability to avoid gas CO and thereby provide environmentally 
benign conditions. In this context, three aromatic provide a CO surrogate (Scheme 2.10). The 
process involves a metal-catalysed decarbonylation to generate CO, which then undergoes 
cyclocarbonylation process. Independent studies by Morimoto213 capitalised on two strategies 
and developed the first example of Rh-catalysed PK reactions employing aldehydes as a CO 
surrogate (Scheme 2.11).
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Scheme 2.10. Utilisation of aldehydes as CO surrogate in the PK reaction.
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Scheme 2.11. Rh-catalysed PK reaction using aldehydes as a CO surrogate.
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Additional studies by Shibata215 described the corresponding enantioselective manifold by 
replacing the dppp with a BINAP-type catalyst using aldehydes or carbon monoxide, which 
provided similar results in terms of yields and stereoselectivity (Scheme 2.12). In this 
context, the Morimoto group envisioned the possibility of developing a novel asymmetric Rh- 
catalysed PK reaction by using aldehydes as a CO surrogate and water as the reaction 
solvent.216a
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Scheme 2.12. Rh-catalysed enantioselective PK reaction using aldehydes as a CO surrogate.
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This accomplishment involved the employment of a Rh-complex with high stability and 
solubility under aqueous conditions.21611 Initial studies on the reaction focused on the 
development of a non-enantioselective Rh-catalysed aqueous PK reaction employing 
formaldehyde as a CO surrogate (Eq. 2.19). Optimisation demonstrated that the dppp ligand, a 
water-soluble phosphine (TPPTS) and a surfactant (SOS) were essential to achieve an 
excellent yield. Hence, the mechanistic hypothesis in Scheme 2.13 outlines the role of the 
reaction components. For instance, TPPTS and dppp phosphine provides the formation of two 
distinct rhodium complexes: a hydrophilic Rh-TPPTS complex and the hydrophobic Rh-dppp 
complex. The water-soluble catalyses the decarbonylation process, to generate the CO- 
containing complex. Employment of SOS surfactant allows the formation of a hydrophobic 
micellar phase, which contains the Rh-dppp complex and the enyne substrate. A CO transfer 
process from the aqueous to the micellar phase allows the CO insertion into metallacycle and 
subsequent formation of the bicyclopentenone derivative. The first Rh-catalysed aqueous PK 
reaction prompted the subsequent development of the related asymmetric manifold, by
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substitution of dppp with the chiral to/-BINAP (Scheme 2.12), thus allowing the remarkable 
opportunity to perform a highly asymmetric carbocyclisation under environmentally friendly 
conditions.21615
Scheme 2.13. Mechanism of the Rh-catalysed aqueous PK reaction in presence of 
aldehydes as a CO surrogate.
R
Nonetheless, the synthetic value of the methodology was partially affected by the necessity to 
employ a surfactant and two different bisphosphine ligands. Hence, these drawbacks 
prompted the development of more practical operating reaction conditions. Extensive studies 
by the Chan group revealed that employment of P-PHOS ligands and cimiamaldehyde as a 
CO surrogate facilitate the aqueous asymmetric Rh-catalysed aqueous Pauson-Khand reaction 
without any requirement of additive or surfactant (Eq. 2.20).217 The low catalyst loading and 
the small excess of cinnamaldehyde enhanced the synthetic value of this protocol. In a similar 
process, Chan and coworkers described the Rh-catalysed PK reaction using SYNPHOS and 
alcoholic solvents to achieve a similar highly enantioselective synthesis of bicyclopentenone 
adducts (Eq. 2.21).218
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Figure 2.7. Effect of the alkyne terminus 
reaction.
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Moreover, they investigated the correlation between the electronic effects on the 1,6-enyne 
substrates and the enantioselectivity of the related Rh-catalysed PK reaction.217 Hence, the 
linear free-energy relationship in the Hammett plot showed an unprecedented correlation of 
the enantiomeric excess with the electronic properties of the substrate. Experimental studies
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outlined the beneficial effect of electron-donating substituents on the enantioselectivity of the 
reaction, from the more efficient stereocommunication between the alkyne moiety and the 
rhodium centre (Figure 2.7), which contrasts to the more electron withdrawing groups that 
have a much “loosen” transition state.
2.2.4. Desymmetrisation of Meso-dienynes.
The desymmetrisation of raaso-dienynes by means of a PK reaction provided an attractive 
methodology in view of the possibility to generate two contiguous stereocenters from 
prochiral 1,6-enynes. Hence, following the successful achievement of the first Rh-catalysed 
asymmetric PK reaction,208 Jeong investigated the feasibility of an asymmetric Rh-catalysed 
desymmetrisation of meso-dienynes. Subsequent studies confinned the feasibility of the 
process in presence of rhodium and iridium catalyst using chiral BINAP-type ligands.219 
Nevertheless, iridium and rhodium congeners displayed a different reactivity in the process 
and a divergent stereochemical outcome (Scheme 2.14).
Scheme 2.14. Desymmetrisation of meso-dienynes by Rh-catalysed enantioselective PK 
reaction.
[lr(cod)CI]2 (15 moi%) [RhCI(CO)2]2 (3 mol%)
(R)-p-OMe-BINAP (30 mol%) 
toluene, CO (1 atm)
130 °C
dr =75:1
96% ee
(R)-p-OMe-BINAP (9 mol%) 
THF, CO (1 atm)
90 °C
dr = 11:1
Although the [Ir(Cod)Cl]2 catalysed process afforded bicyclopentenone 368 with excellent 
diastereo- and enantioselectivity, albeit with 30% metal loading and harsh temperature 
conditions (130 0C), whereas the [RhCl(CO)2]2 catalysed process provided the opposite
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diastereoisomer with less selectivity but high catalytic activity (6 mol% of metal loading).219 
Surprisingly, further experimental studies revealed that the level of stereoinduction provided 
by the rhodium and iridium catalysts was dramatically influence by the alkyne substitution 
pattern (Scheme 2.15).219
Scheme 2.15. Influence of the alkyne substitution pattern on the asymmetric PK reaction of 
mes'o-dienynes.
tsnCD=°
H
(S,/?)-370
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369
[RhCI(CO)2]2 (3 mol%) 
(R)-p-OMe-BINAP (9 mol%) 
THF, CO (1 atm)
90 °C
81% § 
dr =2:1 I 
67% ee I
^ H 
(S,S)-370
In a recent study, the Jeong group applied the Rh-catalysed desymmetrisation of meso- 
dienynes bearing an acetal moiety.220 Unfortunately, these substrates undergo decomposition 
under a CO atmosphere, which required the use of aldehydes as CO surrogate (Eq. 2.21). 
Additionally, the synthetic value of the methodology was affected by poor 
diastereoselectivity.220
O Ph
[Rh(cod)CI]2 (5 mol%) 
(R)-BINAP (12 mol%) 
cinnamaldehyde (20 eq.)
120 °C
I
O
H
(R,S)-370369
S'
81%
dr= 1.6:1 
86% ee
(2.21)
2.2.5. Effect of the CO Concentration.
As discussed in section 2.2.1 kinetic and mechanistic studies by the Consiglio group209 
revealed that the active catalytic species in the asymmetric Rh-catalysed PK coordinated two 
molecule of solvent (complex ii, Scheme 2.9, in which carbon monoxide is solely involved in 
the insertion step. From a conceptual point of view, a high concentration of carbon monoxide 
is not essential for optimal reactivity and stereoselectivity. Furthermore, a high level of CO 
could enhance the formation of Rh complexes viii and ix, which are inactive towards the 
coordination to the enyne substrate. Therefore, the employment of a low concentration could 
enhance the reactivity rate and additionally influence the stereochemical outcome of the 
carbocyclisation. In line with this hypotheses, Jeong envisioned the possibility to perform the 
originally developed Rh-catalysed PK reaction208 under low CO concentration with the aim of 
improving the operating conditions and the level of enantioselectivity (Scheme 2.16).232
Scheme 2.16. Effect of the CO concentration on the Rh-catalysed enantioselective PK 
reaction.
'CpS0
H
(R)-45
[RhCI(CO)2]2 (5 mol%) 
(R)-BINAP (12 moI%), AgOTf 
THF, Ar:CO (10:1, 1 atm)
RT
77% 
93% ee
[RhCI(CO)2]2 (3 mol%) 
(S)-BINAP (6 mol%), AgOTf
oC^>=o
H
(S)-45
The discovery of the positive effect of a low CO concentration and the recent improvements 
in the design of bisphosphine ligands provided the basis for a reinvestigation of the Rh- 
catalysed desymmetrisation of mejo-dienynes.219 In this context, utilisation of 
DIFLUORPHOS ligand under low CO concentration allowed an ambient temperature 
reaction with improved yield and enantioselectivity (Scheme 2.17).221
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Scheme 2.17. Effect of the CO concentration on the Rh-catalysed enantioselective PK 
reaction of we^o-dienynes.
[RhCI(CO)2]2 (3 mol%) [RhCI{CO)2]2 (3 moI%)
(S)-DIFLUORPHOS (9 mol%) 
THF, Ar:CO (10:1,1 atm)
86% ee
(R)-p-OMe-BINAP (9 mol%) 
THF, CO (1 atm)
90 °C
dr = 11:1
O
2.3. Rhodium-catalysed Enantioselective Reactions of Chlorinated 1,6-Enynes.
2.3.1. Introduction.
The synergic ability of the rhodium catalysts and bisphosphine ligands to promote a highly 
enantioselective PK reaction coupled with the improvement of the operating conditions, t 
allowed the development of a process that avoids poisonous CO, in environmentally friendly 
solvents or in absence of a thermal process. Despite these noteworthy achievements, the 
synthetic potential of the enantioselective manifold was largely affected by its limited 
substrate scope. As described in Figure 2.8, 1,6-enynes bearing an unsubstituted alkene 
moiety provided optimal reactivity in the asymmetric process. In contrast, substitution on the 
alkene position exerted a dramatic influence on the reactivity in the carbocyclisation. 1,6- 
Enynes bearing internal alkene substitution displays low or no reactivity in the 
enantioselective process. Therefore, the rare exploitation of these substrates involves harsh 
temperature conditions (T > 100 °C) and is limited to sterically unhindered substituents (R1 = 
Me).2043,207,217 Introduction of a terminal substituent on the alkene moiety provides low 
reactivity towards the enantioselective PK reaction and the undesired formation of undesired
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ene-cycloisomerisation adducts.222 Hence, the poor reactivity these substrates in the Rh- 
catalysed PK reaction is further supported by the absence of any enantioselective version. In a 
similar way, employment of 1,7-enynes provides complete unreactivity towards the 
asymmetric process. In our previous studies we demonstrated that the introduction of a 
chlorine moiety on the alkyne terminus provided enhanced reactivity in the Rh-catalysed 
diastereoselective PK reaction.169 Hence, we decided to examine the enantioselective variant 
with 1,6-chlorinated enynes to examine the influence of the chlorine atom on the reactivity 
and selectivity of the carbocyclisation. Additionally, despite the fact that the first room 
temperature enantioselective Rh-catalysed PK reaction had been reported, it was limited to 
1,6-enynes bearing terminal alkenes.221
Figure 2.8. Reactivity profile of l,«-enynes towards the enantioselective PK reaction.
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In light of this limitation, we envisioned that employment of the chlorine substituted alkyne 
would improve the reactivity and thereby, it should facilitate the enantioselective reaction of 
substituted alkenes at room temperature (Scheme 2.18).
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Scheme 2.18. Rh-catalysed enantioselective PK reaction of chlorinated 1,6-enynes at room 
temperature.
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This study would further demonstrate the beneficial role of the halogen moiety and thereby 
expand the applicability of the methodology to the total synthesis of bioactive natural targets.
2.3.2. Investigation of the Reaction.
Previous works on the Rh-catalysed enantioselective Pauson-Khand process highlighted the 
remarkable influence of the alkyne terminus on the reactivity and enantioselectivity.210,217 
This inspired the examination the of the 1,6-chlorinated enyne 301 and to compare its 
reactivity with the previously employed aliphatic and aromatic substituents. Solvent screening 
demonstrated moderate reactivity and enantioselectivity222 (Table 2.4). However, apolar and 
non-coordinating solvents provided no reactivity in the carbocyclisation (entry 1 and 2, 
Table 2.4), which was attrbiuted to the limited solubility of the cationic Rh-BINAP complex 
in benzene and xylene at room temperature. In contrast, strongly coordinating solvents, such 
as acetonitrile, were relatively unreactive, due to the solvent competing with the enyne for the 
metal centre (entry 4). Gratifiingly, acetone (entry 5) afforded the most promising yield and 
enantioselectivity222 in the reaction and was thereby used in the ligand screening study (Table 
2.5). Previous studies with BINAP-type ligands highlighted the ability to tune the dihedral 
angle of the chiral backbone and the electron density on the phosphorous atom in order to 
enhance the reactivity and the stereoselectivity of the PK reaction.210
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Table 2.4. Effect of solvents in the Rh-catalysed enantioselective PK reaction.11
TsN Cl
[RhCI(CO)2]2 (5 mol%) 
(S)-xyl-BINAP (12 mol%), 
AgOTf (12 mol%), solvent 
(0.050 M), CO:Ar = 1:10 (1 atm)
22 °C
301
Cl
H
(S)-310
Entry Solvent yield (%)b ee (%)c
1 p-xylene NR —
2 benzene NR -
3 THF 32 27
4 CH3CN 17 48
5 Acetone 65 60
aAII reactions were carried out on a 0.1 mmol scale. 
b Isolated yields. c Ratios of enantiomers were 
determined by HPLC analysis of the crude products.
P((3I5-Me)C6H3)2
PK^S-MeJCeHa);,
^S^iNAP^
Table 2.5. Effect of bisphosphine ligands in the Rh-catalysed enantioselective PK reaction.1
TsN Cl
[RhCI(CO)232 (5 moi%) 
ligand (12 mol%), 
AgOTf (12 mol%), acetone 
(0.050 M), CO:Ar= 1:10 (1 atm)
22 °C
301
Cl
H
(S)-310
Entry Ligand Yield (%)b ee (%)c
1 (S)-xy/-BINAP 65 60
2 (S)-P-Phos 54 48
3 (S)-xyl-P-Phos 86 73
4 (S)-Tunephos 58 72
5 (S)-SDP 12 49
6 (S,S)-Me-Duphos NR -
a All reactions were carried out on a 0.1 mmol scale. 
b Isolated yields. c Ratios of enantiomers were 
determined by HPLC analysis of the crude products.
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We envisioned that screening structurally different chiral bisphosphines would provide the 
necessary insights to identify the optimal ligand for the carbocyclisation (Table 2.5). The 
examination of the results confirmed that the variation of the dihedral angle did indeed 
influence the reaction. Hence, using xjWBINAP as a reference ligand, indicated that ligands 
with a larger dihedral angle were inferior in terms of overall reactivity and selectivity (Entry 5 
and 6, Table 2.5), whereas the bisphosphines with a narrow dihedral angle were superior 
(Entry 3 and 4).The structural examination between xy/-BINAP and xyl-P-Phos corroborates 
the aforementioned importance of the dihedral angle. The two ligands show an equal steric 
environment (3,5-methyl) and similar electron density (5 (x^Z-P-Phos) = -14.0 ppm, 8 {xyl- 
BINAP) = -13.8 ppm) on the phosphorous atom. Hence, the narrower dihedral angle of the 
2,2’-bipirydil backbone predominantly accounts for the enhanced yield and enantioselectivity.
Figure 2.9. Dihedral angle of bisphosphine ligands and corresponding reactivity in the Rh-
catalysed enantioselective PK reaction.
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Figure 2.9 summarises the correlation between the dihedral angle of chiral bisphophines and 
the activity in the Rh-catalysed enantioselective PK reaction. Additionally, the correlation 
between P-Phos andxyZ-P-Phos (Entry 2 and 3, Table 2.5) indicates that the steric bulkiness 
of the phosphorous atom increases the yield and stereoselectivity of the process. The observed
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results prompted the utilisation of the xyZ-P-Phos ligand and evaluate the effect of silver 
additives on the carbocyclisation.
As outlined in previous studies, the counter anion of the Rh-phosphine complex plays an 
important role in the PK reaction.211,212 Although the abundance of silver salts provides the 
opportunity to introduce different counter anions on the metal center, previous Rh-catalysed 
PK reactions have demonstrated AgOTf or AgSbFe as optimal additives. Interestingly, the 
examination of counter anions revealed that increasing size has a detrimental effect on the 
efficiency and reactivity (Entry 1-3, Table 2.6). The recent development of a Rh-catalysed 
asymmetric hydroacylation by Dong et al demonstrated that the replacement of (OTf) in 
favour of the less coordinating (N03) provided a surprising enhancement in the 
enantioselectivity of the transformation 224 We decided to investigate the outcome of the 
carbocyclisation in presence of weakly coordinating anions, such as nitrate and sulfate. 
Surprisingly, the evaluation of a wide range of silver additives revealed that the sulfate anion, 
despite providing a lower yield, promoted a high level of enantioselectivity in the process 
(Entry 5, Table 2.6),
Table 2.6. Effect of the silver additives in the Rh-catalysed enantioselective PK reaction.11
TsN ■Cl
[RhCI(CO)2]2 (5 mol%) 
(S)-xyl-P-Phos (12 mol%), 
AgX (12 mol%), acetone 
(0.050 M), CO:Ar= 1:10 (1 atm)
Cl
rr^o
301
22 °C
■■ ^
H
(S)-310
Entry AgX yield (%)b ee (%)c
1 AgOTf 86 73
2 AgBF4 59 61
3 AgSbFe ND 37
4 AgCN NR --
5 Ag2S04 75 92
a All reactions were carried out on a 0.1 mmol scale. 
b Isolated yields. 0 Ratios of enantiomers were 
determined by HPLC analysis of the crude products.
OMe
■P-Phos
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Unfortunately, further application of the methodology to the analogous carbon-tethered 1,6- 
enyne 304 proved to be unsatisfactory in terms of reactivity and enantioselectivity (Table 
2.7). Hence, the experimental results indicate that the nature of the tether alters the geometry 
of the 1,6-enyne and thereby influences the stereochemical outcome in the subsequent 
oxidative addition step (Table 2.7).
Table 2.7. Rh-catalysed enantioselective PK reaction of carbon-tethered 1,6-chlorinated 
enyne 304.a
[RhCI(CO)z]2 (5 mol%)
(S)-xyl-P-Phos (12 mol%), 
AgX (12 mol%), acetone
(S)-313
P-Phos
yield (%)'
1 AgOTf 82 65
2 Ag2S04 44 64
a All reactions were carried out on a 0.1 mmol scale. 
b Isolated yields. c Ratios of enantiomers were 
determined by HPLC analysis of the crude products.
In the previous investigation of the diastereoselective Rh-catalysed PK reaction of chlorinated 
1,6-enynes at room temperature, the efficiency of the reaction was dramatically altered by the 
nature of solvents, ligands and silver additives. Hence, in order to identify an optimal 
combination for the enantioselective variant, the effect of the bisphosphine ligands in the 
presence of silver triflate and polar coordinating solvents (THF or Acetone) were 
investigated. Mechanistic studies by the Consiglio group209 demonstrated that the utilisation 
of MeO-BIPHEP in presence of AgOTf and THF were optimal for an efficient Rh-catalysed 
enantioselective PK reaction. An intriguing feature with this ligand is the availability of 
analogues with identical chiral backbone and structural modifications on the phosphorus unit 
(Figure 2.10).
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Figure 2.10. Solvias (^-MeO-BIPHEP ligands.
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Table 2.8. Effect of BIPHEP-type ligands on the Rh-catalysed enantioselective PK reaction 
of enyne 301.a
TsN
301
[RhCI(CO)2]2 (5 mol%) 
ligand (12 mol%), 
AgOTf (12 mol%), solvent 
.C| (0.050 M), CO:Ar = 1:10 (1 atm)
22 °C
TsNC^'
H
(S)-310
Entry Solvent Ligand Yield (%)b ee (%)'
1 Acetone (S)-MeO-BIPHEP 65 69
2 THF (S)-MeO-BIPHEP 73 70
3 " 3,5-Me-MeO-BIPHEP 78 86
4 » 3,5-fBu-MeO-BIPHEP 13 50
5 3,5-fBu-4-MeO-
MeO-BIPHEP
NR --
a All reactions were carried out on a 0.1 mmol scale. b Isolated yields. 
c Ratios of enantiomers were determined by HPLC analysis of the 
crude products.
Thus, the different substitution pattern in 3,5-Me-MeO-BIPHEP and S.S^Bu-MeO-BIPHEP 
ligands would illustrate the influence of the steric environment, whereas the introduction of a 
methoxy moiety on the aromatic ring (S.S^Bu-d-MeO-MeO-BIPHEP) would provide a
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stereoelectronic component. The analysis of the ligands indicates that (5)-OMe-BIPHEP 
provided good enantiocontrol and that THF provided increased overall yield (Entry 2, Table 
2.8). The subsequent examination of 0S>3,5-Me-OMe-BIPHEP ligand demonstrated the 
beneficial effect of methyl substituents on the aromatic ring to impart improved efficiency 
and enantiocontrol (Entry 3, Table 2.8). In contrast, steric bulk and additional electron 
donating substituents proved more detrimental to the reaction rate (Entry 4 and 5, Table 2.8). 
Hence, these studies provided fundamental insights towards the identification of the optimal 
chiral bisphosphine for an efficient enantioselective Rh-catalysed PK reaction. For instance, a 
narrow dihedral was essential for achieving high reactivity and enantioselectivity (AyZ-P-Phos 
and OMe-BIPHEP). In a similar maimer, lower electrondensity on the phosphorous atom was 
desirable, due to the problems with steric effects and electron-donating groups (S.S^Bu-d- 
OMe-OMe-BIPHEP). Finally, introduction of methyl substituents on the phenyl ring confers 
a moderate steric bulk aroimd the phosphorous atom and provides good enantiocontrol (3,5- 
Me-OMe-BIPHEP).
These experimental findings led to the identification of DM-SEGPHOS225 as the ideal ligand 
for the achievement of an efficient asymmetric manifold (Eq. 2.22). Hence, the chiral 
bisphosphine DAf-SEGPHOS was selected, which has a bis(l,3-benzodioxole) backbone 
with a remarkably narrow dihedral angle (65.2 ° against 86 ° of BINAP) and relatively poor 
electron-density on the phosphorous atom (( 6 (.DM-SEGPHOS) = -12.5 ppm, 8 (BINAP) - - 
14.4 ppm). Additionally, methyl substituents on the phenyl ring provide the desired steric 
environment on the phosphorous atom. Gratifyingly, this ligand provided optimal selectivity 
in the enantioselective Rh-catalysed PK reaction of enyne 301 (Eq. 2.22). In light of this 
piomising result, we elected to apply these conditions to the challenging room temperature 
carbocyclisation of 1,6-enynes with 1,1-disubstituted alkenes. As previously pointed out, 
these substrates provides low in the enantioselective PK reaction, which accounts for the 
limited examples that have been reported. Moreover, they generally require very forcing 
reaction conditions which leads to side reactions and only methyl groups have been 
examined.
185
[RhCI(CO)2]2 (5 mol%) 
(S)-D/W-SEGPHOS (12 mol%), 
AgOTf (12 mol%), THF 
(0.033 M), CO:Ar= 1:10 (1 atm)
Cl
22 °C H
(S)-310
PttS.S-MeJCeHsJs (2.22) 
P((3,5.Me)C6H3)2
301
Solvent: moderately coordinating (THF, Acetone) 
Ligand dihedral angle: narrow 
P electrondensity: low
Silver additive: AgOTf
CO concentration: low
Table 2.9 outlines the preliminary optimisation study to probe the feasibility of the PK 
reaction of 1,6-enynes with 1,1-disubstituted olefins. Unfortunately, treatment of 1,6-enyne 
371 and 372 (entries 1 and 2) in presence of the rhodium complex with xyl-BINAP as a 
ligand did not furnish any of the desired [2+2+1] cycloaddition product. Gratifyingly, 
replacement of alkyne terminus with a chlorine group (entry 3, Table 2.9) provided improved 
reactivity, albeit with the exclusive formation of the homodimerisation adducts 376b and 
376b\226 These initial results confinned that the replacement of the aliphatic or aromatic 
alkyne terminus with a chlorine moiety influences the reactivity of the PK reaction. 
Additionally, as observed in the previous optimisation studies, the xyl-BINAP ligand, bearing 
a large dihedral angle, has a low efficacy in the transformation. Hence, we were prompted to 
investigate the behaviour of the DM-SEGPHOS ligand, which provided optimal reactivity and 
enantioselectivity in the corresponding carbocyclisation of 1,6-enynes bearing a terminal 
substituted alkene unit (Eq. 2.22). Gratifyingly, this chiral bisphosphine could enhance the 
reactivity of chlorinated 1,6-enyne 373 in the carbocyclisation to afford the desired PK adduct 
376a, although with concomitant formation of the homodimerisation products (entry 6, Table 
2.9). We envisaged that lower concentration would limit the formation of the undesired 
[2+2+2] adduct 376b and, thereby, afford bicyclopentenone 376a as the major product.227
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Gratifyingly, reduction of the enyne concentration effectively circumvented the formation of 
the undesired homodimerisation adduct and provided the bicyclopentenone 376a with optimal 
yield and excellent enantioselectivity. Hence, the chlorine group in conjunction with the 
optimal bisphosphine ligand DM-SEGPHOS provided a mild and highly selective 
cyclocarbonylation of 1,1-disubstituted alkenes at room temperature. This outstanding result 
prompted the scope of the reaction to be explored in order to verify the validity of this result 
for related substrates.228
Table 2.9. Examination of the Rh-catalysed enantioselective PK reaction of 1,6-enynes with a 
1,1 -disubstituted alkene.a
TsN
Me
'R
PK Reaction /
TeN X
Me
a
R ™qic>'
Me
b
R
Me
b’
Csu
22 °C
Entry Ligand R [enyne] Ratio Yield (%)c ee (%)d
(moI/L) a:(b+bjb
1 (S)-Xyl-BINAP Me 371 0.066 - NR 374
2 ■■ Ph 372 " -- NR 375 --
3 ■■ Cl 373 " <;1:19e 23e 376 --
4 (S)-DM-SEGPHOS Me 371 0.066 -- - 374 --
5 » Ph 372 " -- NR 375 -
6 ■■ Cl 373 " 0.8:1 87 376 ND
7 II ■■ ■■ 0.033 fe19:1 86 ■■ 94
8 " ■■ 0.025 a19:1 91 •• 96
a All reactions (0.1 mmol) were carried out utilising [RhClfCOhk (5 moI%), AgOTf 
(12%), ligand (12%) in acetone at 22 °C under an atmosphere of Ar:CO = 10:1 (1 
atm). b Ratio were determined by 500 MHz 1H NMR on the crude reaction mixture. 
c Isolated yields.d Ratios of enantiomers were determined by HPLC analysis of 
the crude products. e 376b:376b' = 9:1, 94% ee.226
2.3.3. Scope of the Reaction.
In accord with this reasoning, the conditions were extended to other substituents in the alkene 
for the nitrogen-tethered chlorinated 1,6-enynes. Gratifyingly, replacement of the initial
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methyl moiety with a wide range of substituents provided similar reactivity and 
enantiocontrol in the cycloaddition (entry 2-4, Table 2.10), albeit the CHkOBn substituent 
gave a slight diminution in enantioselectivity (entry 3, Table 2.10). In this context, we 
hypothesised that the presence of a coordinating heteroatom on the aliphatic chain could 
interact with the metal centre and thereby, alter the stereoselective outcome of the process. A 
key feature of this process resides in the mild operating conditions and the possibility to 
employ labile functional groups that would not be tolerated under previous conditions. For 
example, this manifold allows the imprecedented utilisation of aliphatic silanes without any 
decomposition of the starting material and PK adduct (entry 4, Table 2.10).
Table 2.10. Scope of the reaction.3
TsN
PK Reaction
Entry X R Yield (%)b ee (%)G
1 NTs Me 373 91 376 96
2 -■ Bn 377 93 388 97
3 ■■ CH2OBn 378 91 389 88
4 » CH2TMS 379 86 390 96
5 O Me 380 82 391 96
6 » Bn 381 86 392 299
7 " CH2OBn 382 83 393 92
8 ch2tms 383 81 394 98
9 C(C02Me)2 Me 384 74 395 92
10 " Bn 385 81 396 97
11 *■ CH2OBn 386 79 397 86
12 ■' CH2TMS 387 87 398d --
aAll reactions (0.1 mmol) were carried out utilising [RhCI(CO)2]2 (5 
mol%), AgOTf (12%), ligand (12%) in acetone at 22 °C under an 
atmosphere of Ar:CO = 10:1 (1 atm). b Isolated yields. c Ratios of 
enantiomers were determined by HPLC analysis of the crude products. 
d reaction of enyne 387 provided the exclusive formation of SN2’-type 
cyclisation adduct 398 (see Table 2.11)
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The replacement of the nitrogen with the corresponding oxygen tether provided similar levels 
of reactivity and enantioselectivity (Entry 5-8). Although previous studies169 highlighted the 
low reactivity of carbon tethers, the enantioselective process provides good levels of 
reactivity and good levels of reactivity and enantioselectivity (Entry 9-11, Table 2.10), 
Interestingly, application of the methodology to the enyne 387 did not provide any PK adduct 
and resulted in the preferential formation of the SN2’-type cyclisation adduct 398 (Entry 12, 
Table 2.10).229 Attempted optimisation of this particular example under different 
cyclocarbonylation conditions did not provide any PK adduct (Table 2.11). Interestingly, a 
literature survey revealed that unlike the nitrogen and oxygen tethered enynes, carbon- 
tethered enynes bearing an allyl silane moiety can follow a different mechanistic pathway 
which leads to the exclusive fonnation of an SN2’-type cyclisation adduct.230
Table 2.11. Attempted Rh-catalysed enantioselective PK reaction of enyne 387.
387 398 399
Entry Method 398:399 Yield (%) ee (%)
1 A 1:0 87 -
2 B 1:0 85 -
3 C 1:0 64 _
A: [RhCI(CO)2]2 (5 mol%), AgOTf (12%), DM-segphos (12%), acetone, Ar:CO 
10:1 (1 atm), RT; B: [RhCI(CO)2]2 (5 mol%), AgOTf (12%), dppp(12%), xylene,
Ar:CO 10:1 (1 atm), 120 °C; C: ERhCI(CO)2]2 (5 mol%), xylene, CO (1 atm), RT.
We also examined the feasibility of the methodology for enynes bearing a terminal substituent 
on the alkene. As previously outlined, the effective cyclocarbonylation of these substrates was 
precluded by the competitive ene-cycloisomerisation223 and poor reactivity, due to the steric 
interactions between alkene terminus and metal centre. Nonetheless, Narasaka described the 
diastereoselective PK reaction albeit under harsh thermal conditions (Eq. 2.23).
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[RhCI(CO)2]2 (5 mol%)
_____ CO (1 atm), dibutyl 
Me02C ”' ether Me02C
Me02C _^v ------------------------------ Me02C
Me
400
160 °C 
96%
Ph
H Me
401
c EIZ = 91:9 ^ c/s; trans = 95:5
(2.23)
Moreover, these studies also demonstrated the impact of the olefin on the diastereoselectivity 
in the bicyclopentenone adducts, in which the /rafts-derivative 401 undergoes some 
equilibration. Although high temperatures were critical for the efficient formation 
a-substituted bicyclopentenone derivatives, the absence of an asymmetric version inspired 
the examination of this possibility. Disappointingly, the room temperature rhodium-catalysed 
PK reaction of enynes 402 and 403 provided no desired product (entry 1-2, Table 2.12). 
Interestingly, the bicyclopentenone 405 was obtained by a thermal process, employing dppp 
as a bisphosphine ligand (entry 3).
Table 2.12. Attempted Rh-catalysed PK reaction of 1,6-enynes bearing a trans olefm moiety.a
TsN
1 Cl PK Reaction
Cl
o
Entry R Yield (%) ee (%)
1 Me 402 NR 404 -
2 Ph 403 NR 405 -
3b Ph 403 34 405 --
aAII reactions (0.1 mmol) were carried out utilising [RhCI(CO)2]2 
(5 mol%), AgOTf (12%), DM-SEGPHOS (12%) in acetone (0.025M) 
at 22 °C under an atmosphere of Ar:CO = 10:1 (1 atm).b reaction 
was carried out utilising [RhCI(CO)2]2 (5 moi%), AgOTf (12%), 
dppp (12%) in p-xylene (0.03M) at 120 °C under an atmosphere of 
CO (1 atm).
190
A literature survey of related reactions demonstrated that terminal substituted 1,6-enynes 
undergo Rh-catalysed enantioselective ene-cycloisomerisation at room temperature. 
Interestingly, the viability of the methodology was exclusively restricted to 1,6-enynes with 
cw-alkenes (Eq. 2,24).223
[Rh(Me-DUPHOS)Cl]2 Ph
— rn. /in A«cnc. nnc
(2.24)
From a mechanistic standpoint, the Rh-catalysed PK reaction and the ene-cycloisomerisation 
process involve the oxidative addition of the 1,6-enyne to form a common rhodium 
metallacycle. We envisaged that the utilisation of a cA-olefin in the enyne substrate could 
impart a higher reactivity towards the cyclocarbonylation process and, additionally, the 
phenyl group suppress any ene-cycloisomerisation adduct. Gratifyingly, treatment of enyne 
408 under the optimal reaction condition provided the desired adduct 409 in good yield and 
with outstanding diastereo- and enantioselectivity (Eq. 2.25).231 In order to provide a rationale 
for the observed diastereocontrol, we computed the trans and cis rhodium metallacycles that, 
upon CO insertion and reductive elimination, provide the tram-adduct 409 and cA-epimer 
405.232 (Figure 2.11), respectively. Analysis of the cis metallacycle reveals steric interactions 
between the phenyl substituent on the enyne and 3,5-dimethylphenyl on the phosphorous 
atom of the ligand. In contrast, the steric interactions between enyne and ligand in the tram 
metallacycle are minimised. Hence, steric implications can rationalise the preferential 
formation of the tram metallacycle, which in turn provides the trans adduct 409. The racemic 
adduct 409 required for HPLC analysis was prepared via a standard reaction, in an analogous 
manner to the bicyclopentenone 405 (entry 3, Table 2.11).
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[RhCI(CO)2]2 (5 mol%) 
(S)-DM-SEGPHOS (12 mol%), 
AgOTf (12 mol%), acetone 
(0.033 M), CO:Ar = 1:10 (1 atm)
Cl
TsN Cl
22 °C H Ph 
(S,S)-409
Ph
408
Figure 2.11. Computed metallacyclic trans and cis intermediates for the Rh-catalysed 
enantioselective PK reaction of enyne 408.
/-
■
Surprisingly, the thermal Rh-catalysed cyclocarbonylation of enyne 408 did not provide any 
desired adduct 409, but afforded exclusively the epimer 405 with excellent stereoselectivity in 
moderate yield (Scheme 2.19). In contrast to Narasaka studies, we envisioned that the 
cationic rhodium species under the thermal conditions favoured epimerisation to form the 
thermodynamically favoured adduct 405 (Scheme 2.19). An alternative scenario involves the 
preliminary isomerisation of cis enyne 408 to the analogous trans isomer 403, which then 
provides 405 under carbonylative conditions. Gratifyingly, the room temperature conditions 
avoided the epimerisation and provided the desired racemic adduct 409 as a single 
diastereoisomer (Scheme 2.19).
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Scheme 2.19. Thermal isomerisation in the Rh-catalysed PK reaction.
Cl
TsN
q^°
H Ph
[RhCI(CO)2]2 (5 mol%) 
dppp (12 mol%) 
AgOTf (12 mol%) 
xylene, CO (1 atm)
[RhCI(CO)2]2 (5 mol%) 
rac-BINAP (12 mol%) 
^Cl AgOTf (12 mol%), THF 
Ar:CO = 10:1 (1 atm)
Cl
120 °C
43%
TsN
Ph
45 °C
54%
tsnC^>=0
H Ph
405 408 409
We envisioned that the epimerisation of chiral bicyclopentenone (S,S)-409 would provide a 
convenient method to access the corresponding diastereoisomer (5'>l?)-405. The initial HPLC 
analysis of the crude mixture of (S,S)-409 showed a dr of 99:1 in favour of the /ra/?s-isomer 
(^,iS)-409, whereas the subsequent HPLC analysis of the product after chromatographic 
column provided a dr of 25:1 in favour of the /ram’-isomer. Therefore, we hypothesised that 
treatment of (i5',iS)-409 with silica gel could deliver the formation of the epimer (j5'rR)-405 
with similar enantioselectivity. Gratifyingly, treatment of the /ram’-isomer (5r,5)-409 with 
silica gel furnished the c/s-epimcr (*S,,if)-405 as a good stereocontrol. Hence, we demonstrated 
that the asymmetric PK reaction of c/s-enyne 408 could be efficiently employed for the 
selective formation of cis- and tram- bicyclopentenone derivatives with a synthetically useful 
level of diastereo- and enantioselectivity.
Cl
TsN
q^°
H Ph
(S,S)-409
dr = 24:1 
99% ee
Silica Gel
24 hrs, 45 °C
Cl
TSN^?-^0
H Ph
(S,R)-405
dr = 12:1 
99% ee
(2.26)
2.3.4. Limitations of the Reaction.
The successful development of a highly enantioselective PK reaction and the possibility to 
incorporate a wide range of substituents on the alkene provided the impetus to investigate to
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reactivity of different olefin groups towards the cycloaddition. Treatment of a wide range of 
chlorinated 1,6-enynes with different olefin substituents (410-413) furnished none of the 
desired carbocyclisation adducts (Table 2.13). In order to circumvent this problems, we 
attempted to expand the scope of the enantioselective manifold by the 1,6-enynes bearing an 
aliphatic substituent on the c/'s-alkene unit (Table 2.14). Unfortunately, these substrates also 
did not provide any desired PK adduct. Additionally, the Rh-catalysed cyclocarbonylation of 
these substrates did not provide any observable formation of ene-cycloisomerisation product.
Table 2.13. Influence of alkene substitution on the Rh-catalysed enantioselective PK 
reaction.3
-Cl PK Reaction
TsN Ri
i
O
Entry Ri r2 Yield (%) ee (%)
1 Me Me 410 NR 414 -
2 COzMe H 411 NR 415 --
3 CH2S02Ph H 412 NR 416 --
4 CH2=C(CH3) H 413 NR 417 -
a All reactions (0.1 mmol) were carried out utilising [RhClfCO^R 
(5 mol%), AgOTf (12%), DM-SEGPHOS (12%) in acetone (0.025M) 
at 22 °C under an atmosphere of Ar:CO = 10:1 (1 atm).
A plausible rationale for the lack of ene-cycloisomerisation adducts is presumably due to the 
utilisation of a bisphosphine ligand bearing a small dihedral angle in conjunction with a 
coordinating solvent such as acetone. In contrast, Zhang and coworkers have demonstrated 
that ligands with a large dihedral angle (Me-DUPHOS) using a non-coordinating solvent, 
such as DCE, can promote to the formation of these cycloisomerisation adducts (Eq. 2.24).233
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Table 2.14. Influence of alkene terminus on the Rh-catalysed enantioselective PK reaction/’
/- — Cl PK Reaction
Ci
____ i
TsN ^ TsN ^T)c=o
r' H R
Entry R Yield (%) ee (%)
1 Me 418 mixture 420 -
2 CH2OTBS 419 NR 421 --
aAII reactions (0.1 mmol) were carried out utilising [RhCI(CO)2]2 
(5 mol%), AgOTf (12%), DM-SEGPHOS (12%) in acetone (Q.025M) 
at 22 °C under an atmosphere of Ar:CO = 10:1 (1 atm).
Table 2.15. Rh-catalysed enantioselective PK reaction of l,7-enynes.d
aAII reactions (0.1 mmol) were carried out utilising [RhCI(CO)2]2 
(5 mol%), AgOTf (12%), DM-SEGPHOS (12%) in acetone (0.025M) 
at 22 °C under an atmosphere of Ar:CO = 10:1 (1 atm).
Finally we examined the feasibility of the Rh-catalysed enantioselective PK reaction with 1,7- 
enynes bearing substitution on the internal and terminal positions of the alkene moiety (Table 
2.15). Although there have been significant advancements in the area, the viability of the 
process was largely limited to 1,6-enynes. A plausible rationale for the poor reactivity of 1,7- 
enynes may be due to the low aptitude to coordinate to the metal centre and/or the high 
energy associated for the formation a 6/5 membered ring metallacycle in the oxidative
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addition step. Treatment of the 1,7-enynes 422 and 423 under the optimal conditions 
confirmed the low reactivity of such substrates in the carbocyclisation (Table 2.15).
2.3.5. Desymmetrisation of /westf-Dienynes.
The rhodium and iridium catalysed to promote a desymmetrisation of me^o-dienynes provides 
a particularly attractive strategy to generate two stereogenic centres from an achiral starting 
material. ’ In this context, the Rh-catalysed methodology could provide the corresponding 
PK adduct under mild conditions and with low catalyst loading (Scheme 2.18), albeit with 
poor diastereoselectivity.221 In contrast, the Ir-catalysed manifold (Scheme 2.14) provided the 
corresponding adducts with a high level of diastereo- and enantiocontrol, albeit harsh thermal 
conditions and high catalyst loading were necessary to achieve an optimal reactivity.219
Table 2.16. Investigation of the solvent effect in the Rh-catalysed PK reaction of meso- 
dienyne 426.a
[RhCl(CO)2]2 (5 mol%)
(S)-xyl-BINAP (12 mol%), 
AgOTf (12 mol%), solvent
^ TsN
f-BINAP
yield (%)'Solvent
1 THF ND 81:19 7
2 Acetone 34 91:9 57
3 DCE 72 96:4 77
a All reactions were carried out on a 0.1 mmol scale. b Isolated 
yields. c Ratios of stereoisomers were
determined by HPLC analysis of the crude products.
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As outlined in the previous optimisation study, benzene and xylene were detrimental in terms 
of reactivity, which is presumably due to the low solubility of the cationic rhodium 
complexes. As a consequence of this limitation, DCE has been widely employed due to the 
solubility of rhodium complexes in this solvent. Gratifyingly, switching the solvent to DCE 
promoted the formation of the corresponding bicyclopentenone adduct 427 in good yield and 
improved stereoselectivity233, although the mechanism of the Rh-catalysed PK reaction 
indicates that a coordinating solvent is necessary to obtain a high degree of stereoselectivity 
in the process.220 In contrast, meso-dienynes bears an additional C2 vinyl substituent that can 
coordinate to the metal centre in the oxidative addition step, thereby influencing the 
stereochemical outcome of the reaction.233 Hence, the reaction does not require a coordinating 
solvent in order to display a high stereoselectivity and explain the switch in stereocontrol 
(entry 3, Table 2.16).233
Table 2.17. Effect of the silver additive in the Rh-catalysed PK reaction of meso-dienyne
424.a
426
[RhCI(CO)2]2 (5 mol%) 
(S)-xyl-BINAP (12 moI%), 
AgX (12 mol%), DCE 
(0.050 M), CO:Ar = 1:10 (1 atm)
22 °C
P((3,5“Me)CeH3)2
P((3,5-Me)C6H3)2
Entry AgX yield (%)b dr (%)c ee (%)c
1 AgBF4 54 98:2 72
2 AgSbF6 63 99:1 64
3 AgOTf 72 96:4 77
a All reactions were carried out on a 0.1 mmol scale. b Isolated 
yields. c Ratios of stereoisomers were
determined by HPLC analysis of the crude products.
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Additional investigations examined the influence of the counter anion on the process, which 
demonstrated that the triflate anion was the optimal additive for the transformation (Table 
2.17). In light of the fact that we demonstrated a highly enantioselective Rh-catalysed PK 
reaction using chiral bisphosphines with a narrow dihedral angle and lowered electron density 
on the phosphorous atom, we elected to examine xW-P-Phos in the desymmetrisation of enyne 
426. Surprisingly, the employment of this chiral bisphosphine resulted in lower 
stereoselectivity of the reaction (entry 2, Table 2.18), whereas the DIOP ligand, which 
displays a large dihedral angle (104 °), provided good stereocontrol.
In contrast to the enantioselective PK reaction of chlorinated 1,6-enynes, in which a smaller 
dihedral angle has a positive effect in the selectivity, we envisioned that ligands, which have a 
larger dihedral angle than BINAP, would be optimal for this process.234
Table 2.18, Investigation of the chiral bisphophine ligand in the Rh-catalysed PK reaction of 
meso-dienyne 426.a
[RhCI(CO)2]2 (5 mol%) 
(S)-xyl-BINAP (12 moI%), 
AgOTf (12 mol%), DCE
(0.050 M), CO:Ar = 1:10 (1 atm)
TsN Cl ----------------------------------------- TsNc
426
22 °C
Entry Ligand yield (%)b dr (%)c ee (%)c
1 (S,S)-DIOP 52 99:1 73d
2 (S)-xyZ-P-Phos 51 99:1 40
3 (S)-BINAP 65 96:4 64
4 (S)-xy/-BINAP 72 96:4 77
a All reactions were carried out on a 0.1 mmol scale. b Isolated 
yields. c Ratios of stereoisomers were
determined by HPLC analysis of the crude products. d (S,S)- 
427 was detected as the major enantiomer.
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426
[RhCI(CO)2]2 (5 mol%) 
(S)-SPIROP (12 mol%), 
AgOTf (12 mol%), DCE 
(0.050 M), CO:Ar = 1:10 (1 atm)
22 °C
75% \
dr = 99:1 I 
90% ee J
Cl
(S,S)-427 ■SPIROP
Gratifyingly, the spiro-type phosphite (iS)-SPIROP promoted the desired desymmetrisation of 
enyne 426 with remarkable overall stereoselectivity (Eq. 2.26).233’235 Although the 
stereoselectivity is comparable to the Ir-catalysed manifold (Scheme 2.14), this methodology 
avoids thermal conditions and high catalyst loadings.
2.3.6. Determination of the Absolute Configuration.
The development by our group of a highly enantioselective Rh-catalysed PK reaction showed 
that the alkyne terminus has a prominent influence on the reactivity and stereoselectivity of 
the transformation. The completion of this work involves the determination of the absolute 
configuration of the Pauson-Khand products by X-ray analysis. In this context, a sample of 
388, obtained by enantioselective Pauson-Khand reaction of enyne 377 (see Table 2.10) was 
recrystallised and subsequent X-ray analysis established the S stereochemistry of this 
compound (Figure 2.12).236’237
Previous studies described that bicyclopentenones imdergo hydrogenation to promote a 
stereoselective formation of bicyclic ketones.219 Subsequent condensation of the carbonyl 
moiety in presence of hydrazines provides the formation of hydrazone derivatives that display 
high cristallinity and, thereby, are suitable for X-ray analysis. However, as discussed in the 
section 1.6.6, our previous attempts to carry out the hydrogenation of a-chloro enones 
resulted in recovery or decomposition of the starting material.
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Figure 2.12. X-ray structure of bicyclopentenone (S)-377.
Scheme 2.20. Determination of the absolute configuration of PK adducts 409 and 427 by X- 
ray analysis of bicyclopentenone derivatives 429 and 431.
a) MeB(OH)2, Pd(OAc)2 
dpdb, K3PO4, h20
Cl toluene, 65 °C
b) Ethanol, Pd/C, H2, RT
O ...................................................1
H Ph
(S)-SAMP,
TsOH
benzene
reflux
(S,S)-409 428
Cl
TsN o
a) MeB(OH)2, Pd(OAc)2 
dpdb, K3PO4, h20
toluene, 65 °C
b) Ethanol, Pd/C, H2, RT
(S)-SAMP,
TsOH
benzene
reflux
(S,S)-427 430
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In order to prevent this drawback, a Pd-catalysed Suzuki coupling on Pauson-Khand adducts 
409 and 427 could install a methyl moiety on the bicyclopentenone derivatives and reduce 
any decomposition process in the following hydrogenation process (Scheme 2.20). The 
corresponding ketones 428 and 430 could then undergo acid-catalysed condensation with 
chiral hydrazine and afford crystalline hydrazone derivatives 429 and 431 that are amenable 
for X-ray analysis.
2.3.7. Conclusions.
The development of a highly diastereoselective Rh-catalysed PK reaction at room temperature 
established the ability of the chlorine atom on the alkyne terminus to impart higher reactivity 
and stereoselectivity. These findings prompted the analysis of the reactivity of the chlorinated 
1,6-enynes in the corresponding asymmetric manifold. A detailed study on chiral 
bisphosphines described that geometrical and electronic features of these ligands influence the 
reactivity and the stereoselectivity of the enantioselective Rh-catalysed PK reaction. 
Therefore, bisphosphine ligands with a narrow dihedral angle and lowered electron density on 
the phosphorous atom, such as SEGPHOS, provided optimal reactivity and enantioselectivity 
in the asymmetric manifold of chlorinated 1,6-enynes. The synergic ability of chlorinated 1,6- 
enynes and SEGPHOS ligand to deliver an efficient carbocyclisation process was further 
exploited towards substrates that display poor reactivity in the reaction, such as 1,6-enynes 
bearing an internal substituent on the alkyne moiety. Subsequent application of our reaction 
conditions to these substrates provides a remarkable opportunity to carry out a highly 
enantioselective PK reaction of chlorinated 1,6-enynes at room temperature. This 
methodology allowed the employment of a wide array of tethers and alkene substituents, 
thereby delivering the effective formation of bicyclopentenone derivatives with high degree 
of enantioselectivity. Application of this methodology to 1,6-enynes bearing a terminal 
substituent on the alkene moiety revealed that the cA-geometry on the olefin imparts high 
reactivity to the carbocyclisation. Additionally, a silica-promoted epimerisation allows the
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preferential formation of the enantiopure diastereoisomer. Finally, the enantio selective Rh- 
catalysed desymmetrisation of chlorinated maso-dienynes provides superior diastereo- and 
enantioselectivity, in a preparatively more convenient process, compared to that previously 
reported for the Rh-catalysed variant.
2.4. Experimental.
2.4.1. General.
Unless otherwise indicated, all reactions were carried out in flame-dried glassware under 
atmosphere of argon. Xylene and benzene were distilled from CalU and kept over sieves, 
under Ar atmosphere, THF was distilled from benzophenone ketyl. Dry acetone (99.8% Extra 
Dry, Acroseal ®) was used without any further purification under an atmosphere of argon. 
Acetonitrile (HPLC grade) was purchased from Fischer and kept over 3A molecular sieves 
under an Ar atmosphere. All other starting materials and solvents were purchased from Acros, 
Aldrich, Alfa Aesar, Fluorochem or Strem and used without further purification. Catalyst 
[RhCl(CO)2]2 was purchased by Strem, kept in the glove box at RT and utilised entirely in the 
glove box. Although Strem Chemicals specifies to store the catalyst at low temperature, the 
storage of the catalyst in the freezer revealed to be detrimental in time. Bisphosphine ligands 
were purchased by Strem Chemicals, kept in the glove box at RT and utilised entirely in the 
glove box. Silver triflate was purchased by Strem, stored and utilised entirely in the glove 
box. This silver salt is highly sensitive to moisture and experimental analysis showed that the 
employment of wet silver triflate resulted in low yields and low ee. Cannulas are washed with 
acetone and kept under vacuum (p = 3 torr) for two days prior to their use in the PK reaction. 
Carbon monoxide gas and mixture of Ar:CO (10:1) gas were purchased by CK Gas (CO 
purity = 99.97%). High purity of CO (>99.95) proved to be essential for the optimal 
exploitation of the PK reaction.
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Thin layer chromatography (TLC) was performed on Whatman F254 precoated silica gel 
plates. Visualisation was accomplished with a UV light and/or KMn04 solution. Flash 
chromatography (FC) was performed using either Merck Silica Gel 60 (230-400 mesh) or 
Whatman Silica Gel Purasil® 60 (230-400 mesh). Solvents for extraction and FC were 
analytical grade. Reported solvent mixtures for TLC and FC are volume/volume mixtures. 
Infrared spectra were obtained on a Perkin-Elmer spectrum 100 series FTIR spectrometer. 
Peaks are reported in cm'1 with the following relative intensities: vs (very strong), s (strong), 
m (medium) and w (weak). Mass spectra were performed at either the University of Liverpool 
Mass Spectrometry Center or the EPSRC National Mass Spectrometry Service Centre, 
Swansea. High resolution electron-impact (El, ionization voltages of 70 eV), chemical 
ionization (Cl, reagent gas CH4 or NH3) were obtained on either an Autospec ZAB 2SE, 
Kratos MS-80, VG 7070E double focusing magnetic sector mass spectrometer equipped with 
a solid probe inlet, a QUATRO II, MAT 95, or MAT 900. The electrospray ionization (ESI) 
and mass spectra were obtained on a Waters micromass and LCT mass spectrometer. lH and 
13C NMR were recorded on a Bruker AV 500 MhZ NMR spectrometer in the indicated 
deuterated solvent, which were obtained from Cambridge Isotope Labs. For ’H NMR, CDC13 
was set to 7.26 ppm (CDCI3, singlet). For 13C NMR, CDCI3 was set to 77.16 ppm (CDC13, 
center of triplet). ^I data are reported in the following order: chemical shift in ppm (5) 
(multiplicity, which are indicated by br (broadened), s (singlet), d (doublet), t (triplet), q 
(quartet), m (multiplet)); assignment of 2nd order pattern, if applicable; coupling constant (./, 
Hz); integration values for all 13C NMR spectra data using the descriptor o and e refer to 
whether the peak is odd or even respectively, and correlate to an attached proton test (APT) 
experiments. All liquid chromatograms were obtained on a HPLC Agilent 1200 machine with 
a variable UV detector. The instrument was fitted with AS-H, AD-H, OD-H, OJ-FI Agilent 
Chiralpak analytical columns (4.6 mm x 250 mm, 5 p).
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2.4.2. Experimental Procedures.
r
Ts-N
Boc
/erZ-Butyl prop-2-ynyl(tosyl)carbamate.238
NaH (0.4 g, 10 mmol) was weighted into a flame-dried 250 mL flask that was then evacuated 
and backfilled with an argon balloon. DMF (40 mL) was added and the resulting suspension 
was cooled down to 0°C. After 30 minutes, a solution of 4-methyl-A-(prop-2- 
ynyl)benzenesulfonamide (1.75 g, 8.36 mmol) in DMF (20 mL) was slowly added by syringe, 
the ice bath was removed and the suspension was stirred for ca 30 minutes. Then, a solution 
of Boc20 (2.20 g, 10 mmol) in DMF (20 mL) was added at RT and resulting mixture was 
stirred for an additional 3 horn's (tic control). The reaction was then quenched with a saturated 
solution of ammonium chloride (100 mL) and extracted with diethyl ether (3x 100 mL). . The 
combined organic layer was washed with water (2 x 200 mL) and then filtered through a short 
plug of silica. Removal of the solvent afforded pure /erZ-butyl prop-2-ynyl(tosyl)carbamate as 
a white solid (2.430 g, 94% yield).
Colour and State: white solid; mp - 79-81 °C.
‘H NMR (500 MHz, CDCl3) 5 7.88 (d, 7= 8.3 Hz, 2H), 7.29 (d, 7- 8.1 Hz, 2H), 4.60 (d, 7 = 
2.4 Hz, 2H), 2.41 (s, 3H), 2.32 (t, J = 2.4 Hz, 1H), 1.32 (s, 9H).
13C NMR (125 MHz, CDC13) 5 150.16 (e), 144.51 (e), 136.61 (e), 129.27 (o), 128.22 (o), 
85.00 (e), 78.93 (e), 72.20 (e), 35.68 (e), 27.85 (o), 21.66 (o).
IR (Neat) 3286 (m), 2990 (w), 1723 (s), 1596 (w), 1349 (s), 1155 (s), 1088 (s), 910 (m) cm"5. 
HRMS (ESI, [M+Na]+) calcd for ChsHigNNaCLS 332.0932, found 332.0947.
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/—=^CI 
Ts-N
Boc
?e/^-Butyl 3-chIoroprop-2-yiiyl(tosyl)carbaraate.
Cesium carbonate (2.606 g, 8 mmol) and tetra-w-bulylammonium fluoride trihydrate (0.630 g, 
2 mmol) were added to a solution of fe/Y-butyl prop-2-ynyl(tosyl)carbamate (1.237 g, 4 
mmol) in CC14 (7 mL) and the reaction mixture stirred for 1 hour at room temperature. The 
resulting mixture was then diluted by the addition of dichloromethane (25 mL), filtered 
through a short pad of celite and the filtrate concentrated in vacuo to afford a crude oil. 
Purification by flash chromatography (silica gel, petroleum ether-diethyl ether, 95:5) afforded 
re/y-butyl 3-chloroprop-2-ynyl(tosyl)carbamate as a pale yellow solid (1.22 g, 89% yield). 
Colour and State: off-white solid; mp = 75-77 °C.
lH NMR (500 MHz, CDC13) 5 7.85 (d, J= 8.3 Hz, 2H), 7.31 (d, 7= 8.3 Hz, 2H), 4.60 (s, 2H), 
2.43 (s, 3H), 1.34 (s, 9H).
13C NMR (125 MHz, CDC13) 5 150.19 (e), 144.66 (e), 136.58 (e), 129.34 (o), 128.27 (o), 
85.13 (e), 64.79 (e), 62.35 (e), 36.13 (e), 27.90 (o), 21.70 (o).
IR (Neat) 2982 (w), 2251 (w), 1728 (s), 1598 (w), 1356 (s), 1153 (s), 1088 (s), 912 (m) cm"1. 
HRMS (ESI, [M+Na]4) calcd for C15H1835ClNNa04S 366.0543, found 366.0549.
/ =—Cl
Ts-NH
iV-P-Chloroprop-Z-ynylLd-methylbenzenesulfonamide.
Trifluoroacetic acid (2 mL, 25 mmol) was added to a solution of te/t-butyl 3-chloroprop-2- 
ynyl(tosyl)carbamate (1.03 g, 3 mmol) in DCM (10 mL) and the resulting solution was stirred 
for 1 hour. The solution was then poured into a 100 mL Erlenmeyer flask and a solution of 
saturated potassium carbonate was slowly added until neutralization (pH = 7). After 
extraction of the aqueous layer with DCM (2 x 20 mL), the combined organic layers were 
dried over MgS04 and concentrated in vacuo to afford a crude oil. Purification by flash
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chromatography (silica gel, petroleum ether-diethyl ether, 95:5)) afforded the desired N-(3- 
chloroprop-2-ynyl)-4-methylbenzenesulfonamide as a white solid (0.947 g, 89%).
Colour and State: white solid; mp = 64-66 °C
^ NMR (500 MHz, CDC13) 5 7.77 (d, 7= 8.3 Hz, 2H), 7.32 (d, 7= 8.3 Hz, 2H), 4.97 (bs, 
1H), 3.83 (d, 7= 6.2 Hz, 2H), 2.42 (s, 3H).
13C NMR (125 MHz, CDC13) 5 144.04 (e), 136.65 (e), 129.82 (o), 127.53 (o), 63.78 (e), 
63.23 (e), 33.32 (e), 21.67 (o).
IR (Neat) 3257 (w), 2246 (w), 1597 (w), 1323 (m), 1156 (m), 1087 (m), 811 (m) cm-1.
HRMS (ESI, [M-HNa]4) calcd for QoH^ClNNaCbS 266.0018, found 266.0015.
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iV-(But-2-ynyl)-4-methyl-iV-(2-metliylallyl)benzenesiiIfonamide.239
A flame-dried 100 mL flask was charged with triphenylphosphine (1.18 g, 4.5 mmol) and N- 
4-methyl-iV-(2-methylallyl)benzenesulfonamide (0.680 g, 3 mmol), evacuated and backfilled 
with argon. Anhydrous THE (12 mL) and but-2-yn-l-ol (0.315 g, 4.5 mmol) were added and 
resulting solution was placed in an ice bath for ca 15 minutes. Diisopropyldiazodicarboxylate 
(DIAD) (0.88 mL, 4.5 mmol) was added drop-wise over 5 minutes via syringe. The resultant 
reaction mixture was stirred for 18 hours, slowly warming to room temperature, then a TLC 
(20% diethyl ether/ petroleum ether) showed complete consumption of the secondary amine. 
The reaction mixture was concentrated in vacuo onto silica gel. Purification by flash 
chromatography (silica gel, petroleum ether-diethyl ether, 95:5) gel provided the desired N- 
(but-2-ynyl)-4-methyl-Ar-(2-methylallyl)benzenesulfonamide as a white solid (0.665 g, 80% 
yield).
Colour and State: white solid; mp = 48-50 °C
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lii NMR (500 MHz, CDC13) 5 7.73 (d,J= 8.2 Hz, 2H), 7.28 (d, 7= 8.1 Hz, 2H), 4.94 (s, 2H), 
3.96 (q, J= 2.2 Hz, 2H), 3.68 (s, 2H), 2.41 (s, 3H), 1.75 (s, 3H), 1.49 (t, 2.2 Hz, 3H).
13C NMR (125 MHz, CDCI3) 8 143.27 (e), 139.59 (e), 136.64 (e), 129.28 (o), 128.04 (o), 
115.23 (e), 81.62 (e), 71.60 (e), 52.52 (e), 36.13 (e), 21.61 (o), 19.84 (o), 3.29 (o).
IR (Neat) 2920 (w), 1655 (w), 1598 (w), 1331 (m), 1159 (s), 1095 (m), 904 (m).
HRMS (ESI, [M+Na]+) calcd for CisH^NNaOzS 300.1034, found 300.1027.
372
4-Methyl-iV-(2-methylallyl)-7V-(3-plienylprop-2-yiiyl)benzenesulfonainide.240
A flame-dried 100 mL flask was charged with triphenylphosphine (1.18 g, 4.5 mmol) and A- 
4-methyl-A-(2-methylallyl)benzenesulfonamide (0.680 g, 3 mmol), evacuated and backfilled 
with argon. Anhydrous THF (12 mL) and 3-phenylprop-2-yn-l-ol (0.595 g, 4.5 mmol) were 
added and resulting solution was placed in an ice bath for ca 15 minutes. 
Diisopropyldiazodicarboxylate (DIAD) (0.88 mL, 4.5 mmol) was added drop-wise over 5 
minutes via syringe. The resultant reaction mixture was stirred for 18 hours, slowly warming 
to room temperature, then a TLC (20% diethyl ether/ petroleum ether) showed complete 
consumption of the secondary amine. The reaction mixture was concentrated in vacuo onto 
silica gel. Purification by flash chromatography (silica gel, petroleum ether-diethyl ether, 9:1) 
gel provided the desired 4-methyl-iV-(2-methylallyl)-A^-(3-phenylprop-2- 
ynyl)benzenesulfonamide as a white solid (0.870 g, 85% yield).
Colour and State: white crystalline solid; mp = 62-64 C
^ NMR (500 MHz, CDCf) 5 7.78 (d, J= 8.2 Hz, 2H), 7.30-7.20 (m, 5H), 7.03 (d, J= 7.3 
Hz, 2H), 5.01 (s, 2H), 4.26 (s, 2H), 3.80 (s, 2H), 2.33 (s, 3H), 1.81 (s, 3H).
13C NMR (125 MHz, CDC13) 5 143.54 (e), 139.41 (e), 136.16 (e), 131.57 (0), 129.60 (o), 
128.45 (o), 128.20 (o), 127.93 (o), 122.36 (e), 115.67 (e), 85.80 (e), 81.70 (e), 52.83 (e), 
36.51 (e), 21.51 (o), 19.87 (0).
207
IR (Neat) 2917 (w), 1655 (w), 1598 (w), 1490 (m), 1348 (m), 1162 (s), 1097 (m), 903 (m), 
659 (m).
HRMS (ESI, [M+Na]+) calcd for C2oH2iNNa02S 362.1181, found 362.1174.
General Procedure for the Preparation of Nitrogen-Tethered 1-Chloro-l,6-enynes: a flame- 
dried 100 mL flask was charged with triphenylphosphine (1.18 g, 4.5 mmol) and JV-(3- 
chloroprop-2-ynyl)-4-methylbenzenesulfonamide (0.670 g, 3 mmol), evacuated and 
backfilled with argon. Anhydrous THE (12 mL) and the required alcohol (4.5 mmol) were 
added and resulting solution was placed in an ice bath for ca 15 minutes. 
Diisopropyldiazodicarboxylate (DIAD) (0.88 mL, 4.5 mmol) was added drop-wise over 5 
minutes via syringe. The resultant reaction mixture was stirred for 18 hours, slowly warming 
to room temperature, then a TLC (20% diethyl ether/ petroleum ether) showed complete 
consumption of the secondary amine. The reaction mixture was concentrated in vacuo onto 
silica gel. Purification via flash chromatography column on silica gel (petroleum ether-diethyl 
ether, 95:5) provided the requisite nitrogen-tethered l-chloro-l,6-enyne.
General Procedure for the Preparation of Oxygen- and Malonate-Tethered l-Chloro-1,6- 
Enynes: a solution of the requisite 1,6-enyne (2 mmol) in THE (4 mL) was cooled to -78 °C 
under an argon atmosphere. LiHMDS (2.2 mL, 2.2 mmol, 1M solution in hexane) was added 
dropwise and the resulting suspension stirred for 20 minutes at -78 °C. Then, a solution of p- 
toluenesulfonyl chloride (0.420 g, 2.2 mmol) in THE (2 mL) was added dropwise and the 
reaction stirred for 4 hours at -78 °C. The resulting suspension was allowed to warm to RT 
and quenched with brine (10 mL) and diethyl ether (10 mL) and extracted with diethyl ether 
(3x15 mL). The organic layer was dried over MgSCL, filtered and concentrated in vacuo to 
afford a crude oil. Purification by flash chromatography (silica gel, eluting with diethyl 
ether/hexanes) afforded the desired 1-chloro-1,6-enyne.
208
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Me
iV-(3-Chloroprop-2-ynyl)-4-methyWV-(2-methylallyl)benzenesulfonamide.
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 79%).
Colour and State: white crystalline solid; mp = 69-71 C.
NMR (500 MHz, CDC13) 8 7.72 (d, J= 8.3 Hz, 2H), 7.32 (d, J = 8.2 Hz, 2H), 4.97 (s, 1H), 
4.95 (s, 1H), 4.02 (s, 2H), 3.68 (s, 2H), 2.43 (s, 3H), 1.75 (s, 3H).
13C NMR (125 MHz, CDC13) 5 143.79 (e), 139.27 (e), 135.77 (e), 129.58 (o), 127.88 (o), 
115.78 (e), 63.46 (e), 62.31 (e), 52.90 (e), 36.02 (e), 21.67 (o), 19.79 (o).
IR (Neat) 2946 (w), 2243 (w), 1597 (w), 1343 (m), 1332 (s), 1162 (s), 894 (s) cnT1.
HRMS (ESI, [M+Naf) calcd for Ci4Hi635ClNNa02S 320.0488, found 320.0497.
7V-(2-Benzylallyl)-iV-(3-cliloroprop-2-ynyl)-4-inethylbenzenesulfonamide.
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 82%).
Colour and State: white solid; mp = 71-73 C.
NMR (500 MHz, CDC13) 5 7.69 (d, J= 8.3 Hz, 2H), 7.33-7.20 (m, 7H), 5.08 (s, 1H), 4.98 
(s, 1H), 4.02 (s, 2H), 3.67 (s, 2H), 3.39 (s, 2H), 2.42 (s, 3H).
13C NMR (125 MHz, CDC13) 8 143.84 (e), 142.80 (e), 138.71 (e), 135.56 (e), 129.58 (o), 
129.35 (o), 128.55 (o), 127.92 (o), 126.49 (o), 116.87 (e), 63.59 (e), 62.21 (e), 51.27 (e), 
39.84 (e), 36.23 (e), 21.67 (o).
209
IR (Neat) 3029 (w), 2921 (w), 2247 (w), 1650 (w), 1597 (w), 1344 (m), 1326 (m), 1163 (s), 
892 (s) cm”1.
HRMS (ESI, [M+Na]^ calcd for C2oH2035ClNNa02S 396.0801, found 396.0789.
OBn 
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J/V-(2-(BenzyIoxymethyl)alIyI)-Ar-(3-chloroprop-2-ynyl)-4-methylbenzenesulfonamide.
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 72%).
Colour and State: white crystalline solid; mp = 39-41 G.
NMR (500 MHz, CDC13) 5 7.73 (d, 7= 8.3 Hz, 2H), 7.40-7.27 (m, 5H), 7.32 (d, J= 8.0 
Hz, 2H), 5.34 (s, 1H), 5.21 (s, 1H), 4.53 (s, 2H), 4.06 (s, 2H), 4.03 (s, 2H), 3.81 (s, 2H), 2.43 
(s, 3H).
13C NMR (125 MHz, CDC13) 143.89 (e), 139.85 (e), 138.21 (e), 135.60 (e), 129.63 (o), 
128.55 (o), 127.93 (o), 127.90 (o), 127.80 (o), 116.88 (e), 72.75 (e), 70.65 (e), 63.72 (e), 
62.31 (e), 49.31 (e), 36.46 (e), 21.69 (o).
IR (Neat) 3031 (w), 2857 (w), 2241 (m), 1598 (w), 1349 (m), 1093 (m), 903 (m)
HRMS (ESI, [M+Na]+) calcd for C2IH2235ClNNa03S 429.0907, found 429.0901.
jV-(3-Chloroprop-2-ynyl)-4-methyI-iV-(2-
((triinethyIsilyl)methyI)allyl)benzenesulfonamide.
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 64%).
Colour and State: white solid; mp = 60-62 C.
210
^ NMR (500 MHz, CDC13) 5 7.72 (d, J= 8.3 Hz, 2H), 7.32 (d, J = 8.1 Hz, 2H), 4.86 (d, / = 
1.0 Hz, 1H), 4.75 (s, 1H), 4.04 (s, 2H), 3.60 (s, 2H), 2.43 (s, 3H), 1.56 (s, 2H), 0.05 (s, 9H). 
13C NMR (125 MHz, CDC13) 5 143.75 (e), 140.93 (e), 135.90 (e), 129.57 (o), 127.91 (o), 
112.57 (e), 63.41 (e), 62.48 (e), 53.16 (e), 36.07 (e), 23.03 (e), 21.67 (o), -1.38 (o).
IR (Neat) 2957 (w), 2239 (w), 1637 (w), 1598 (w), 1345 (m), 1160 (s), 1089 (m), 894 (s) cm-
i
HRMS (ESI, [M+Na]4) calcd for C17H2435ClNNa02SSi 392.0883, found 392.0878.
Cl
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3-(3-Chloroprop-2-ynyloxy)-2-methylprop-l-ene.
Synthesised by the general procedure for the preparation of oxygen- and malonate-tethered 1 - 
chloro-l,6-enynes (yield = 31%).
Colour and State: colourless liquid.
NMR (500 MHz, CDC13) 5 4.98 (s, 1H), 4.93 (s,lH), 4.13 (s, 2H), 3.95 (s, 2H), 1.74 (s, 
3H).
13C NMR (125 MHz, CDC13) 5 141.38 (e), 113.20 (e), 73.82 (e), 65.67 (e), 64.35 (e), 57.41 
(e), 19.55 (o).
IR (Neat) 2920 (w), 2239 (w), 1655 (w), 1353 (m), 1098 (s), 901 (m).
HRMS (Cl, [M+NH4]+) calcd for C7H1335C1N0 162.0680, found 162.0681.
(2-((3-Chloroprop-2-ynyloxy)methyl)allyl)benzene.
Synthesised by the general procedure for the preparation of oxygen- and malonate-tethered 1- 
chloro-l,6-enynes (yield = 82%).
211
Colour and State: colourless liquid.
lB. NMR (500 MHz, CDC13) 5 7.27-7.32 (m, 2H), 7.24-7.18 (m, 3H), 5.12 (s, 1H), 4.96 (s, 
1H), 4.11 (s, 2H), 3.93 (s, 2H), 3.40 (s, 2H).
13C NMR (125 MHz, CDC13) 5 144.83 (e), 139.04 (e), 129.19 (o), 128.50 (o), 126.37 (o), 
114.50 (e), 72.14 (e), 65.65 (e), 64.49 (e), 57.61 (e), 40.03 (e).
IR (Neat) 3028 (w), 2849 (w), 2238 (w), 1652 (w), 1495 (w), 1354 (w), 1095 (m), 907 (m). 
HRMS (ESI, [M+Na]+) calcd for C13H1335ClNaO 243.0553, found 243.0545.
382
((2-((3-Chloroprop-2-ynyloxy)methyl)allyloxy)methyl)benzene.
Synthesised by the general procedure for the preparation of oxygen- and malonate-tethered 1- 
chloro-l,6-enynes (yield = 85%).
Colour and State: colourless liquid.
NMR (500 MHz, CDC13) 6 7.39-7.28 (m, 5H), 5.27 (s, 1H), 5.25 (s, 1H), 4.52 (s, 2H), 
4.15 (s, 2H), 4.09 (s, 2H), 4.04 (s, 2H).
13C NMR (125 MHz, CDC13) 6 141.95 (e), 138.29 (e), 128.51 (o), 127.80 (o), 127.74 (o), 
115.22 (e), 72.33 (e), 70.88 (e), 70.58 (e), 65.55 (e), 64.61 (e), 57.79 (e).
IR (Neat) 3031 (w), 2854 (w), 2238 (w), 1724 (w), 1454 (w), 1355 (w), 1092 (m), 698 (m). 
HRMS (ESI, [M+Naf) calcd for CnH^ClNaCb 273.0658, found 273.0658.
383
(2-((3-Chloroprop-2-ynyloxy)methyl)allyl)trimethylsilane.
Synthesised by the general procedure for the preparation of oxygen- and malonate-tethered 1- 
chloro-l,6-enynes (yield = 77%).
212
Colour and State: colourless liquid.
NMR (500 MHz, CDC13) 5 4.90 (q, J = 1.6 Hz, 1H), 4.73 (s, 1H), 4.13 (s, 2H), 3.90 (s, 
2H), 1.54 (s, 2H), 0.03 (s, 9H).
13C NMR (125 MHz, CDC13) 8 143.13 (e), 110.15 (e), 73.94 (e), 65.75 (e), 64.41 (e), 57.46 
(e), 23.39 (e),-1.28 (o).
IR (Neat) 2953 (w), 2894 (w), 2239 (w), 1637 (w), 1247 (m), 1094 (m), 843 (m).
HRMS (ESI, [M+Naf) calcd for Cl0Hi735ClNaOSi 239.0635, found 239.0636.
Dimethyl 2-(3-chloroprop-2-ynyl)-2-(2-methylallyl)malonate.
Synthesised by the general procedure for the preparation of oxygen- and malonate-tethered 1- 
chloro-1,6-enynes (yield = 92%).
Colour and State: pale yellow solid; mp = 38-40 C.
‘H NMR (500 MHz, CDC13) 8 4.93-4.89 (m, 1H), 4.82 (s, 1H), 3.74 (s, 6H), 2.83 (s, 2H), 
2.82 (s, 2H), 1.64 (s, 3H).
13C NMR (125 MHz, CDC13) 5 170.61 (e), 139.81 (e), 116.59 (e), 64.65 (e), 60.86 (e), 56.55 
(e), 52.97 (o), 39.89 (e), 23.28 (e), 23.18 (o).
IR (Neat) 2954 (w), 2246 (w), 1737 (s), 1647 (w), 1436 (m), 1208 (m), 1058 (m), 902 (w). 
HRMS (ESI, [M+Na]+) calcd for Ci2H1535ClNa04 281.0557, found 281.0554.
385
Dimethyl 2-(2-beiizylallyl)-2-(3-chloroprop-2-ynyl)malonate.
Synthesised by the general procedure for the preparation of oxygen- and malonate-tethered 1 - 
chloro-l,6-enynes (yield = 90%).
213
Colour and State: colourless oil.
lH NMR (500 MHz, CDC13) 5 7.32-7.12 (m, 5H), 4.95 (s, 1H), 4.91 (s, 1H), 3.74 (s, 6H), 
3.24 (s, 2H), 2.90 (s, 2H), 2.79 (s, 2H).
13C NMR (125 MHz, CDC13) 5 170.53 (e), 143.25 (e), 138.97 (e), 129.19 (o), 128.50 (o), 
126.44 (o), 117.54 (e), 64.64 (e), 61.17 (e), 56.91 (e), 52.98 (o), 43.53 (e), 36.89 (e), 23.32 
(e).
IR (Neat) 3028 (w), 2953 (w), 2246 (w), 1736 (s), 1642 (w), 1436 (m), 1291 (m), 1201 (s), 
1064 (w), 909 (w).
HRMS (ESI, [M+Naf) calcd for C18H1935ClNa04 357.0870, found 357.0871.
Me02C
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Dimethyl 2-(2-(benzyloxymethyl)allyl)-2-(3-cliloroprop-2-ynyl)malonate.
Synthesised by the general procedure for the preparation of oxygen- and malonate-tethered 1- 
chloro-l,6-enynes (yield = 88%).
Colour and State: colourless oil.
NMR (500 MHz, CDC13) 8 7.37-7.26 (m, 5H), 5.27 (q, 7= 1.4 Hz, 1H), 5.07 (s, 1H), 4.47 
(s, 2H), 3.84 (s, 2H), 3.69 (s, 6H), 2.90 (s, 2H), 2.85 (s, 2H).
13C NMR (125 MHz, CDC13) 8 170.42 (e), 140.45 (e), 138.21 (e), 128.46 (o), 127.75 (o), 
127.69 (o), 117.47 (e), 72.97 (e), 72.19 (e), 64.57 (e), 61.01 (e), 56.65 (e), 52.95 (o), 35.10 
(e), 23.30 (e).
IR (Neat) 2953 (w), 2855 (w), 2245 (w), 1736 (s), 1497 (w), 1436 (m), 1291 (m), 1205 (s), 
1091 (m), 917 (w).
HRMS (ESI, [M+Na]+) calcd for C19H2135ClNa05 387.0975, found 387.0962.
214
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Dimethyl 2-(3-chloroprop-2-ynyl)-2-(2-((trimethylsilyl)methyl)aIlyl)malonate.
Synthesised by the general procedure for the preparation of oxygen- and malonate-tethered 1- 
chloro-l,6-enynes (yield = 91%).
Colour and State: colourless oil.
lH NMR (500 MHz, CDC13) 5 4.68 (s, 1H), 4.64 (s, 1H), 3.73 (s, 6H), 2.87 (s, 2H), 2.73 (s, 
2H), 1.42 (s, 2H), 0.02 (s, 9H).
13C NMR (125 MHz, CDC13) 8 170.54 (e), 141.65 (e), 112.58 (e), 64.87 (e), 61.02 (e), 57.10 
(e), 52.89 (o), 39.40 (e), 27.64 (e), 23.13 (e), -1.39 (o).
IR (Neat) 2954 (w), 2246 (w), 1740 (s), 1630 (w), 1435 (m), 1248 (m), 1181 (m), 850 (m). 
HRMS (ESI, [M+Na]+) calcd for C15H2335ClNa04Si 353.0952, found 353.0943.
402
(£)-iV-(But“2“enyl)-Ar-(3-chloroprop-2-ynyl)-4-methylbenzenesulfonamide.
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield =85%).
Colour and State: white solid; mp = 51-53 C.
^ NMR (500 MHz, CDC13) 8 7.68 (d, J= 8.3 Hz, 2H), 7.29 (d, J= 8.1 Hz, 2H), 5.66 (dq, J 
= 15.1, 6.5 Hz, 1H), 5.36-5.28 (m, 1H), 4.02 (s, 2H), 3.68 (d, /= 6.8 Hz, 2H), 2.40 (s, 3H), 
1.66 (d, J= 6.5 Hz, 3H).
13C NMR (125 MHz, CDC13) 8 143.67 (e), 135.73 (e), 131.82 (o), 129.50 (o), 127.76 (o), 
124.52 (o), 63.23 (e), 62.50 (e), 48.68 (e), 35.94 (e), 21.57 (o), 17.77 (o).
IR (Neat) 2922 (w), 2241 (w), 1598 (w), 1347 (s), 1160 (s), 900 (s) cm-1.
HRMS (ESI, [M+Na]+) calcd for C14Hi635ClNNa02S 320.0488, found 320.0478.
215
iV-(3-Chloroprop-2-ynyI)-iV-cinnamyl-4“methylbenzeiiesuIfoiiamide.
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 77%).
Colour and State: white solid; mp = 57-59 °C.
lH NMR (500 MHz, CDC13) 5 7.79-7.73 (m, 2H), 7.38-7.23 (m, 7H), 6.56 (d, 15.8 Hz,
1H), 6.08 (dt, J = 15.8, 6.9 Hz, 1H), 4.11 (s, 2H), 3.95 (dd, J= 6.6, 0.9 Hz, 1H), 2.45 (s, 3H). 
13C NMR (125 MHz, CDC13) 5 143.91 (e), 136.17 (e), 135.84 (e), 135.10 (o), 129.68 (o), 
128.78 (o), 128.27 (o), 127.92 (o), 126.70 (o), 123.02 (o), 63.66 (e), 62.56 (e), 49.08 (e), 
36.48 (e), 21.70 (o).
IR (Neat) 3028 (w), 2922 (w), 2240 (w), 1598 (w), 1348 (m), 1161 (s), 903 (s) cm-1.
HRMS (ESI, [M+Na]4) calcd for C]9H1835ClNNa02S 382.0644, found 382.0648.
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(Z)-Ar-(3-Chloroprop-2-ynyl)-4-methyl-iV-(3-phenyIallyl)benzenesulfonamide.
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 80%).
Colour and State: white solid; mp = 48-50 °C.
lH NMR (500 MHz, CDC13) 5 7.69 (d, J= 8.3 Hz, 2H), 7.37-7.17 (m, 7H), 6.69 (d, J= 11.7 
Hz, 1H), 5.61 (dt, 7= 11.7, 6.9 Hz, 1H), 4.09-4.05 (m, 4H), 2.42 (s, 3H).
216
13C NMR (125 MHz, CDC13) 5 143.83 (e), 136.01 (e), 135.79 (e), 134.25 (o), 129.65 (o), 
128.84 (o), 128.43 (o), 127.84 (o), 127.54 (o), 126.01 (o), 63.61 (e), 62.49 (e), 49.61 (e), 
36.87 (e), 21.67(o).
IR (Neat) 3025 (w), 2241 (w), 1598 (w), 1494 (w), 1347 (s), 1160 (s), 901 (s) cm-1.
HRMS (ESI, [M+Na]+) calcd for C19HI835ClNNa02S 382.0644, found 382.0642.
410
(Z)-Ar“(3-Chloroprop-2-ynyl)-4-methyl-iV-(2-methylbut-2"enyl)benzenesulfonamide. 
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 75%).
Colour and State: white solid; mp = 50-52 °C.
‘H NMR (500 MHz, CDC13) 5 7.72 (d, J= 8.3 Hz, 2H), 7.31 (d, J= 8.1 Hz, 2H), 5.51 (q, J = 
6.7 Hz, 1H), 3.95 (s, 2H), 3.75 (s, 2H), 2.42 (s, 3H), 1.69 (t,/= 1.0 Hz, 3H), 1.59 (t, J= 6.9 
Hz, 3H).
13C NMR (125 MHz, CDC13) 5 143.67 (e), 135.78 (e), 129.51 (o), 129.28 (e), 127.88 (o), 
126.41 (o), 63.27 (e), 62.86 (e), 46.14 (e), 35.57 (e), 21.61 (o), 21.40 (o), 13.28 (o).
IR (Neat) 2967 (w), 2920 (w), 2241 (w), 1921 (w), 1597 (w), 1446 (w), 1329 (s), 1160 (s), 
963 (s) cm"1.
HRMS (ESI, [M+Na]^ calcd for C15H1835ClNNa02S 334.0644, found 334.0639.
217
Methyl 2-((Ar-(3-chloroprop-2-ynyl)-4-methylpheiiylsulfonamido)methyl)acrylate. 
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 87%).
Colour and State: white solid; mp = 60-62 C.
NMR (500 MHz, CDC13) 6 7.75 (d, J= 8.3 Hz, 2H), 7.33 (d, J = 8.2 Hz, 2H), 6.40 (s, 1H), 
5.93 (s, 1H), 4.09 (s, 2H), 4.04 (s, 2H), 3.77 (s, 3H), 2.44 (s, 3H).
13C NMR (125 MHz, CDC13) 5 166.20 (e), 143.97 (e), 135.64 (e), 134.82 (e), 129.64 (o), 
127.79 (o), 63.86 (e), 62.45 (e), 52.13 (o), 47.13 (e), 37.46 (e), 21.59 (o).
IR (Neat) 2963 (w), 2239 (w), 1717 (s), 1633 (w), 1433 (s), 1334 (m), 890 (s) cm"1.
HRMS (ESI, [M+Na]^ calcd for C15H1635ClNNa04S 364.0386, found 364.0383.
N-(3-Ch]oroprop-2-ynyl)-4-methyl-iV-(2“(phenylsulfonyl)allyl)benzenesulfonamide.
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 82%).
Colour and State: white solid; mp = 135-137 °C.
^ NMR (500 MHz, CDC13) 5 7.94 (d, J = 7.9 Hz, 2H), 7.73-7.52 (m, 5H), 7.34-7.28 (m, 
2H), 5.39 (s, 1H), 5.27 (s, 1H), 3.98 (s, 2H), 3.89 (s, 2H), 3.74 (s, 2H), 2.43 (s, 3H).
13C NMR (125 MHz, CDC13) 5 144.14 (e), 138.76 (e), 135.29 (e), 133.95 (o), 131.36 (e), 
129.68 (o), 129.33 (o), 128.65 (o), 127.91 (o), 63.96 (e), 62.23 (e), 58.86 (e), 51.54 (e), 36.85 
(e), 21.67 (o).
IR (Neat) 2924 (w), 2241 (w), 1650 (s), 1597 (w), 1447 (m), 1307 (s), 1086 (s), 906 (s) cm"1.
218
HRMS (ESI, [M+Na]+) calcd for C2oH2o35ClNNa04S2 460.0420, found 460.0423.
iV-(3-chloroprop-2-ynyl)-4-methyI-Ar-(3-methyl“2-methyleiiebut-3-
enyi)benzenesulfonamide.
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 79%).
Colour and State: white crystalline solid; mp = 81-83 C.
lU NMR (500 MHz, CDC13) 5 7.75 (d, J= 8.3 Hz, 2H), 7.33 (d, J = 8.3 Hz, 2H), 5.40 (s, 1H), 
5.31 (s, 1H), 5.20 (s, 1H), 5.09 (s, 1H), 3.99 (s, 2H), 3.97 (s, 2H), 2.44 (s, 3H), 1.92 (s, 3H). 
13C NMR (125 MHz, CDC13) 5 143.87 (e), 141.06 (e), 140.16 (e), 135.29 (e), 129.58 (o), 
128.05 (o), 117.37 (e), 115.42 (e), 63.68 (e), 62.31 (e), 49.71 (e), 36.16 (e), 21.68 (o), 21.22 
(o).
IR (Neat) 2924 (w), 2240 (w), 1599 (m), 1349 (m), 1122 (s), 1093 (m), 897 (m).
HRMS (ESI, [M+Na]+) calcd for Ci6H1835ClNNa02S 346.0644, found 346.0640.
Cl
Me
418
(Z)-jV-(But-2-enyl)-iV-(3“Chloroprop-2-ynyl)-4-methylbenzenesulfonamide.
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 79%).
Colour and State: white solid; mp = 70-72 C.
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^ NMR (500 MHz, CDC13) 5 7.72 (d,J= 8.3 Hz, 2H), 7.32 (d, 8.1 Hz, 2H), 5.79-5.70
(m, 1H), 5.36-5.28 (m, 1H), 4.05 (s, 2H), 3.82 (d, J= 7.3 Hz, 2H), 2.43 (s, 3H), 1.66-1.64 (m, 
3H).
13C NMR (125 MHz, CDC13) 5 143.77 (e), 135.66 (e), 130.81 (o), 129.59 (o), 127.87 (o), 
123.65 (o), 63.31 (e), 62.69 (e), 42.96 (e), 36.14 (e), 21.65 (o), 13.01 (o).
IR (Neat) 3026 (w), 2923 (w), 2241 (w), 1598 (w), 1347 (s), 1161 (s), 1092 (m), 908 (s) cm"1. 
HRMS (ESI, [M+Naf) calcd for C^e^ClNNaOaS 320.0488, found 320.0489.
OTBS
(Z)-Ar-(4-(ter/-Butyldimethylsilyloxy)but-2-enyl)-J/V-(3-chloroprop-2-yiiyl)-4-
methylbenzenesulfonamide.
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 71%).
Colour and State: white solid; mp = 61-63 C.
^ NMR (500 MHz, CDC13) 6 7.71 (d, J= 8.3 Hz, 2H), 7.31 (d, 8.0 Hz, 2H), 5.80-5.74
(m, 1H), 5.40-5.33 (m, 1H), 4.21 (dd, 6.0, 0.9 Hz, 2H), 4.05 (s, 2H), 3.83 (d, 7.2 Hz,
2H), 2.42 (s, 3H), 0.87 (s, 9H), 0.04 (s, 6H).
13C NMR (125 MHz, CDC13) 5 143.83 (e), 135.63 (o), 135.59 (e), 129.60 (o), 127.83 (o), 
123.92 (o), 63.46 (e), 62.55 (e), 59.10 (e), 43.56 (e), 36.32 (e), 25.94 (o), 21.62 (o), 21.65 (o), 
18.35(e), -5.22 (o).
IR (Neat) 2953 (w), 2928 (w), 2241 (w), 1598 (w), 1350 (m), 1161 (s), 1090 (m), 835 (s) cm"
i
HRMS (ESI, [M+Naf) calcd for C20H3o35ClNNa03SSi 450.1302, found 450.1289.
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Y“
423
7V-(4-Chlorobut-3-ynyl)-4-methyl-Ar-(2-methylallyl)benzenesulfonamide.
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 74%).
Colour and State: colourless oil.
lH NMR (500 MHz, CDC13) 5 7.68 (d, 8.3 Hz, 2H), 7.30 (d, J= 8.2 Hz, 2H), 4.92 (s, 1H),
4.87 (s, 1H), 3.69 (s, 1H), 3.21 (t, J= 7.6 Hz, 2H), 2.42 (s, 3H), 2.40 (t, /= 7.6 Hz, 2H), 1.70 
(s, 3H).
13C NMR (125 MHz, CDC13) 5 143.54 (e), 140.55 (e), 136.62 (e), 129.83 (o), 127.22 (o), 
115.08 (e), 66.46 (e), 59.25 (e), 55.21 (e), 46.41 (e), 21.59 (o), 19.81 (e), 19.34 (o).
IR (Neat) 2921 (w), 2245 (w), 1655 (w), 1449 (w), 1338 (m), 1158 (s), 1103 (m), 921 (m) 
cm-1.
HRMS (ESI, [M+Na]+) calcd for 334.0644 Ci5H1835ClNNa02S, found 334.0644.
TsN
Cl
424
iV-(4-Chlorobut-3-ynyl)-iV-(cycIopentenylmethyl)-4-methylbenzenesulfonamide.
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 69%).
Colour and State: pale yellow oil.
^ NMR (500 MHz, CDC13) 5 7.77 (d, J= 8.3 Hz, 2H), 2.28 (d, J= 8.2 Hz, 2H), 5.84 (ddd, J 
= 17.2, 10.7, 6.1 Hz, 2H), 5.24 (d, 10.4 Hz, 2H), 5.19 (d, ./= 17.3 Hz, 2H), 5.03-4.96 (m,
1H), 4.04 (s, 2H), 2.42 (s, 3H).
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13C NMR (125 MHz, CDC13) 5 143.57 (e), 137.64 (e), 134.45 (o), 129.46 (o), 127.89 (o), 
119.14 (e), 65.36 (e), 62.79 (e), 62.01 (o), 34.01 (e), 21.69 (o).
IR (Neat) 2980 (w), 2242 (w), 1597 (w), 1421 (m), 1327 (s), 1152 (s), 1091 (m), 935 (m) cm”
HRMS (ESI, [M+Na]+) calcd for C17H2035ClNNaO2S 360.0801, found 360.0804.
Cl
426
Ar-(3-Chloroprop~2-ynyl)-4-methyWV-(2-vinylbut-3-enyl)benzenesuIfonamide.
Synthesised by the general procedure for the preparation of nitrogen-tethered l-chloro-1,6- 
enynes (yield = 29%).
Colour and State: off-white solid; mp = 55-57 °C.
^ NMR (500 MHz, CDC13) 5 7.68 (d,J= 8.3 Hz, 2H), 7.29 (d, 8.0 Hz, 2H), 5.56 (s, 1H),
3.85 (s, 2H), 3.23 (t, J= 7.6 Hz, 2H), 2.42 (s, 3H), 2.43-2.38 (m, 2H), 2.33-2.12 (m, 4H), 1.84 
(quint, J= 7.6 Hz, 2H).
13C NMR (125 MHz, CDC13) 8 143.44 (e), 139.41 (e), 136.85 (e), 130.16 (o), 129.75 (o), 
127.27 (o), 66.56 (e), 59.23 (e), 49.06 (e), 46.26 (e), 33.19 (e), 32.51 (e), 23.20 (e), 21.62 (o), 
19.55 (e).
IR (Neat) 2925 (w), 2242 (w), 2241 (w), 1598 (w), 1445 (m), 1337 (m), 1156 (s), 1096 (m) 
cm-1.
HRMS (ESI, [M+Na]^ calcd for Ci5H1635ClNNa02S 332.0491, found 332.0492.
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H
(S)-310
General Procedure for the Synthesis of (S)-310 by Rh-catalysed Enantioselective Pauson- 
Khand Reaction of 1,6-Enyne 301: [R1iC1(CO)2]2 (2 mg, 0.005 mmol) and the required 
bisphosphine ligand (0.012 mmol) were placed into a flame-dried 10 mL round-bottom flask 
equipped with a 10 mm stirrer bar under inert atmosphere (glove-box). The flask was 
removed from the glove box, equipped with an argon balloon and the specified solvent (1 
mL) was added to the mixture via tared syringe. The resulting solution was stirred for ca 2 
hours and subsequently transferred via cannula into a 10 mL round-bottom flask containing 
the specified silver salt (0.012 mmol). After 30 minutes, a solution of enyne 301 (0.1 mmol, 
28.4 mg) in the specified solvent (1 mL) under Ar atmosphere was added to the catalyst 
solution via cannula and the argon balloon was promptly replaced with a CO balloon (10:1 
Ar:CO, 1 atm). The reaction was stirred at RT (22 °C) for 48 hours. The reaction mixture was 
concentrated in vacuo onto silica gel. Purification via flash chromatography column (silica 
gel, eluting via a gradient 10-40% diethyl ether/hexane) provided (i5)-310 as a pale yellow oil. 
Colour and State: pale yellow oil.
HPLC analysis (25 cm x 4.6 mm Agilent Chiral AS-H), 34% isopropanol/hexane at 1.0 
mL/min, 230 nm, T = 22 °C; tR {major) 62.3 min, tR {minor) 47.2 min.
^ NMR (500 MHz, CDC13) 6 7.72 (d, J= 8.2 Hz, 2H), 7.35 (d, J= 8.1 Hz, 2H), 4.34 (d, A 
of AB, JAB = 17.2 Hz, 1H), 4.06-4.03 (m, 1H), 4.03 (d, B of AB, Jab = 17.4 Hz, 1H), 3.21- 
3.15 (m, 1H), 2.76 (dd, A of ABX, Jm = 18.2 Hz, JAX = 6.4 Hz, 1H), 2.62 (dd, B of ABX, JAB 
= 11.0 Hz, JBx = 9.6 Hz, 1H), 2.44 (s, 3H), 2.18 (dd, B of ABX, JAB - 18.2 Hz, 7BX = 2.9 Hz, 
1H).
13C NMR (125 MHz, CDC13) 5 199.09 (e), 170.70 (e), 144.53 (e), 133.26 (e), 130.25 (o), 
128.69 (e), 127.59 (o), 52.69 (e), 47.17 (e), 41.60 (o), 38.50 (e), 21.71 (o).
IR (Neat) 2923 (w), 1732 (vs), 1667 (s), 1597 (m), 1345 (vs), 1161 (vs) cm-1.
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HRMS (Cl, [M+H]4) calcd for ChHjs^CINOjS 312.0456, found 312.0461.
Cl
Me02C
Me02C
H
(S}-313
General Procedure for the Synthesis of (S)-313 by Rh-catalysed Enantioselective Pauson- 
KhandReaction of 1,6-Enyne 304\ [R1iC1(CO)2]2 (2 mg, 0.005 mmol) and (^-x^Z-P-Phos (7.8 
mg, 0.012 mmol) were placed into a flame-dried 10 mL round-bottom flask equipped with a 
10 mm stirrer bar under inert atmosphere (glove-box). The flask was removed from the glove 
box, equipped with an argon balloon and acetone (1 mL) was added to the mixture via tared 
syringe. The resulting solution was stirred for ca 2 hours and subsequently transferred via 
cannula into a 10 mL round-bottom flask containing the specified silver salt (0.012 mmol). 
After 30 minutes, a solution of enyne 304 (0.1 mmol, 24.5 mg) in acetone (1 mL) under Ar 
atmosphere was added to the catalyst solution via cannula and the argon balloon was 
promptly replaced with a CO balloon (10:1 Ar:CO, 1 atm). The reaction was stirred at RT (22 
°C) for 48 hours. The reaction mixture was concentrated in vacuo onto silica gel. Purification 
via flash chromatography column (silica gel, eluting via a gradient 10-30% diethyl 
ether/hexane) provided (S)-313 as a yellow oil.
Colour and State: yellow oil.
HPLC analysis (25 cm x 4.6 mm Agilent Chiral AS-H), 10% isopropanol/hexane at 0.8 
mL/min, 230 nm, T = 30 °C; tR {major) 14.0 min, tR {minor) 15.8 min.
^ NMR (500 MHz, CDC13) 5 3.80 (s, 3H), 3.77 (s, 3H), 3.38 (d, A of AB, Jab = 19.7 Hz,
1H), 3.31 (d, B of AB, Jab = 19.6 Hz, 1H), 3.16-3.10 (m, 1H), 2.84 (dd, A of ABX, Jab =
12.9 Hz, Jax = 7.3 Hz, 1H), 2.81 (ddd, A of ABMX, Jab - 18.2 Hz, JAm = 6.3 Hz, Jkx = 0.8 
Hz, 1H), 2.25 (dd, B of ABX, Jab - 18.2 Hz, /ax = 2.9 Hz, 1H), 1.78 {app. t, Jr= 12.8 Hz, 
1H).
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I3c NMR (125 MHz, CDC13) 5 200.78 (e), 176.93 (e), 171.68 (e), 170.86 (e), 127.81 (e), 
60.60 (e), 53.61 (o), 53.46 (o), 42.59 (o), 40.55 (e), 39.36 (e), 34.56 (e).
IR (Neat) 2956 (m), 2925 (w), 1733 (vs), 1655 (s), 1262 (s), 955 (m) cm'1.
HRMS (Cl, [M+H]4) calcd for C,2H,435C105 273.0524, found 273.0531.
General Procedure for the Rh-catalysed Enantioselective Pauson-Khand Reaction of 
Chlorinated 1,6-Enynes: [RhCl(CO)2]2 (2 mg, 0.005 mmol) and ZW-SEGPHOS (8.7 mg, 
0.012 mmol) were placed into a flame-dried 10 mL round-bottom flask equipped with a 10 
mm stirrer bar under inert atmosphere (glove-box). The flask was removed from the glove 
box, equipped with an argon balloon and acetone (2 mL) was added to the mixture via fared 
syringe. The resulting yellow clear solution was stirred for ca 2 hours and subsequently 
transferred via cannula into a 10 mL round-bottom flask containing silver triflate (3.2 mg, 
0.012 mmol). The resulting solution was stirred for an additional 30 minutes with
precipitation of silver chloride and formation of an orange solution. Then, a solution of the
required enyne (0.1 mmol) in acetone (2mL) under Ar atmosphere was added to the catalyst 
solution via cannula and the argon balloon was promptly replaced with a CO balloon (10:1 
Ar:CO, 1 atm). The reaction was stirred at RT (22 °C) until consumption of the starting 1,6- 
enyne (t.l.c. control). The reaction mixture was concentrated in vacuo onto silica gel. 
Purification via FCC (silica gel, eluting via a gradient 10-50% diethyl ether/hexane) provided 
the desired bicyclopentenone adduct.
Cl
Me
376a
(iS')-6-Chloro-3a-methyl-2-tosyl-2,3,3a,4-tetrahydrocyclopenta[c]pyrrol-5(l/Z)-one.
Synthesised by the general procedure for the Rh-catalysed enantioselective Pauson-Khand 
reaction of chlorinated 1,6-enynes (t = 3 days, yield - 91%).
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Colour and State: Pale yellow foam; Selectivity: 96% ee. [a]p - 6.5 (c = 0.5, CH2C12).
HPLC analysis (25 cm x 4.6 mm Agilent Chiral AS-H), 34% isopropanol/hexane at 1.0 
mL/min, 230 nm, T = 22 °C; 1r {major) 52.6 min, tR {minor) 25.2 min.
^ NMR (500 MHz, CDC13) 5 7.73 (d, J= 8.1 Hz, 2H), 7.36 (d, 7= 8.1 Hz, 2H), 4.34 (d, A 
of AB, ./AB = 16.8 Hz, 1H), 4.07 (d, B of AB, 7AB = 16.8 Hz, 1H), 3.72 (d, A of AB, 7AB = 9.2 
Hz, 1H), 2.81 (d, B of AB, JAB = 9.2 Hz, 1H), 2.53 (d, A of AB,7ab = 17.8 Hz, 1H), 2.44 (s, 
3H), 2.39 (d, B of AB, JAB = 17.8 Hz, 1H), 1.25 (s, 3H).
13C NMR (125 MHz, CDC13) 5 198.74 (e), 173.89 (e), 144.45 (e), 133.63 (e), 130.20 (o), 
127.68 (e), 127.53 (o), 58.28 (e), 47.15 (e), 46.92 (e), 45.97 (e), 25.25 (o), 21.71 (o).
IR (Neat) 2923 (w), 2255 (w), 1731 (m), 1667 (m), 1348 (m), 1157 (m), 1094 (m), 910 (m). 
HRMS (ESI, [M+Naf) calcd for C15Hl635ClNNa03S 348.0437, found 348.0430.
(N)-Ar-((4,6-Dichloro-7a-metliyl-2-tosyl-2,3,7,7a-tetrahydro-lEf-isoindol-5-yl)methyl)-4- 
methyl-A-(2-methylallyl)benzeiiesulfonamide 376b (Table 2.9, entry 3).
[RhCl(CO)2]2 (2 mg, 0.005 mmol) and (iS)-.ry/-BINAP (8.8 mg, 0.012 mmol) were placed into 
a flame-dried 10 mL round-bottom flask equipped with a 10 mm stirrer bar under inert 
atmosphere (glove-box). The flask was removed from the glove box, equipped with an argon 
balloon and acetone (1 mL) was added to the mixture via tared syringe. The resulting solution 
was stirred for ca 2 hours and subsequently transferred via cannula into a 10 mL round- 
bottom flask containing silver triflate (3.1 mg, 0.012 mmol). After 30 minutes, a solution of 
enyne 373 (0.1 mmol, 29.8 mg) in acetone (0.5 mL) under Ar atmosphere was added to the 
catalyst solution via cannula and the argon balloon was promptly replaced with a CO balloon 
(10:1 Ar:CO, 1 atm). The reaction was stirred at RT (22 °C) for 48 hours. The reaction
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mixture was concentrated in vacuo onto silica gel. Purification via flash chromatography 
column (silica gel, eluting via a gradient 10-30% diethyl ether/hexane) provided a mixture of 
376b and 376b’ (376b:376b’ = 9:1) as a yellow oil.
Colour and State: yellow oil. Selectivity 376b: 94% ee. [a]p0 + 60.1 (c = 0.5, CH2C12).
PIPLC analysis (25 cm x 4.6 mm Agilent Chiral AS-H), 34% isopropanol/hexane at 1.0 
mL/min, 230 nm, T = 22 °C; tR = 50.5 min (major), tR (minor) = 36.3 min.
‘H NMR (500 MHz, CDC13) 5 7.73-7.65 (m, 4H), 7.36 (d, /= 7.9 Hz, 2H), 7.31 (d, /= 7.9 
Hz, 2H), 4.96 (s, 1H), 4.83 (s, 1H), 4.36 (dd, 7= 13.3, 2.3 Hz, 1H), 4.21 (d, A of AB, JAb = 
16.0 Hz, 1H), 4.07 (d, B of AB, JAB = 13.3 Hz, 1H), 3.81 (d, B of AB,/ab = 16.1 PIz, 1H), 
3.70 (d, A of AB,/ab = 16.3 Hz, 1H), 3.65 (d, A of AB,/ab = 8.7 Hz, 1H), 3.52 (d, B of AB, 
</AB = 16.3 Hz, 1H), 2.86 (d, B of AB, JAB = 8.7 Hz, 1H), 2.72 (d, A of AB, JAB = 16.4 Hz, 
1H), 2.56 (s, 3H), 2.55 (s, 3H), 2.43 (d, B of AB, JAB = 16.7 Hz, 1H), 1.76 (s, 3H), 1.29 (s, 
3H).
13C NMR (125 MHz, CDC13) 5 144.20 (e), 143.69 (e), 140.79 (e), 137.81 (e), 132.53 (e), 
130.03 (o), 129.79 (0), 127.90 (o), 127.80 (o), 125.67 (e), 121.08 (e), 112.48 (e), 61.91 (e), 
54.13 (e), 50.23 (e), 47.52 (e), 43.73 (e), 43.61 (e), 21.75 (0), 21.71 (o), 21.47 (0), 20.35 (0). 
HRMS (ESI, [M+Na]+) calcd for C28H3235ClN2Na04S 619.1078, found 619.1075.
Cl
((N)-3a-Benzyl-6-cliloro-2-tosyl-2,3,3a,4“tetrahydrocyclopenta[c]pyrrol-5(lJf0"one'
Synthesised by the general procedure for the Rh-catalysed enantioselective Pauson-Khand 
reaction of chlorinated 1,6-enynes (t = 3 days, yield = 93%).
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Colour and State: white crystalline solid; mp = 131-133 °C. Selectivity: 97% ee.
[a]2D°-46.7 (c-0.3, CH2C12).
HPLC analysis (25 cm x 4.6 mm Agilent Chiral AD-H), 15% isopropanol/hexane at 1.0 
mL/min, 230 nm, T = 25 °C; tR (major)-. 29.2 min, tR (minor) min. 46.6.
NMR (500 MHz, CDC13) 5 7.75 (d, J= 8.3 Hz, 2H), 7.37 (d, J = 8.0 Hz, 2H), 138-1.23 
(m, 3H), 7.05-7.01 (m, 2H), 4.47 (d, A of AB, JAB = 16.9 Hz, 1H), 4.08 (d, B of AB, JAB = 
16.9 Hz, 1H), 3.96 (d, A of AB, JAB = 9.4 Hz, 1H), 2.98 (d, A of AB, JAB = 13.6 Hz, 1H), 
2.76 (d, A of AB, JAB = 17.8 Hz, 1H), 2.72 (d, B of AB, JAB = 9.2 Hz, 1H), 2.70 (d, B of AB, 
JAB = 13.3 Hz, 1H), 2.45 (s, 3H), 2.14 (d, B of AB, JAB - 17.8 Hz, 1H).
I3C NMR (125 MHz, CDC13) 5 198.00 (e), 171.80 (e), 144.54 (e), 135.40 (e), 133.52 (e), 
133.49 (e), 130.26 (o), 129.15 (o), 128.82 (o), 127.63 (o), 127.59 (o), 5631 (e), 51.81 (e), 
46.37 (e), 44.30 (e), 42.48 (e), 21.74 (o).
IR (Neat) 3029 (w), 2924 (w), 1731 (m), 1667 (w), 1346 (m), 1164 (m), 1093 (m), 669 (m). 
HRMS (ESI, [M+Naf) calcd for C21H2035CINNaO3S 424.0750, found 424.0751.
Cl
OBn
389
(if)-3a-(Beiizyloxymethyl)-6-chloro-2-tosyl-2,3,3a,4-tetrahydrocyclopentalc]pyrrol“
5(lff)-one.
Synthesised by the general procedure for the Rh-catalysed enantioselective Pauson-Khand 
reaction of chlorinated 1,6-enynes (t = 3 days, yield = 91%).
Colour and State: yellow oil. Selectivity: 88% ee. [a]20 -19.1 (c = 0.4, CH2C12).
HPLC analysis (25 cm x 4.6 mm Agilent Chiral AD-H), 10% isopropanol/hexane at 1.0 
mL/min, 230 nm, T = 22 °C; tR (major): 28.3 min, tR (minor) min. 38.5.
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ln NMR (500 MHz, CDC13) 8 7.70 (d, J = 8.2 Hz, 2H), 7.38-7.25 (m, 5H), 7.23-7.15 (m, 
2H), 4.39 (d, A of AB, JAB = 12.2 Hz, 1H), 4.33 (d, B of AB, yAB - 12.2 Hz, 1H), 4.15 (d, A 
of AB, Jab = 16.7 Hz, 1H), 4.07 (d, B of AB, JAB - 16.7 Hz, 1H), 3.86 (d, A of AB, yAB = 9.8 
Hz, 1H), 3.34 (d, A of AB, JAB = 9.0 Hz, 1H), 3.11 (d, B of AB, JAB = 9.0 Hz, 1H), 2.85 (d, B 
of AB, JAB = 9.8 Hz, 1H), 2.71 (d, A of AB, JAB = 17.6 Hz, 1H), 2.43 (s, 3H), 2.23 (d, B of 
AB,Jab= 17.6 Hz, 1H).
I3C NMR (125 MHz, CDC13) 8 198.39 (e), 168.71 (e), 144.29 (e), 137.15 (e), 133.53 (e), 
130.09 (o) (e), 129.52 (e), 128.57 (o), 128.03 (o), 127.64 (o), 127.41 (o), 73.39 (e), 71.63 (e), 
54.19 (e), 51.86 (e), 46.16 (e), 43.91 (e), 21.60 (o).
IR (Neat) 3029 (w), 2924 (w), 1731 (m), 1667 (w), 1346 (m), 1164 (m), 1093 (m), 669 (m). 
HRMS (ESI, [M+Na]^ calcd for C22H2235ClNNa04S 454.0856, found 454.0837.
Ci
390
(if)-6-Chloro-2-tosyl-3a-((trimethylsilyl)methyl)-2,3,3a,4-tetrahydrocyclopenta[c]pyrrol-
5(l/Z)-one.
Synthesised by the general procedure for the Rh-catalysed enantioselective Pauson-Khand 
reaction of chlorinated 1,6-enynes (t = 3 days, yield - 86%).
Colour and State: transparent oil; Selectivity: 96% ee. [a]^° -13.0 (c = 0.5, CH2C12).
HPLC analysis (25 cm x 4.6 mm Agilent Chiral AS-H), 34% isopropanol/hexane at 1.0 
mL/min, 230 nm, T = 22 °C; tR {major) 21.0 min, tR {minor) 14.7 min.
^ NMR (500 MHz, CDC13) 8 7.73 (d, 8.3 PIz, 2H), 7.36 (d, 8.0 Hz, 2H), 4.31 (d, A
of AB,/ab = 16.6 Hz, 1H), 4.02 (d, B of AB, JAB - 16.6 Hz, 1H), 3.76 (d, A of AB,/ab = 9.1 
Hz, 1H), 2.71 (d, B of ABX, JAB = 9.1, 0.8 Hz, 1H), 2.56 (d, A of AB,/ab - 18.0 Hz, 1H),
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2.44 (s, 3H), 2.35 (d, B of AB, JAB - 18.0 Hz, 1H), 1.17 (d, A of AB, JAB = 14.8 Hz, 1H), 
0.76 (d, B of AB, JAB = 14.8 Hz, 1H), 0.01 (s, 9H).
13C NMR (125 MHz, CDC13) 5 198.89 (e), 175.37 (e), 144.45 (e), 133.61 (e), 130.21 (o), 
127.56 (e), 127.40 (o), 59.27 (e), 49.41 (e), 46.38 (e), 46.06 (e), 16.64 (e), 26.64 (o), 21.71 
(o).
IR (Neat) 2953 (w), 1731 (m), 1667 (m), 1349 (m), 1163 (m), 1093 (m), 845 (m).
HRMS (ESI, [M+Na]+) calcd for Ci8H2435ClNNa03SSi 420.0832, found 408.0833.
Cl
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0S)-6-Chloro-3a-metliyl-3a,4-dihydro-l#-cyclopenta[c]furan-5(3.ff)-one.
Synthesised by the general procedure for the Rh-catalysed enantioselective Pauson-Khand 
reaction of chlorinated 1,6-enynes (t = 2 days, yield = 82%).
Colour and State: pale yellow oil; Selectivity: 96% ee, [ct]p0 -15.0 (c = 0.5, CH2C12).
HPLC analysis (25 cm x 4.6 mm Agilent Chiral OJ-H), 15% isopropanol/hexane at 0.9 
mL/min, 230 nm, T ^ 30 °C; tR {major) 30.0 min, tR {minor) 27.1 min. 
lH NMR (500 MHz, CDC13) 8 4.71 (d, A of AB, JAB = 16.6 Hz, 1H), 4.59 (d, B of AB, yAB = 
16.6 Hz, III), 4.01 (d, A of AB, Jab - 8.2 Hz, 1H), 3.46 (d, B of AB, JAB = 8.2 Hz, 1H), 2.57 
(d, A of AB, JAB = 17.6 Hz, 1H), 2.48 (d, B of AB, JAB = 17.6 Hz, 1H), 1.36 (s, 3H).
13C NMR (125 MHz, CDC13) 8 200.15 (e), 178.86 (e), 126.22 (e), 77.16 (e), 64.23 (e), 48.53 
(e), 46.23 (e), 24.69 (o).
IR (Neat) 2928 (w), 2857 (w), 1727 (m), 1662 (m), 1449 (w), 1206 (m), 1024 (m), 890 (m). 
HRMS (Cl, [M+H]^ calcd for C8H1035ClO2 173.0364, found 173.0365.
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(jS)-3a-Benzyl-6-chloro-3a,4-dihydro-ljFr-cydopenta[c]furan-5(3//)-one.
Synthesised by the general procedure for the Rh-catalysed enantioselective Pauson-Khand 
reaction of chlorinated 1,6-enynes (t = 2 days, yield = 86%).
Colour and State: pale yellow oil; Selectivity: >99% ee. [ct]^0 - 88.0 (c = 0.5, CH2C12).
HPLC analysis (25 cm x 4.6 mm Agilent Chiral AD-H), 10% isopropanol/hexane at 0.5 
mL/min, 230 nm, T = 22 °C; tR {major) 15.7 min, tR {minor) 18.1 min.
NMR (500 MPIz, CDC13) 5 7.32-7.23 (m, 3H), 7.09-7.05 (m, 2PI), 4.78 (d, A of AB, Jab =
16.6 Hz, 1H), 4.65 (d, B of AB, JAb = 16.6 Hz, 1H), 4.24 (d, A of AB, JAB = 8.6 Hz, 1PI), 3.47 
(d, B of AB, JAB - 8.6 Hz, 1PI), 2.98 (d, A of AB, JAB = 13.6 Hz, 1H), 2.84 (d, B of AB, JAB =
13.6 Hz, 1H), 2.78 (d, A of AB, JAB - 17.6 Hz, HI), 2.26 (d, B of AB, JAB = 17.6 Hz, 1H).
13C NMR (125 MHz, CDC13) 5 199.36 (e), 176.47 (e), 136.00 (e), 130.27 (o), 128.70 (o), 
127.52 (e), 127.45 (o), 75.64 (e), 64.69 (e), 53.16 (e), 43.72 (e), 42.24 (e).
IR (Neat) 2921 (w), 2855 (w), 1729 (m), 1662 (m), 1454 (w), 1039 (m), 958 (m), 705 (m). 
HRMS (ESI, [M+Naf) calcd for Ci4HI335ClNa02 271.0502, found 271.0503.
Cl
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(50-3a-(Benzyloxymethyl)-6-chloro-3a,4-dihydro-17J-cyclopenta[c]furan-5(3Jfi?)"one-
Synthesised by the general procedure for the Rh-catalysed enantioselective Pauson-Khand 
reaction of chlorinated 1,6-enynes (t = 2 days, yield = 83%).
Colour and State: pale yellow oil; Selectivity: 92% ee. [a]™ -11.2 (c = 0.5, CH2C12).
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HPLC analysis (25 cm x 4.6 mm Agilent Chiral AD-H), 10% isopropanol/hexane at 0.7 
mL/min, 230 nm, T = 22 °C; tR {major) 12.7 min, tR {minor) 14.1 min,
‘H NMR (500 MHz, CDC13) 5 7.37-7.23 (m, 5H), 4.58 (d, A of AB, JAB = 16.6 Hz, 1H), 4.54 
(d, B of AB, JAB = 16.9 Hz, 1H), 4.53 (d, A of AB, JAB = 12.2 Hz, 1H), 4.48 (d, B of AB, JAB 
= 12.1 Hz, 1H), 4.19 (d, A of AB, JAB = 8.7 Hz, 1H), 3.58 (d, A of AB, JAB = 8.9 Hz, 1H), 
3.47 (d, B of AB, JAB = 8.7 Hz, 1H), 3.31 (d, B of AB, JAB = 8.9 Hz, 1H), 2.81 (d, A of AB, 
JAB - 17.5 Hz, 1H), 2.34 (d, B of AB, JAB - 17.5 Hz, 1H).
13C NMR (125 MHz, CDC13) 5 199.91 (e), 173.70 (e), 137.51 (e), 128.69 (o), 128.32 (e), 
128.13 (0), 127.88 (o), 73.65 (e), 73.60 (e), 71.16 (e), 64.60 (e), 53.59 (e), 43.34 (e).
IR (Neat) 2857 (w), 1730 (m), 1662 (m), 1454 (w), 1237 (w), 1095 (m), 1025 (m), 739 (m). 
HRMS (ESI, [M+Na]4) calcd for QsH^ClNaC^ 301.0607, found 301.0608.
Cl
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(i?)-6-chloro-3a-((trimethylsiIyl)methyl)-3a,4-dihydro-l#-cyclopenta[c]furan-5(3#)-one.
Synthesised by the general procedure for the Rh-catalysed enantioselective Pauson-Khand 
reaction of chlorinated 1,6-enynes (t = 2 days, yield = 81%).
Colour and State: transparent oil; Selectivity: 98% ee. [a]p0 +4.9 (c = 0.3, CH2C12).
HPLC analysis (25 cm x 4.6 mm Agilent Chiral AS-H), 10% isopropanol/hexane at 1.0 
mL/min, 230 nm, T = 22 °C; tR {major) 17.4 min, tR {minor) 19.6 min.
^ NMR (500 MHz, CDC13) 6 4.68 (d, A of AB, JAB - 16.4 Hz, 1H), 4.56 (d, B of AB, JAB = 
16.4 Hz, 1H), 4.05 (d, A of AB, JAB = 8.2 Hz, 1H), 3.38 (d, B of ABX, JAB = 8.2 Hz, JRX= 1.3 
Hz, 1H), 2.60 (d, A of AB, JAB = 17.8 Hz, 1H), 2.44 (d, B of AB, JAB - 17.8 Hz, 1H), 1.26 (d, 
A of AB, JAB = 14.9 Hz, 1H), 0.9 (d, B of ABX, JAB = 1.2 Hz, JBx = 1.2 Hz, 1H), 0.05 (s, 9H).
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13C NMR (125 MHz, CDC13) 5 200.25 (e), 180.30 (e), 126.11 (e), 76.91 (e), 64.31 (e), 50.77 
(e), 45.80 (e), 26.22 (e), 0.16 (o).
IR (Neat) 2954 (w), 1728 (s), 1661 (m), 1451 (w), 1250 (m), 955 (m), 839 (s).
HRMS (ESI, [M+Na]+) calcd for CnH^ClNaCbSi 267.0584, found 267.0577.
Cl
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(50-Dim ethyl 6-chloro-3a-methyl-5-oxo-3,3a,4,5-tetrahydropentalene-2,2(li7)-
dicarboxylate.
Synthesised by the general procedure for the Rh-catalysed enantioselective Pauson-Khand 
reaction of chlorinated 1,6-enynes (t = 3 days, yield = 74%).
Colour and State: pale yellow oil; Selectivity: 92% ee. [a]p0 - 82.82 (c = 0.5, CH2C12).
HPLC analysis (25 cm x 4.6 mm Agilent Chiral AS-H), 15% isopropanol/hexane at 0.9 
mL/min, 230 nm, T = 30 °C; t^ {major) 25.2 min, tR (minor) 15.7 min. 
lK NMR (500 MHz, CDC13) 8 3.82 (s, 3H), 3.75 (s, 3H), 3.55 (d, A of AB, JAB = 18.3 Hz, 
1H), 3.30 (d, B of AB, Ab = 18.3 Hz, 1H), 2.65 (d, A of AB, JAb = 13.7 Hz, 1H), 2.55 (d, A 
of AB, Ab = 17.7 Hz, 1H), 2.48 (d, B of AB, An = 17.7 Hz, 1H), 2.27 (d, B of AB, Ab = 
13.8 Hz, 1H), 1.18 (s, 3H).
13C NMR (125 MHz, CDC13) 5 200.49 (e), 179.79 (e), 171.91 (e), 171.48 (e), 126.87 (e), 
60.01 (e), 53.65 (o), 53.63 (o), 50.19 (e), 47.96 (e), 45.01 (e), 33.62 (e), 26.78 (o).
IR (Neat) 2956 (w), 1731 (m), 1655 (m), 1435 (w), 1261 (m), 1167 (m), 1065 (w), 955 (w). 
HRMS (ESI, [M+Na]+) calcd for C13H1535ClNa05 309.0506, found 309.0506.
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(»S)-diraethyl 3a-benzyl-6-chloro-5-oxo-3,3a,4,5-tetrahydropentalene-2,2(lH)-
dicarboxylate.
Synthesised by the general procedure for the Rh-catalysed enantioselective Pauson-Khand 
reaction of chlorinated 1,6-enynes (t = 3 days, yield = 81%).
Colour and State: pale yellow oil; Selectivity: 97% ee. [a]^0 -129.4 (c = 0.5, CH2C12)
HPLC analysis (25 cm x 4.6 mm Agilent Chiral AS-H), 10% isopropanol/hexane at 0.9 
mL/min, 230 nm, T = 22 °C; tR {major) 27.2 min, tR {minor) 31.1 min.
NMR (500 MHz, CDC13) 5 7.30-7.20 (m, 3H), 7.03-6.90 (m, 2H), 3.85 (s, 3H), 3.76 (s, 
3H), 3.61 (d, AofAB,yAB= 18. Hz, 1H), 3.37 (d, B of AB, JAB= 18.1 Hz, 1H), 2.85 (d, A of 
AB./ab = 14.1 Hz, 1H), 2.79 (d, A of AB, JAB - 17.7 Hz, 1H), 2.78 (d, A of AB, Jab = 13.7 
Hz, 1H), 2.67 (d, B of AB, JAB - 13.7 Hz, 1H), 2.33 (d, B of AB, JAB - 14.2 Hz, 1H), 2.28 (d, 
B of AB, ,/Ab = 17.7 Hz, 1H).
13C NMR (125 MHz, CDC13) 5 199.61 (e), 177.07 (e), 171.97 (e), 171.46 (e), 135.91 (e), 
130.24 (o), 128.58 (o), 128.27 (e), 127.38 (0), 60.02 (e), 53.71 (o), 53.68 (e), 52.32 (e), 47.44 
(e), 43.89 (e), 43.47 (e), 34.01 (e).
IR (Neat) 2954 (w), 1727 (s), 1655 (m), 1435 (m), 1259 (m), 1165 (m), 957 (m), 705 (m). 
HRMS (ESI, [M+Na]+) calcdfor CigH^ClNaOs 385.0819, found 385.0813.
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(if)-dimethyl 3a-(benzyloxymethyl)-6“Chloro-5-oxo-3,3a,4,5-tetrahydropentalene-
2,2(lJHr)-dicarboxylate.
Synthesised by the general procedure for the Rh-catalysed enantioselective Pauson-Khand 
reaction of chlorinated 1,6-enynes (t = 3 days, yield = 79%).
Colour and State: bright yellow oil. Selectivity: 86% ee. [a]^0 - 67.25 (c = 0.5, CH2C12).
HPLC analysis (25 cm x 4.6 mm Agilent Chiral AS-H), 10% isopropanol/hexane at 1.0 
mL/min, 230 nm, T = 22 °C; tR {major) 25.6 min, tR {minor) 42.7 min.
‘H NMR (500 MHz, CDC13) 5 7.37-7.20 (m, 5H), 4.45 (d, A of AB, JAB = 12.2 Hz, 1H), 4.41 
(d, B of AB, Jab = 12.2 PIz, 1H), 3.73 (s, 3H), 3.69 (s, 3H), 3.37 (d, A of AB, JAB = 17.9 Hz, 
1H), 3.29 (d, A of AB, JAB = 9.0 Hz, 1H), 3.28 (d, B of AB, JAB = 18.0 Hz, 1H), 3.27 (d, B of 
AB, JAB - 9.1 Hz, 1H), 2.77 (d, A of AB, JAB - 14.2 Hz, 1H), 2.67 (d, A of AB, JAB = 17.4 
Hz, 1H), 2.36 (d, B of AB, JAB = 17.4 Hz, 1H), 2.27 (d, B of AB, JAB = 14.2 Hz, 1H.
13C NMR (125 MHz, CDC13) 5 200.03 (e), 175.83 (e), 171.72 (e), 171.46 (e), 137.42 (e), 
128.61 (e), 128.51 (0), 128.05 (e), 127.89 (e), 74.42 (e), 73.51 (e), 60.42 (e), 53.58 (0), 53.40 
(o), 52.36 (e), 46.83 (e), 40.98 (e), 34.65 (e).
IR (Neat) 2954 (w), 1727 (s), 1655 (m), 1454 (w), 1435 (m), 1256 (m), 1166 (m), 1091 (m), 
960 (m).
HRMS (ESI, [M+Na]+) calcd for C2oH2i35ClNa06 415.0924, found 415.0924.
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(£)-Dimethyl 3-(chIoromethylene)-5-methylenecyclohexane-l,l-dicarboxyIate.
Synthesised by the general procedure for the Rh-catalysed enantioselective Pauson-Khand 
reaction of chlorinated 1,6-enynes (t = 24 h, yield = 87%).
^ NMR (500 MHz, CDC13) 8 5.90 (s, 1H), 4.88 (s, 1H), 4.84 (d, 0.8 Hz, 1H), 3.71 (s,
6H), 3.03 (d, y = 1.0 Hz, 2H), 2.78 (s, 2H), 2.75 (s, 2H).
I3C NMR (125 MHz, CDC13) 5 170.64 (e), 140.52 (e), 135.52 (e), 113.03 (e), 112.77 (0), 
56.78 (e), 52.92 (o), 39.65 (e), 38.01 (e), 36.37 (e).
IR (Neat) 3079 (w), 2955 (w), 1733 (s), 1655 (m), 1433 (m), 1243 (m), 894 (m).
HRMS (ESI, [M+Na]+) calcd for C12H1535ClNa04 281.0557, found 281.0558.
Cl
(3aN,4iS)-6-Chloro-4-phenyl-2-tosyl-2,3,3a,4-tetrahydrocyclopenta[c]pyrroI-5(l^r)-one.
Synthesised by the general procedure for the Rh-catalysed enantioselective Pauson-Khand 
reaction of chlorinated 1,6-enynes (t = 3 days, yield = 72%).
Colour and State: pale yellow oil; Selectivity: dr = 24:1, 99% ee.
[a]^0-26.9 (c = 0.25, CH2C12).
HPLC analysis (25 cm x 4.6 mm Agilent Chiral AD-PI), 10% isopropanol/hexane at 1 
mL/min, 230 nm, T = 22 °C; tR {major) 48.8 min, tR {minor) 31.8 min.
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‘H NMR 8 (500 MHz, CDC13) 7.62 (d, 8.30 Hz, 2H), 7.38-7.20 (m, 5H), 6.84-6.78 (m,
2H), 4.36 (d, Aof AB, JAB = 17.4 Hz, lH),4.14(d, B of AB, JAB = 17.5 Hz, 1H), 4.05 (d,J = 
6.7 Hz, 1H), 3.55-3.47 (m, 2H), 2.45 (s, 3H), 2.35-2.27 (m, 1H).
lH NMR 5 (500 MHz, CD3CN) 7.63 (d, J - 8.3 Hz, 2H), 7.47-7.24 (m, 5H), 6.90-6.83 (m, 
2H), 4.41 (ddd, J = 17.5, 1.5, 0.9 Hz, 1H), 4.21 (dd, J= 17.5, 1.6 Hz, 1H), 4.1 (d, J=7.0Hz, 
1H), 3.63-3.55 (m, 1H), 3.47 (app t, J= 9.2 Hz, 1H), 2.46 (s, 3H), 2.26 (dd,7= 11.2, 9.7 Hz, 
1H).
13C NMR (125 MHz, CDC13) 8 200.25 (e), 170.98 (e), 144.42 (e), 135.20 (e), 133.48 (e), 
130.16 (o), 129.22 (o), 128.57 (e), 128.23 (o), 128.05 (o), 127.55 (o), 53.16 (o), 49.08 (e), 
47.69 (e), 46.84 (o), 21.74 (o).
IR (Neat) 3030 (w), 2924 (w), 1727 (m), 1655 (m), 1497 (w), 1343 (m), 1158 (s), 1090 (m), 
953 (m).
HRMS (ESI, [M+Na]+) calcd for C2oH1835ClNNa03S 410.0594, found 410.0594.
Cl
(3a5,4R)-6-Chloro-4-phenyl-2-t()syl-2,3,3a,4-tetrahydrocyclopenta[c]pyiTol-5(li7)-one. 
(iS',5)-409 (19.4 mg, 0.05 mmol) was placed into a flame-dried 10 mL round-bottom flask 
equipped with a 10 mm stirrer bar and silica gel (1 g) was added. The resulting solid mixture 
was stirred in a preheated bath at 45 °C for ca. 24 hrs. Then, the bath was removed and the 
solid mixture was allowed to cool at room temperature. DCM (4 mL) was added into the 
flask, the resulting suspension was stirred for ca 5 minutes. The suspension was then passed 
through a glass pipette equipped with cotton plug, and the residual silica gel was further 
washed with DCM (2x3 mL). Removal of the solvent /« vacuo afforded (<S,^i)-405 as a pale 
yellow oil (18.1 mg, 93%).
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Colour and State: pale yellow oil; Selectivity: dr = 12:1, 99% ee.
[a]”-16.2(c = 0.2, CH2C12).
HPLC analysis (25 cm x 4.6 mm Agilent Chiral AD-H), 10% isopropanol/hexane at 1 
mL/min, 230 nm, T = 22 °C; tR {major) 40.0 min, ta {minor) 71.8 min.
‘H NMR 5 (500 MHz, CDC13) 7.75 (d, J= 8.20 Hz, 2H), 7.40-7.25 (m, 5H), 7.11 (d, 7.0
Hz, 2H), 4.42 (dd, A of ABX, /AB = 17.5, J^x = 0.9 Hz, 1H), 4.16-4.11 (m, 2H), 3.40-3.32 (m, 
2H), 2.80 {app t, 7= 9.9 Hz, 1H), 2.45 (s, 3H).
^ NMR 6 (500 MHz, CD3CN) 7.78 (d, J - 8.3 Hz, 2H), 7.48-7.30 (m, 5H), 7.18-7.15 (m, 
2H), 4.43 (dd, 7= 17.5, 1.0 Hz, 1H), 4.13 (d, 7= 17.4, 1H), 4.03 (dd, 7- 9.2, 8.4 Hz, 1H), 
3.49 (d, 7= 3.7 Hz, 1H), 3.38-3.30 (m, 1H), 2.93 (dd, 7- 10.7, 9.7 Hz, 1H), 2.46 (s, 3H).
13C NMR (125 MHz, CDC13) 5 198.82 (e), 168.79 (e), 144.60 (e), 135.87 (e), 133.36 (e), 
130.28 (o), 129.21 (o), 128.18 (o), 128.08 (o), 127.68 (o), 127.55 (e), 57.05 (o), 52.51 (e), 
50.51 (o), 47.27 (e), 21.74 (o).
IR (Neat) 3030 (w), 2925 (w), 1731 (m), 1667 (m), 1597 (w), 1347 (m), 1162 (s), 1093 (m), 
953 (m).
HRMS (ESI, [M+Na]+) calcd for C2oH1835ClNNa03S 410.0594, found 410.0591.
Cl
(S,S)-427
(3N,3ai$r)-6-Cliloro-2“tosyl-3-vinyI-2,3,3a,4-tetrahydrocyclopenta[c]pyrrol-5(Lfir)-one.
[RhCl(CO)2]2 (2 mg, 0.005 mmol) and (i5)-SPIROP (6.3 mg, 0.012 mmol) were placed into a 
flame-dried 10 mL round-bottom flask equipped with a 10 mm stirrer bar under inert 
atmosphere (glove-box). The flask was removed from the glove box, equipped with an argon 
balloon and DCE (1 mL) was added to the mixture via tared syringe. The resulting solution 
was stirred for ca 2 hours and subsequently transferred via cannula into a 10 mL round-
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bottom flask containing AgOTf (3.1 mg, 0.012 mmol). After 30 minutes, a solution of enyne 
426 (0.1 mmol, 31 mg) in DCE (1 mL) under Ar atmosphere was added to the catalyst 
solution via cannula and the argon balloon was promptly replaced with a CO balloon (10:1 
Ar:CO, 1 atm). The reaction was stirred at 22 °C for 3 days. The reaction mixture was 
concentrated in vacuo onto silica gel. Purification via flash chromatography column (silica 
gel, eluting via a gradient 10-40% diethyl ether/hexane) provided (£,S>427 as a pale yellow 
oil (25 mg, 75%).
Colour and State: pale yellow oil; Selectivity: dr = 99:1, 90% ee.
[a]*0 28.6 (c = 0.25, CH2C12).
HPLC analysis (25 cm x 4.6 mm Agilent Chiral AD-H), 10% isopropanol/hexane at 1 
mL/min, 230 nm, T - 22 °C; tR {major) 40.0 min, tR {minor) 41.8 min.
NMR 8 (500 MHz, CDC13) 7.75 (d, J = 8.3 Hz, 2H), 7.33 (d, J - 8.1 Hz, 2H), 5.35-5.22 
(m, 3H), 4.76-4.70 (m, 1H), 4.37 (dd, J= 17.0. 0.6 Hz, 1H), 4.22 (d, A of AB, J =17.0 Hz, 
1H), 3.19 (dddd, J= 9.8, 6.6, 3.3, 1.8 Hz, 1H), 2.59 (ddd, J= 18.7, 6.6, 0.7 Hz, 1H), 2.43 (s, 
3H), 2.26 (dd, A of ABX, J= 18.6, 3.0 Hz, 1H).
13C NMR (125 MHz, CDC13) 8 199.57 (e), 170.02 (e), 144.26 (e), 135.72 (e), 130.83 (o), 
130.04 (o), 128.76 (e), 127.55 (o), 121.04 (e), 63.43 (o), 46.23 (e), 45.46 (o), 35.99 (e), 21.72 
(o).
IR (Neat) 2927 (w), 1732 (m), 1669 (m), 1598 (w), 1346 (m), 1159 (s), 1093 (m), 815 (m). 
HRMS (ESI, [M+Na]^ calcd for C16Hl635ClNNa03S 360.0437, found 360.0421.
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